BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Z, Li C, Kang B, Gao G, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98-W102. [PMID: 28407145 DOI: 10.1093/nar/gkx247] [Cited by in Crossref: 4189] [Cited by in F6Publishing: 4764] [Article Influence: 1047.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Sahar AM, Li C, Chaudhary A, Yousaf I, Saeedah MA, Mubarak A, Haris M, Nawaz M, Reem MA, Ramadan FA, Mostafa AAM, Feng W, Hameed Y. A detailed multi-omics analysis of GNB2 gene in human cancers. Braz J Biol 2024;84. [DOI: 10.1590/1519-6984.260169] [Reference Citation Analysis]
2 Xi R, Li D, Yang S, Zhang H, Hu L, Wang X, Wang G, Wang Y. Identification of potential prognostic biomarkers in vulval squamous cell carcinoma based on human papillomavirus infection Status-Analysis of GSE183454. J Obstet Gynaecol 2023;43:2160930. [PMID: 36689258 DOI: 10.1080/01443615.2022.2160930] [Reference Citation Analysis]
3 Qiu J, Wu X, Luo Y, Yao Y, Zhang X, Pan B, Wang X, Tang N. Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysis. Gene 2023;856:147132. [PMID: 36566982 DOI: 10.1016/j.gene.2022.147132] [Reference Citation Analysis]
4 Zhang M, Lin D, Luo C, Wei P, Cui K, Chen K, Chen Z. saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activation. Biochem Biophys Res Commun 2023;643:157-68. [PMID: 36610381 DOI: 10.1016/j.bbrc.2022.12.075] [Reference Citation Analysis]
5 Gómez-Gómez Y, Organista-Nava J, Clemente-Periván SI, Lagunas-Martínez A, Salmerón-Bárcenas EG, Villanueva-Morales D, Ayala-Reyna DY, Del Carmen Alarcón-Romero L, Ortiz-Ortiz J, Jiménez-López MA, Bello-Rios C, Leyva-Vázquez MA, Illades-Aguiar B. The expression of Oct3/4A mRNA and not its isoforms is upregulated by the HPV16 E7 oncoprotein. Mol Biol Rep 2023;50:981-91. [PMID: 36378419 DOI: 10.1007/s11033-022-07988-9] [Reference Citation Analysis]
6 Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, Chan WN, Chan AK, Cheung AH, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, Xiao J, Wong CC, Wu WK, Cheng AS, Ma BB, Yu J, Lo KW, Kang W; Ka Fai To. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways. J Pathol 2023;259:205-19. [PMID: 36373776 DOI: 10.1002/path.6033] [Reference Citation Analysis]
7 Wang T, Liu M, Jia M. Integrated Bioinformatic Analysis of the Correlation of HOXA10 Expression with Survival and Immune Cell Infiltration in Lower Grade Glioma. Biochem Genet 2023;61:238-57. [PMID: 35836029 DOI: 10.1007/s10528-022-10258-9] [Reference Citation Analysis]
8 Doğan B, Ayar B, Pirim D. Investigation of putative roles of smoking-associated salivary microbiome alterations on carcinogenesis by integrative in silico analysis. Comput Biol Chem 2023;102:107805. [PMID: 36587566 DOI: 10.1016/j.compbiolchem.2022.107805] [Reference Citation Analysis]
9 Qiu J, Qu X, Wang Y, Guo C, Lv B, Jiang Q, Su W, Wang L, Hua K. Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma. Adv Sci (Weinh) 2023;:e2204951. [PMID: 36725337 DOI: 10.1002/advs.202204951] [Reference Citation Analysis]
10 Yu Q, Wang Y, Yi G, Yang W, Chen K, Tan X, Zhang X, Xu Z, Yang Z, Peng Y. BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis. Immunology 2023;168:320-30. [PMID: 36151890 DOI: 10.1111/imm.13581] [Reference Citation Analysis]
11 Ortiz C, Klein S, Reul WH, Magdaleno F, Gröschl S, Dietrich P, Schierwagen R, Uschner FE, Torres S, Hieber C, Meier C, Kraus N, Tyc O, Brol M, Zeuzem S, Welsch C, Poglitsch M, Hellerbrand C, Alfonso-Prieto M, Mira F, Keller UAD, Tetzner A, Moore A, Walther T, Trebicka J. Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1. Cell Rep 2023;42:112059. [PMID: 36729833 DOI: 10.1016/j.celrep.2023.112059] [Reference Citation Analysis]
12 Jiang G, Chen J, Li Y, Zhou J, Wang W, Wu G, Zhang Y. Association of SMC4 with prognosis and immune infiltration of sarcoma. Aging (Albany NY) 2023;15. [PMID: 36719264 DOI: 10.18632/aging.204503] [Reference Citation Analysis]
13 Qin Z, Bai J, He H, Li B. Expression and significance of m6A-RNA-methylation in oral cancer and precancerous lesion. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1013054] [Reference Citation Analysis]
14 Wang Z, Coban B, Liao C, Chen Y, Liu Q, Danen EHJ. GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer. IJMS 2023;24:2512. [DOI: 10.3390/ijms24032512] [Reference Citation Analysis]
15 Kong F, Ye Q, Xiong Y. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer. Funct Integr Genomics 2023;23:48. [PMID: 36700974 DOI: 10.1007/s10142-023-00977-6] [Reference Citation Analysis]
16 Coppieters N, Scalisi J, Digregorio M, Leparc L, Velazquez Saez L, Lombard A, Rogister B, Neirinckx V. Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. J Neurooncol 2023. [PMID: 36695974 DOI: 10.1007/s11060-023-04240-7] [Reference Citation Analysis]
17 Gong B, Liang Y, Zhang Q, Li H, Xiao J, Wang L, Chen H, Yang W, Wang X, Wang Y, He Z. Epigenetic and transcriptional activation of the secretory kinase FAM20C as an oncogene in glioma. J Genet Genomics 2023:S1673-8527(23)00023-1. [PMID: 36708808 DOI: 10.1016/j.jgg.2023.01.008] [Reference Citation Analysis]
18 Li Y, Chen M, Chen Q, Yuan M, Zeng X, Zeng Y, He M, Wang B, Han B. Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer. Adv Ther 2023. [PMID: 36694099 DOI: 10.1007/s12325-023-02428-x] [Reference Citation Analysis]
19 Song Y, Zou Y, Zhao Z, Wang J, Ma L, Liu Y, Sun L. Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway.. [DOI: 10.21203/rs.3.rs-2465768/v1] [Reference Citation Analysis]
20 Zhang Y, Zhang J, Zhang W, Wang M, Wang S, Xu Y, Zhao L, Li X, Li G. Mapping Multiple Factors-mediated Chromatin Interactions to Assess Dysregulation of Lung Cancer-related Genes. Genomics Proteomics Bioinformatics 2023:S1672-0229(23)00004-9. [PMID: 36702236 DOI: 10.1016/j.gpb.2023.01.004] [Reference Citation Analysis]
21 Hu FJ, Li YJ, Zhang L, Ji DB, Liu XZ, Chen YJ, Wang L, Wu AW. Single-cell profiling reveals differences between human classical adenocarcinoma and mucinous adenocarcinoma. Commun Biol 2023;6:85. [PMID: 36690709 DOI: 10.1038/s42003-023-04441-w] [Reference Citation Analysis]
22 Nayak R, Chattopadhyay T, Gupta P, Mallick B. Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma. Mol Omics 2023. [PMID: 36688618 DOI: 10.1039/d2mo00245k] [Reference Citation Analysis]
23 Lv C, Yang D, Zhang D, Shen J, Wang Z, He S, Meng L, Song J, Zhao J. The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy. J Immunol Res 2023;2023:2623317. [PMID: 36726491 DOI: 10.1155/2023/2623317] [Reference Citation Analysis]
24 Bellah SF, Salam MA, Billah SMS, Karim MR. Genetic Association in CYP3A4 and CYP3A5 genes elevate the risk of Prostate Cancer. Ann Hum Biol 2023;:1-19. [PMID: 36688864 DOI: 10.1080/03014460.2023.2171122] [Reference Citation Analysis]
25 Nassar AH, Abou Alaiwi S, Baca SC, Adib E, Corona RI, Seo JH, Fonseca MAS, Spisak S, El Zarif T, Tisza V, Braun DA, Du H, He M, Flaifel A, Alchoueiry M, Denize T, Matar SG, Acosta A, Shukla S, Hou Y, Steinharter J, Bouchard G, Berchuck JE, O'Connor E, Bell C, Nuzzo PV, Mary Lee GS, Signoretti S, Hirsch MS, Pomerantz M, Henske E, Gusev A, Lawrenson K, Choueiri TK, Kwiatkowski DJ, Freedman ML. Epigenomic charting and functional annotation of risk loci in renal cell carcinoma. Nat Commun 2023;14:346. [PMID: 36681680 DOI: 10.1038/s41467-023-35833-5] [Reference Citation Analysis]
26 Alasiri G. Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development. IJMS 2023;24:2049. [DOI: 10.3390/ijms24032049] [Reference Citation Analysis]
27 Xu Y, Ke S, Lu S, Wang C, Li Z, Feng Z, Yu H, Bai M, Qian B, Yin B, Li X, Hua Y, Jiang H, Ma Y. HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway. Oncogenesis 2023;12:2. [PMID: 36670110 DOI: 10.1038/s41389-023-00447-5] [Reference Citation Analysis]
28 Guertin DA, Wellen KE. Acetyl-CoA metabolism in cancer. Nat Rev Cancer 2023. [PMID: 36658431 DOI: 10.1038/s41568-022-00543-5] [Reference Citation Analysis]
29 Peng Y, Yin D, Li X, Wang K, Li W, Huang Y, Liu X, Ren Z, Yang X, Zhang Z, Zhang S, Fan T. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis. J Cancer Res Clin Oncol 2023. [PMID: 36656379 DOI: 10.1007/s00432-023-04572-x] [Reference Citation Analysis]
30 Chen P, Wong C, Wong C, Chu P. Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer. IJMS 2023;24:2016. [DOI: 10.3390/ijms24032016] [Reference Citation Analysis]
31 Li Z, Wu Y, Zhang C, Dai S, Wei S, Zhao R, Gao F, Zhao L, Shan B. LncRNA SNHG5 Suppresses Cell Migration and Invasion of Human Lung Adenocarcinoma via Regulation of Epithelial-Mesenchymal Transition. J Oncol 2023;2023:3335959. [PMID: 36711024 DOI: 10.1155/2023/3335959] [Reference Citation Analysis]
32 Lu W, Xie B, Tan G, Dai W, Ren J, Pervaz S, Li K, Li F, Wang Y, Wang M. Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer. Front Endocrinol 2023;14. [DOI: 10.3389/fendo.2023.1088944] [Reference Citation Analysis]
33 Rafia C, Loizeau C, Renoult O, Harly C, Pecqueur C, Joalland N, Scotet E. The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1066336] [Reference Citation Analysis]
34 Feng Y, Han X, Zhang Z, Qiao H, Tang H. ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. Front Genet 2023;13. [DOI: 10.3389/fgene.2022.1085785] [Reference Citation Analysis]
35 Deng H, Li T, Wei F, Han W, Xu X, Zhang Y. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer. Pathol Oncol Res 2023;29. [DOI: 10.3389/pore.2023.1610893] [Reference Citation Analysis]
36 Peng Y, Tang R, Ding L, Zheng R, Liu Y, Yin L, Fu Y, Deng T, Li X. Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation. Eur J Pharmacol 2023;942:175522. [PMID: 36681316 DOI: 10.1016/j.ejphar.2023.175522] [Reference Citation Analysis]
37 Gu Z, Feng J, Hai B, Lou Y, Duan M, Guo P, Lv P, Zhu B, chen Y. RNF115 deficiency upregulates autophagy and inhibits hepatocellular carcinoma growth.. [DOI: 10.21203/rs.3.rs-2405532/v1] [Reference Citation Analysis]
38 Lehman N, Kowalska W, Zarobkiewicz M, Mazurek M, Mrozowska K, Bojarska-junak A, Rola R. Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients. IJMS 2023;24:1879. [DOI: 10.3390/ijms24031879] [Reference Citation Analysis]
39 Zhang W, Li L, Bian PP, Luo QP, Xiong ZT. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. Biomed Res Int 2023;2023:4504474. [PMID: 36714030 DOI: 10.1155/2023/4504474] [Reference Citation Analysis]
40 Chen WJ, Dong KQ, Pan XW, Gan SS, Xu D, Chen JX, Chen WJ, Li WY, Wang YQ, Zhou W, Rini B, Cui XG. Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma. Cell Death Dis 2023;14:30. [PMID: 36646679 DOI: 10.1038/s41419-023-05566-w] [Reference Citation Analysis]
41 Eid RA, Eldeen MA, Soltan MA, Al-Shraim M, Aldehri M, Alqahtani LS, Alsharif G, Albogami S, Jafri I, Fayad E, Park MN, Bibi S, Behairy MY, Kim B, Zaki MSA. Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors. Front Genet 2022;13:1008502. [PMID: 36726716 DOI: 10.3389/fgene.2022.1008502] [Reference Citation Analysis]
42 Wang T, Zhang Y, Cheng H, Li L, Xu L. TGFβ1/integrin β3 positive feedback loop contributes to acquired EGFR TKI resistance in EGFR-mutant lung cancer. J Drug Target 2023;:1-9. [PMID: 36217893 DOI: 10.1080/1061186X.2022.2064480] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Luo L, Wang Z, Hu T, Feng Z, Zeng Q, Shu X, Wu A, Huang P, Cao Y, Tu Y, Li Z. Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer. Biosci Rep 2023;43. [PMID: 36545914 DOI: 10.1042/BSR20222230] [Reference Citation Analysis]
44 Zhu HP, Chai J, Qin R, Leng HJ, Wen X, Peng C, He G, Han B. Discovery of tetrahydrofuranyl spirooxindole-based SMYD3 inhibitors against gastric cancer via inducing lethal autophagy. Eur J Med Chem 2023;246:115009. [PMID: 36527933 DOI: 10.1016/j.ejmech.2022.115009] [Reference Citation Analysis]
45 Wu F, Tu C, Zhang K, Che H, Lin Q, Li Z, Zhou Q, Tang B, Yang Y, Chen M, Shao C. Knockdown of PKMYT1 is associated with autophagy inhibition and apoptosis induction and suppresses tumor progression in hepatocellular carcinoma. Biochem Biophys Res Commun 2023;640:173-82. [PMID: 36512849 DOI: 10.1016/j.bbrc.2022.11.084] [Reference Citation Analysis]
46 Li Y, Wang L, Tian J, Zu Y, Wang F, Yang Y, Ma S, Cao J, Huang Q, Ha C. The role of Connexin26 regulated by MiR-2114-3p in the pathogenesis of ovarian cancer. Biochem Biophys Res Commun 2023;640:105-16. [PMID: 36565612 DOI: 10.1016/j.bbrc.2022.11.082] [Reference Citation Analysis]
47 Yang K, Xie Y, Xue L, Li F, Luo C, Liang W, Zhang H, Li Y, Ren Y, Zhao M, Wang W, Liu J, Shen X, Zhou W, Fei J, Chen W, Gu W, Wang L, Li F, Hu J. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma. J Transl Med 2023;21:26. [PMID: 36641471 DOI: 10.1186/s12967-022-03863-0] [Reference Citation Analysis]
48 Zheng W, Jin F, Wang F, Wang L, Fu S, Pan Z, Long H. Analysis of eEF1A2 gene expression and copy number in cervical carcinoma. Medicine (Baltimore) 2023;102:e32559. [PMID: 36637958 DOI: 10.1097/MD.0000000000032559] [Reference Citation Analysis]
49 Li Y, Zhang Y, Wu Z, Sun P. Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma. BMC Neurol 2023;23:17. [PMID: 36639743 DOI: 10.1186/s12883-023-03058-0] [Reference Citation Analysis]
50 Liu H, Wang J, Luo T, Zhen Z, Liu L, Zheng Y, Zhang C, Hu X. Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG). Front Endocrinol (Lausanne) 2022;13:1106120. [PMID: 36714574 DOI: 10.3389/fendo.2022.1106120] [Reference Citation Analysis]
51 Xue VW, Ng SSM, Tsang HF, Wong HT, Leung WW, Wong YN, Wong YKE, Yu ACS, Yim AKY, Cho WCS, Tai WCS, Wong SCC. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel. Clin Exp Med 2023. [PMID: 36637582 DOI: 10.1007/s10238-022-00970-6] [Reference Citation Analysis]
52 Chen E, He Y, Jiang J, Yi J, Zou Z, Song Q, Ren Q, Lin Z, Lu Y, Liu J, Zhang J. CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway. Exp Hematol Oncol 2023;12:9. [PMID: 36639822 DOI: 10.1186/s40164-022-00366-y] [Reference Citation Analysis]
53 Kocatürk B. In silico analysis reveals PRDX4 as a prognostic and oncogenic marker in renal papillary cell carcinoma. Gene 2023;859:147201. [PMID: 36646187 DOI: 10.1016/j.gene.2023.147201] [Reference Citation Analysis]
54 Liu S, Miao M, Kang L. Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review. Medicine (Baltimore) 2023;102:e32625. [PMID: 36637946 DOI: 10.1097/MD.0000000000032625] [Reference Citation Analysis]
55 Ye Y, Zhong W, Qian J, Zhang J, Xu T, Han R, Han J, Wang C, Song L, Zeng X, Wang H. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme. Front Cell Dev Biol 2023;11:1042490. [PMID: 36711038 DOI: 10.3389/fcell.2023.1042490] [Reference Citation Analysis]
56 Yang J, Hasenbilige, Bao S, Luo S, Jiang L, Li Q, Kong Y, Cao J. Inhibition of ATF4-mediated elevation of both autophagy and AKT/mTOR was involved in antitumorigenic activity of curcumin. Food Chem Toxicol 2023;173:113609. [PMID: 36640941 DOI: 10.1016/j.fct.2023.113609] [Reference Citation Analysis]
57 Liao M, Wang Z, Yao J, Xing H, Hao Y, Qiu B. Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis. Mol Cell Biochem 2023. [PMID: 36635603 DOI: 10.1007/s11010-022-04606-x] [Reference Citation Analysis]
58 Basu B, Karmakar S, Basu M, Ghosh MK. A novel role of USP7 in imparting partial EMT state in colorectal cancer through the DDX3X-β-catenin axis.. [DOI: 10.1101/2023.01.11.523622] [Reference Citation Analysis]
59 Honar YS, Javaher S, Soleimani M, Zarebkohan A, Farhadihosseinabadi B, Tohidfar M, Abdollahpour-alitappeh M. Advanced Stage, High-Grade Primary Tumor Ovarian Cancer: A Multi-Omics Dissection and Biomarker Prediction Process.. [DOI: 10.21203/rs.3.rs-2296880/v2] [Reference Citation Analysis]
60 Sukphokkit S, Kiatwuthinon P, Kumkate S, Janvilisri T. Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localization. Front Oncol 2022;12:999158. [PMID: 36713574 DOI: 10.3389/fonc.2022.999158] [Reference Citation Analysis]
61 Wang Y, Wang K, Zhang H, Jia X, Li X, Sun S, Sun D. Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer. Front Genet 2022;13:1068462. [PMID: 36712872 DOI: 10.3389/fgene.2022.1068462] [Reference Citation Analysis]
62 Zheng GL, Zhang GJ, Zhao Y, Zheng ZC. The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer. J Oncol 2023;2023:9315027. [PMID: 36660243 DOI: 10.1155/2023/9315027] [Reference Citation Analysis]
63 Bakr MN, Takahashi H, Kikuchi Y. CHRNA1 and its correlated-myogenesis/cell cycle genes are prognosis-related markers of metastatic melanoma. Biochem Biophys Rep 2023;33:101425. [PMID: 36654921 DOI: 10.1016/j.bbrep.2023.101425] [Reference Citation Analysis]
64 Wang Z, Wu S, Wang G, Yang Z, Zhang Y, Zhu C, Qin X. ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation. Medicina (Kaunas) 2023;59. [PMID: 36676763 DOI: 10.3390/medicina59010139] [Reference Citation Analysis]
65 Taylor KM. The LIV-1 Subfamily of Zinc Transporters: From Origins to Present Day Discoveries. Int J Mol Sci 2023;24. [PMID: 36674777 DOI: 10.3390/ijms24021255] [Reference Citation Analysis]
66 Liu Y, Zhang J, Du Z, Huang J, Cheng Y, Yi W, Li T, Yang J, Chen C. Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia. Front Genet 2022;13:1087938. [PMID: 36699453 DOI: 10.3389/fgene.2022.1087938] [Reference Citation Analysis]
67 Ma J, Wang F, Chen C, Ji J, Huang P, Wei D, Zhang Y, Ren L. Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer. Breast Cancer 2023. [PMID: 36622564 DOI: 10.1007/s12282-023-01433-w] [Reference Citation Analysis]
68 Cui Z, Wang J, Chen G, Li D, Cheng B, Lai Y, Wu Z. The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression. Front Oncol 2022;12:1081510. [PMID: 36698420 DOI: 10.3389/fonc.2022.1081510] [Reference Citation Analysis]
69 Zhao H, Wei S, Zhou D, Liu Y, Guo Z, Fang C, Pang X, Li F, Hou H, Cui X. Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodeling the tumor microenvironment via the NF-κB/IL-1𝛽/CXCL1 signaling pathway.. [DOI: 10.21203/rs.3.rs-2391325/v1] [Reference Citation Analysis]
70 Jia H, Tang WJ, Sun L, Wan C, Zhou Y, Shen WZ. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma. Front Genet 2022;13:1017866. [PMID: 36699466 DOI: 10.3389/fgene.2022.1017866] [Reference Citation Analysis]
71 Wu W, Wang X, Le W, Lu C, Li H, Zhu Y, Chen X, An W, Xu C, Wu Q, Wang L. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer. Front Immunol 2022;13:1001297. [PMID: 36700224 DOI: 10.3389/fimmu.2022.1001297] [Reference Citation Analysis]
72 Pei T, Dai Y, Tan X, Geng A, Li S, Gui Y, Hu C, An J, Yu X, Bao X, Wang D. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS(2) technology. J Ethnopharmacol 2023;306:116134. [PMID: 36627003 DOI: 10.1016/j.jep.2023.116134] [Reference Citation Analysis]
73 Wu Y, Clark KC, Niranjan B, Chüeh AC, Horvath LG, Taylor RA, Daly RJ. Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts. Mol Oncol 2023. [PMID: 36608258 DOI: 10.1002/1878-0261.13376] [Reference Citation Analysis]
74 Liu Y, Ouyang L, Mao C, Chen Y, Liu N, Chen L, Shi Y, Xiao D, Liu S, Tao Y. Inhibition of RNF182 mediated by Bap promotes non-small cell lung cancer progression. Front Oncol 2022;12:1009508. [PMID: 36686776 DOI: 10.3389/fonc.2022.1009508] [Reference Citation Analysis]
75 Zheng Y, Lang Y, Qi B, Wang Y, Gao W, Li T. TSPAN4 is a prognostic and immune target in Glioblastoma multiforme. Front Mol Biosci 2022;9:1030057. [PMID: 36685274 DOI: 10.3389/fmolb.2022.1030057] [Reference Citation Analysis]
76 Wang J, Chen H, Deng Q, Chen Y, Wang Z, Yan Z, Wang Y, Tang H, Liang H, Jiang Y. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration. Front Genet 2022;13:1022626. [PMID: 36685833 DOI: 10.3389/fgene.2022.1022626] [Reference Citation Analysis]
77 Yang WS, Caliva MJ, Khadka VS, Tiirikainen M, Matter ML, Deng Y, Ramos JW. RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer. Front Cell Dev Biol 2022;10:1015665. [PMID: 36684450 DOI: 10.3389/fcell.2022.1015665] [Reference Citation Analysis]
78 Hu W, Li M, Wang Y, Zhong C, Si X, Shi X, Wang Z. Comprehensive bioinformatics analysis reveals the significance of forkhead box family members in pancreatic adenocarcinoma. Aging (Albany NY) 2023;15:92-107. [PMID: 36622275 DOI: 10.18632/aging.204455] [Reference Citation Analysis]
79 Wang X, Li X, Liu D, Tang Z. Correlation between prognostic indicator FGFR1 and immune infiltrates in non‑small cell lung cancer.. [DOI: 10.21203/rs.3.rs-2421144/v1] [Reference Citation Analysis]
80 Guo R, Gong X, Li K, Qiu Z, Yang L, Wan Y, Yao X, Long C, Xu J, Li K, Liu J, Liu J. Xanthine oxidase, a therapeutic target of realgar for non-small cell lung cancer. Heliyon 2023;9:e12666. [PMID: 36685422 DOI: 10.1016/j.heliyon.2022.e12666] [Reference Citation Analysis]
81 Yu L, Liang X, Wang J, Ding G, Tang J, Xue J, He X, Ge J, Jin X, Yang Z, Li X, Yao H, Yin H, Liu W, Yin S, Sun B, Sheng J. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis. Genet Res (Camb) 2023;2023:6782732. [PMID: 36688087 DOI: 10.1155/2023/6782732] [Reference Citation Analysis]
82 Guo P, Hou W, He B, Sun B, Nie Z, Peng H, Lin K, Gao T, Xie H. Identification of autophagy-related genes for regulating cancer stem cell characteristics in colon adenocarcinoma by the analysis of transcriptome data stemness indices.. [DOI: 10.21203/rs.3.rs-2401860/v1] [Reference Citation Analysis]
83 Ejtehadifar M, Zahedi S, Gameiro P, Cabeçadas J, da Silva MG, Beck HC, Carvalho AS, Matthiesen R. Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. Cells 2023;12. [PMID: 36611989 DOI: 10.3390/cells12010196] [Reference Citation Analysis]
84 Khan SU, Jannat S, Shaukat H, Unab S, Tanzeela, Akram M, Khan Khattak MN, Soto MV, Khan MF, Ali A, Rizvi SSR. Stress Induced Cortisol Release Depresses The Secretion of Testosterone in Patients With Type 2 Diabetes Mellitus. Clin Med Insights Endocrinol Diabetes 2023;16:11795514221145841. [PMID: 36636127 DOI: 10.1177/11795514221145841] [Reference Citation Analysis]
85 Sun P, Zhang H, Shi J, Xu M, Cheng T, Lu B, Yang L, Zhang X, Huang J. KRTCAP2 as an immunological and prognostic biomarker of hepatocellular carcinoma. Colloids Surf B Biointerfaces 2023;222:113124. [PMID: 36634487 DOI: 10.1016/j.colsurfb.2023.113124] [Reference Citation Analysis]
86 Hu R, Li Y, Guo Y, Li X, Du S, Liao M, Hou H, Sun H, Zhao S, Su J, Chen X, Yin M. BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway. Pharmacol Res 2023;187:106609. [PMID: 36516883 DOI: 10.1016/j.phrs.2022.106609] [Reference Citation Analysis]
87 Sun X, Li Y, Lan H, Jiang T, Wan X, Cheng Y. Identification of KCNK1 as a potential prognostic biomarker and therapeutic target of breast cancer. Pathol Res Pract 2023;241:154286. [PMID: 36566598 DOI: 10.1016/j.prp.2022.154286] [Reference Citation Analysis]
88 Li Y, Zhang L, Zhao Y, Peng H, Zhang N, Bai W. MEG3 sponges miRNA-376a and YBX1 to regulate angiogenesis in ovarian cancer endothelial cells. Heliyon 2023. [DOI: 10.1016/j.heliyon.2023.e13204] [Reference Citation Analysis]
89 Wang G, Ouyang B, Jing F, Dai X. GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways. Korean J Physiol Pharmacol 2023;27:21-9. [PMID: 36575930 DOI: 10.4196/kjpp.2023.27.1.21] [Reference Citation Analysis]
90 Dumétier B, Zadoroznyj A, Berthelet J, Causse S, Allègre J, Bourgeois P, Cattin F, Racoeur C, Paul C, Garrido C, Dubrez L. cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3. Oncogene 2023;42:198-208. [PMID: 36400972 DOI: 10.1038/s41388-022-02544-y] [Reference Citation Analysis]
91 Yan D, Cui D, Zhu Y, Chan CKW, Choi CHJ, Liu T, Lee NPY, Law S, Tsao SW, Ma S, Cheung ALM. M6PR- and EphB4-Rich Exosomes Secreted by Serglycin-Overexpressing Esophageal Cancer Cells Promote Cancer Progression. Int J Biol Sci 2023;19:625-40. [PMID: 36632458 DOI: 10.7150/ijbs.79875] [Reference Citation Analysis]
92 Palo A, Patel SA, Sahoo B, Chowdary TK, Dixit M. FRG1 is a direct transcriptional regulator of nonsense-mediated mRNA decay genes. Genomics 2023;115:110539. [PMID: 36521634 DOI: 10.1016/j.ygeno.2022.110539] [Reference Citation Analysis]
93 Babic T, Lygirou V, Rosic J, Miladinov M, Rom AD, Baira E, Stroggilos R, Pappa E, Zoidakis J, Krivokapic Z, Nikolic A. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue. Proteomics Clin Appl 2023;17:e2100116. [PMID: 35997210 DOI: 10.1002/prca.202100116] [Reference Citation Analysis]
94 Noei-khesht Masjedi M, Asgari Y, Sadroddiny E. Differential expression analysis in epithelial ovarian cancer using functional genomics and integrated bioinformatics approaches. Informatics in Medicine Unlocked 2023. [DOI: 10.1016/j.imu.2023.101172] [Reference Citation Analysis]
95 Li K, Huang G, Wang Z, Yang R, Zhang W, Ni B, Guan J, Yi G, Li Z, Zhu Q, Peng Q, Yang L, Qi L, Liu Y. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023;1869:166571. [DOI: 10.1016/j.bbadis.2022.166571] [Reference Citation Analysis]
96 Zhao Y, Zhang L, Hu Q, Zhu D, Xie Z. Identification and analysis of C17orf53 as a prognostic signature for hepatocellular carcinoma. Comput Biol Med 2023;152:106348. [PMID: 36470143 DOI: 10.1016/j.compbiomed.2022.106348] [Reference Citation Analysis]
97 Di Y, Jing X, Hu K, Wen X, Ye L, Zhang X, Qin J, Ye J, Lin R, Wang Z, He W. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity. Drug Resist Updat 2023;66:100909. [PMID: 36525936 DOI: 10.1016/j.drup.2022.100909] [Reference Citation Analysis]
98 Huang L, Long JP, Irajizad E, Doecke JD, Do KA, Ha MJ. A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes. Bioinformatics 2023;39. [PMID: 36648331 DOI: 10.1093/bioinformatics/btad023] [Reference Citation Analysis]
99 Zhang W, Ye J, Li X, Li Y, Feng G. Integrin α6 targeted cancer imaging and therapy. Vis Cancer Med 2023;4:4. [DOI: 10.1051/vcm/2022007] [Reference Citation Analysis]
100 Jia Q, Song J, Xu T, Liu J, Chai J, Yang Y, Li L, Li M, Yang X. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma. Pathol Res Pract 2023;241:154268. [PMID: 36495760 DOI: 10.1016/j.prp.2022.154268] [Reference Citation Analysis]
101 Liu X, Zhang Q, Mao T, Min C, Guo J, Zhang C, Tian Z, Li X. Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment. Gastroenterology & Endoscopy 2023. [DOI: 10.1016/j.gande.2022.11.006] [Reference Citation Analysis]
102 Shree B, Sengar S, Tripathi S, Sharma V. LINC01711 promotes transforming growth factor-beta (TGF-β) induced invasion in glioblastoma multiforme (GBM) by acting as a competing endogenous RNA for miR-34a and promoting ZEB1 expression. Neurosci Lett 2023;792:136937. [PMID: 36341927 DOI: 10.1016/j.neulet.2022.136937] [Reference Citation Analysis]
103 黎 金. Expression and Immune Infiltration of LIX1 in Prostate Cancer Based on Bioinformatics. ACM 2023;13:152-162. [DOI: 10.12677/acm.2023.131024] [Reference Citation Analysis]
104 Nunes-Xavier CE, Emaldi M, Guldvik IJ, Ramberg H, Taskén KA, Mælandsmo GM, Fodstad Ø, Llarena R, Pulido R, López JI. Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer. Pathol Res Pract 2023;241:154243. [PMID: 36481650 DOI: 10.1016/j.prp.2022.154243] [Reference Citation Analysis]
105 Ali W, Jacobs D, Zhen S, Diamond AM, Kajdacsy-Balla A. Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma. Arch Biochem Biophys 2023;733:109470. [PMID: 36442530 DOI: 10.1016/j.abb.2022.109470] [Reference Citation Analysis]
106 Papadakos KS, Lundgren S, Gialeli C, Micke P, Mezheyeuski A, Elebro J, Jirström K, Blom AM. Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion. OncoImmunology 2022;11:2111906. [DOI: 10.1080/2162402x.2022.2111906] [Reference Citation Analysis]
107 Bajpai S, Jin HR, Mucha B, Diehl JA. Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCFFbxl8. Cancer Biol Ther 2022;23:348-57. [PMID: 35438057 DOI: 10.1080/15384047.2022.2061279] [Reference Citation Analysis]
108 Tan X, Zhou H, Hou L, Li H, Liu J, Li Y, Xue X. Expression and prognosis of GNG5 in lower-grade glioma using public database. All Life 2022;15:1101-1116. [DOI: 10.1080/26895293.2022.2131636] [Reference Citation Analysis]
109 Lu Z, Chen C, Gao Y, Li Y, Zhao X, Zhang H, Wei Q, Zeng X, Li Y, Wan M. Screening target genes for the treatment of PCOS via analysis of single-cell sequencing data. Annals of Medicine 2022;54:2975-2989. [DOI: 10.1080/07853890.2022.2136401] [Reference Citation Analysis]
110 Gao W, Liu D, Sun H, Shao Z, Shi P, Li T, Yin S, Zhu T. SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. BMC Cancer 2022;22:1367. [PMID: 36585688 DOI: 10.1186/s12885-022-10485-8] [Reference Citation Analysis]
111 Tian H, Zhao T, Li Y, Sun N, Ma D, Shi Q, Zhang G, Chen Q, Zhang K, Chen C, Zhang Y, Qi X. Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation. Breast Cancer (Dove Med Press) 2022;14:515-35. [PMID: 36605919 DOI: 10.2147/BCTT.S381856] [Reference Citation Analysis]
112 Alshammari FO, Satari AO, Aljabali AS, Al-Mahdy YS, Alabdallat YJ, Al-Sarayra YM, Alkhojah MA, Alwardat ARM, Haddad M, Al-Sarayreh SA, Al-Saraireh YM. Glypican-3 Differentiates Intraductal Carcinoma and Paget's Disease from Other Types of Breast Cancer. Medicina (Kaunas) 2022;59. [PMID: 36676710 DOI: 10.3390/medicina59010086] [Reference Citation Analysis]
113 Guo M, Zhuang H, Huang J, Shao X, Bai N, Li M, Niu M, Wei W, Sun L, Li Y, Qiang Z. LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression. Mol Cell Biochem 2022. [PMID: 36583796 DOI: 10.1007/s11010-022-04575-1] [Reference Citation Analysis]
114 Han L, Liu Y, Wu J, Fan B, Wang L, Li G, Yao Z, Ye L, Li D, Yang Z. Uncovering the relationship between YTHDF1 related to immune cells and prognosis and diagnosis in lung adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2340615/v1] [Reference Citation Analysis]
115 Yesharim L, Talebi S, Mojbafan M, Alemrajabi M, Teimourian S. An evaluation of gastric adenocarcinoma-associated CircRNAs based on microarray meta-analysis and ceRNA networks. Transl Oncol 2023;28:101611. [PMID: 36586189 DOI: 10.1016/j.tranon.2022.101611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Zhang H, Zhou L, Li Z, Wei H, Lei P, Chen Q, Cai Q. Identification key genes influence cell cycle process in glioma by bioinformatics analysis.. [DOI: 10.21203/rs.3.rs-2366586/v1] [Reference Citation Analysis]
117 Papadakos KS, Ekström A, Slipek P, Skourti E, Reid S, Pietras K, Blom AM. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner. J Exp Clin Cancer Res 2022;41:363. [PMID: 36578014 DOI: 10.1186/s13046-022-02565-1] [Reference Citation Analysis]
118 Liman A, Zhu Q. TMEM88 is a protective gene in HCC and has the function of promotes immune escape.. [DOI: 10.21203/rs.3.rs-2380456/v1] [Reference Citation Analysis]
119 Wang Z, Cui Y, Wang F, Xu L, Yan Y, Tong X, Yan H. DNA methylation-regulated LINC02587 inhibits ferroptosis and promotes the progression of glioma cells through the CoQ-FSP1 pathway.. [DOI: 10.21203/rs.3.rs-2401259/v1] [Reference Citation Analysis]
120 Cai Q, Wu D, Shen Y, Li SL, Liu L, Liu D, Li Y, Chen X, Wang L, Zheng J. High LRRC1 expression indicates poor prognosis of hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-1849971/v2] [Reference Citation Analysis]
121 Pan Z, Zhang M, Zhang F, Pan H, Li Y, Shao Y, Yuan X, Wang J, Chen J. Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells. Int J Mol Sci 2022;24. [PMID: 36613925 DOI: 10.3390/ijms24010482] [Reference Citation Analysis]
122 Fu J, Song B, Du J, Liu S, He J, Xiao T, Zhou B, Li D, Liu X, He T, Cheng J, Fu J. Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Mol Biol Rep 2022;:1-13. [PMID: 36574092 DOI: 10.1007/s11033-022-08231-1] [Reference Citation Analysis]
123 Xiong Q, Zhang Z, Yang Y, Xu Y, Zhou Y, Zhang S, Liu J, Zheng Y, Zhu Q. Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. J Clin Med 2022;12. [PMID: 36615000 DOI: 10.3390/jcm12010200] [Reference Citation Analysis]
124 Gadwal A, Purohit P, Khokhar M, Vishnoi DJR, Pareek DP, Choudhary DR, Elhence DP, Mithu Banerjee1 DM, Sharma DP. Identification of potential key genes and their regulatory microRNAs and transcription factors in lymph node and skin metastasis in breast cancer using in silico analysis. (Preprint).. [DOI: 10.2196/preprints.45357] [Reference Citation Analysis]
125 Gloriane C Luna H, Severino Imasa M, Juat N, Hernandez KV, May Sayo T, Cristal-Luna G, Marie Asur-Galang S, Bellengan M, John Duga K, Brian Buenaobra B, De Los Santos MI, Medina D, Samo J, Minerva Literal V, Andrew Bascos N, Sy-Naval S. Expression landscapes in non-small cell lung cancer shaped by the thyroid transcription factor 1. Lung Cancer 2022;176:121-31. [PMID: 36634573 DOI: 10.1016/j.lungcan.2022.12.015] [Reference Citation Analysis]
126 Bai Y, Cao K, Zhang P, Ma J, Zhu J. Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations. Int J Mol Sci 2022;24. [PMID: 36613817 DOI: 10.3390/ijms24010375] [Reference Citation Analysis]
127 Cui Z, Du L, Wang J, Li Z, Xu J, Ou S, Li D, Li S, Hu H, Chen G, Wu Z. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. BMC Cancer 2022;22:1354. [PMID: 36572856 DOI: 10.1186/s12885-022-10450-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Priego-Hernández VD, Arizmendi-Izazaga A, Soto-Flores DG, Santiago-Ramón N, Feria-Valadez MD, Navarro-Tito N, Jiménez-Wences H, Martínez-Carrillo DN, Salmerón-Bárcenas EG, Leyva-Vázquez MA, Illades-Aguiar B, Alarcón-Romero LDC, Ortiz-Ortiz J. Expression of HIF-1α and Genes Involved in Glucose Metabolism Is Increased in Cervical Cancer and HPV-16-Positive Cell Lines. Pathogens 2022;12. [PMID: 36678382 DOI: 10.3390/pathogens12010033] [Reference Citation Analysis]
129 Xu X, Ma L, Zhang X, Guo S, Guo W, Wang Y, Qiu S, Tian X, Miao Y, Yu Y, Wang J. A positive feedback circuit between RN7SK snRNA and m(6)A readers is essential for tumorigenesis. Mol Ther 2022:S1525-0016(22)00717-1. [PMID: 36566349 DOI: 10.1016/j.ymthe.2022.12.013] [Reference Citation Analysis]
130 Cui X, Yu H, Yao J, Li J, Li Z, Jiang Z. ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration. BMC Cancer 2022;22:1350. [PMID: 36564767 DOI: 10.1186/s12885-022-10424-7] [Reference Citation Analysis]
131 Pan YQ, Xiao Y, Li Z, Tao L, Chen G, Zhu JF, Lv L, Liu JC, Qi JQ, Shao A. Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma. Front Oncol 2022;12:1071100. [PMID: 36620541 DOI: 10.3389/fonc.2022.1071100] [Reference Citation Analysis]
132 Zhang J, Xu L, Gao J, Li J, Zhao X, Yang P, Ge Y, Guo D, Liu Z, Wang X, Gu W, Wang P, Hu X, Gong Z, Zhang D. Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma. Sci Rep 2022;12:22201. [PMID: 36564433 DOI: 10.1038/s41598-022-24183-9] [Reference Citation Analysis]
133 Li C, Huang L, Wen Y, Yi M, Gao M. Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF-κB Signaling Pathway and Affecting the Apoptosis and Signal Transduction. Genet Res (Camb) 2022;2022:3222253. [PMID: 36619898 DOI: 10.1155/2022/3222253] [Reference Citation Analysis]
134 Ye S, Wang D, Jin M, Du J, Chen X, Zhang H, Zhou C, Fang S, Liu K. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma. J Clin Lab Anal 2023;37:e24820. [PMID: 36550070 DOI: 10.1002/jcla.24820] [Reference Citation Analysis]
135 Chen C, Zhang L, Ruan Z. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis. Mol Pharmaceutics 2022. [DOI: 10.1021/acs.molpharmaceut.2c00557] [Reference Citation Analysis]
136 Lopez-Charcas O, Poisson L, Benouna O, Lemoine R, Chadet S, Pétereau A, Lahlou W, Guyétant S, Ouaissi M, Pukkanasut P, Dutta S, Velu SE, Besson P, Moussata D, Roger S. Voltage-Gated Sodium Channel Na(V)1.5 Controls NHE-1-Dependent Invasive Properties in Colon Cancer Cells. Cancers (Basel) 2022;15. [PMID: 36612049 DOI: 10.3390/cancers15010046] [Reference Citation Analysis]
137 Leng R, Meng Y, Sun X, Zhao Y. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes. Front Oncol 2022;12:1057198. [PMID: 36620547 DOI: 10.3389/fonc.2022.1057198] [Reference Citation Analysis]
138 Yan T, Zhu M, Weng F, Zhu S, Wang C, Guo C. Comprehensive analysis of roles of atrial-fibrillation-related genes in lung adenocarcinoma using bioinformatic methods. Med Oncol 2022;40:55. [PMID: 36542177 DOI: 10.1007/s12032-022-01912-8] [Reference Citation Analysis]
139 Qi YH, Yang LZ, Zhou L, Gao LJ, Hou JY, Yan Z, Bi XG, Yan CP, Wang DP, Cao JM. Sympathetic nerve infiltration promotes stomach adenocarcinoma progression via norepinephrine/β2-adrenoceptor/YKL-40 signaling pathway. Heliyon 2022;8:e12468. [PMID: 36593854 DOI: 10.1016/j.heliyon.2022.e12468] [Reference Citation Analysis]
140 Jia M, Liu C, Liu Y, Bao Z, Jiang Y, Sun X. Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. J Pers Med 2022;13. [PMID: 36675674 DOI: 10.3390/jpm13010013] [Reference Citation Analysis]
141 Wu Z, Ou J, Liu N, Wang Z, Chen J, Cai Z, Liu X, Yu X, Dai M, Zhou H. Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia. Cancer Medicine 2022. [DOI: 10.1002/cam4.5549] [Reference Citation Analysis]
142 Nie X, Liu D, Zheng M, Li X, Liu O, Guo Q, Zhu L, Lin B. HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways. BMC Cancer 2022;22:1338. [PMID: 36544104 DOI: 10.1186/s12885-022-10248-5] [Reference Citation Analysis]
143 Jaschke NP, Pählig S, Sinha A, Adolph TE, Colunga ML, Hofmann M, Wang A, Thiele S, Schwärzler J, Kleymann A, Gentzel M, Tilg H, Wielockx B, Hofbauer LC, Rauner M, Göbel A, Rachner TD. Dickkopf1 fuels inflammatory cytokine responses. Commun Biol 2022;5:1391. [PMID: 36539532 DOI: 10.1038/s42003-022-04368-8] [Reference Citation Analysis]
144 Wang Y, Zhou D, Kong Y, Yang Q, Ding Y, Wang W. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. Biomed Res Int 2022;2022:6109052. [PMID: 36582601 DOI: 10.1155/2022/6109052] [Reference Citation Analysis]
145 Huang C, Zhao Z, Zhu F, Qian Y, Lin D, Zheng J, Chen H, Wang N, Li W, Kong X, Huang Q, Qin J, Du B. Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through unbiased machine learning.. [DOI: 10.1101/2022.12.20.521217] [Reference Citation Analysis]
146 Hermawan A, Putri H, Hanif N, Fatimah N, Prasetio HH. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen. Front Oncol 2022;12:1019025. [PMID: 36601474 DOI: 10.3389/fonc.2022.1019025] [Reference Citation Analysis]
147 Ju L, Shi Y, Liu G. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. PeerJ 2022;10:e14506. [PMID: 36570012 DOI: 10.7717/peerj.14506] [Reference Citation Analysis]
148 Huang X, Long X, Liu Y, Chen Z, Xiang X, Mo X, Liu J, Tang W. Monkeypox and cancer: a pan-cancer based multi-omics analysis and single cell sequencing analysis.. [DOI: 10.21203/rs.3.rs-2361702/v1] [Reference Citation Analysis]
149 Zhang M, Duan X, Wang L, Wen J, Fang P. Deregulation of HSF1-mediated endoplasmic reticulum unfolded protein response promotes cisplatin resistance in lung cancer cells. FEBS J 2022. [PMID: 36536996 DOI: 10.1111/febs.16709] [Reference Citation Analysis]
150 Zhao H, Jia P, Nanding K, Wu M, Bai X, Morigen M, Fan L. Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-A(Thr288)-geminin dual signaling pathways. Front Pharmacol 2022;13:1046269. [PMID: 36601056 DOI: 10.3389/fphar.2022.1046269] [Reference Citation Analysis]
151 Jiang F, Hedaya OM, Khor E, Wu J, Auguste M, Yao P. RNA binding protein PRRC2B mediates translation of specific proteins and regulates cell cycle progression.. [DOI: 10.1101/2022.12.16.520836] [Reference Citation Analysis]
152 Dong He, Tao Xin, Bo Pang, Jun Sun, Zi Hao Liu, Zhen Qin, Xiao Shuai Ji, Fan Yang, Yan Bang Wei, Zi Xiao Wang, Jia Jia Gao, Qi Pang, Qian Liu. A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy. J Exp Clin Cancer Res 2022;41:349. [PMID: 36527092 DOI: 10.1186/s13046-022-02543-7] [Reference Citation Analysis]
153 Hu W, Abdel-Maksoud MA, Khalid SY, Malik A, Alkholief M, Mubarak A, Aufy M. Angiotensinogen, a promising gene signature for rectum and stomach adenocarcinoma patients. Am J Transl Res 2022;14:8879-92. [PMID: 36628228] [Reference Citation Analysis]
154 Li X, Abdel-Maksoud MA, Iqbal I, Mubarak A, Farrag MA, Haris M, Alghamdi S, Ain QU, Almekhlafi S. Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach. Am J Transl Res 2022;14:8843-61. [PMID: 36628250] [Reference Citation Analysis]
155 Kohil A, Amir SS, Behrens A, Khan OM. A small Rho GTPase RAB25 with a potential role in chemotherapy resistance in pancreatic cancer. Cancer Biomark 2022. [PMID: 36565104 DOI: 10.3233/CBM-220214] [Reference Citation Analysis]
156 Park JH, Kang I, Lee HK. The immune landscape of high-grade brain tumor after treatment with immune checkpoint blockade. Front Immunol 2022;13:1044544. [PMID: 36591276 DOI: 10.3389/fimmu.2022.1044544] [Reference Citation Analysis]
157 Pang X, Wan W, Wu X, Shen Y. The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental Investigation. Int J Genomics 2022;2022:8755263. [PMID: 36600989 DOI: 10.1155/2022/8755263] [Reference Citation Analysis]
158 Hu G, Zheng Z, He Y, Wang D, Liu W. CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in Cancer. J Proteome Res 2022. [DOI: 10.1021/acs.jproteome.2c00512] [Reference Citation Analysis]
159 Wei Zhang, Chen Y, Zeng Z, Peng Y, Li L, Hu N, Gao X, Cai W, Yin L, Xu Y, Zhang X, Tang D, Dai Y. The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer. Heliyon 2022;8:e12078. [PMID: 36619469 DOI: 10.1016/j.heliyon.2022.e12078] [Reference Citation Analysis]
160 Xu L, Sun F, Zhang Y, Liu X, Liu Z, Ma Y, Wang L, Xing F. Mining of Gene Modules and Identification of Key Genes for early diagnosis of gastric cancer.. [DOI: 10.21203/rs.3.rs-2325598/v1] [Reference Citation Analysis]
161 Zhang K, Yang W, Zhang Z, Ma K, Li L, Xu Y, Qiu J, Yu C, Zhou J, Cai L, Gong Y, Gong K. A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/2124088] [Reference Citation Analysis]
162 Lv L, Huang B, Yi L, Zhang L. Long non-coding RNA SNHG4 enhances RNF14 mRNA stability to promote the progression of colorectal cancer by recruiting TAF15 protein. Apoptosis 2022. [DOI: 10.1007/s10495-022-01781-6] [Reference Citation Analysis]
163 Shen C, Chen Z, Zhang Y, Xu W, Peng R, Jiang J, Zuo W, Fan Y, Zheng B. Biochemical and clinical effects of RPS20 expression in renal clear cell carcinoma. Oncol Rep 2023;49:22. [PMID: 36484407 DOI: 10.3892/or.2022.8459] [Reference Citation Analysis]
164 Su K, Wang Y, Gu H, Ma L, Xuan G. Overexpression of fatty acid desaturase 3 predicts poor prognosis in head and neck squamous cell carcinoma. Medicine (Baltimore) 2022;101:e32119. [PMID: 36626435 DOI: 10.1097/MD.0000000000032119] [Reference Citation Analysis]
165 Yang X, Zhou Y, Ge H, Tian Z, Li P, Zhao X. Identification of a transcription factor‑cyclin family genes network in lung adenocarcinoma through bioinformatics analysis and validation through RT‑qPCR. Exp Ther Med 2023;25:63. [PMID: 36605530 DOI: 10.3892/etm.2022.11762] [Reference Citation Analysis]
166 Xu M, Huang X, Zheng C, Long J, Dai Q, Chen Y, Lu J, Pan C, Yao S, Li J. Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition. Cancers (Basel) 2022;14. [PMID: 36551554 DOI: 10.3390/cancers14246068] [Reference Citation Analysis]
167 He XJ, Li J, Tian F, Yin GC, Tian HY, Sha W, Qi LZ, Li YF, Wang XX, Pan X. Excavate the role of E2F family in the prognosis, drug sensitivity analyses, and Immune cell infiltration of KIRC (Kidney Clear Cell Carcinoma).. [DOI: 10.21203/rs.3.rs-2339943/v1] [Reference Citation Analysis]
168 Liang Y, Chen W, Tang Y, Chen M. Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer. Biochem Genet 2022. [DOI: 10.1007/s10528-022-10308-2] [Reference Citation Analysis]
169 Wang K, Li H, Zhao J, Yao J, Lu Y, Dong J, Bai J, Liao L. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients. Front Cell Dev Biol 2022;10:1001954. [PMID: 36568979 DOI: 10.3389/fcell.2022.1001954] [Reference Citation Analysis]
170 Hsieh CY, Lin CC, Huang YW, Chen JH, Tsou YA, Chang LC, Fan CC, Lin CY, Chang WC. Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling. JCI Insight 2022;7. [PMID: 36264639 DOI: 10.1172/jci.insight.157285] [Reference Citation Analysis]
171 Gu A. A pan-cancer analysis of charged ubiquitin-specific protease 14's carcinogenic effects.. [DOI: 10.21203/rs.3.rs-2346079/v1] [Reference Citation Analysis]
172 Rai S, Singh MP, Srivastava S. Integrated Analysis Identifies Novel Fusion Transcripts in Laterally Spreading Tumors Suggestive of Distinct Etiology Than Colorectal Cancers. J Gastrointest Canc 2022. [DOI: 10.1007/s12029-022-00881-5] [Reference Citation Analysis]
173 Zeng TT, Deng TH, Liu Z, Zhan JR, Ma YZ, Yan YY, Sun X, Zhu YH, Li Y, Guan XY, Li L. HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma. Cell Death Dis 2022;13:1026. [PMID: 36476988 DOI: 10.1038/s41419-022-05478-1] [Reference Citation Analysis]
174 Wang S, Wu W, Han X. Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia. Mol Biotechnol 2022. [DOI: 10.1007/s12033-022-00623-9] [Reference Citation Analysis]
175 Zhu P, Liu G, Wang X, Lu J, Zhou Y, Chen S, Gao Y, Wang C, Yu J, Sun Y, Zhou P. Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis. BMC Cancer 2022;22:1283. [PMID: 36476606 DOI: 10.1186/s12885-022-10393-x] [Reference Citation Analysis]
176 Mohammadisoleimani E, Firoozi Z, Naghizadeh MM, Asad AG, Jafari A, Pourjafarian MH, Ariafar A, Mansoori H, Dastsooz H, Sabaie H, Zeighami S, Mansoori Y. Expression analysis of hsa_circ_0020397, hsa_circ_0005986, hsa_circ_0003028, and hsa_circ_0006990 in renal cell carcinoma. Exp Mol Pathol 2022;129:104848. [PMID: 36496205 DOI: 10.1016/j.yexmp.2022.104848] [Reference Citation Analysis]
177 Xu W, Lou W, Mei L. A key regulatory loop AK4P1/miR-375/SP1 in pancreatic adenocarcinoma. Epigenetics 2022. [DOI: 10.1080/15592294.2022.2148433] [Reference Citation Analysis]
178 Wang B, Chen H, Yang R, Xing L, Chen C, Chen J. LncRNA RP11-551L14.4 suppresses breast cancer development by inhibiting the expression of miR-4472. PeerJ 2022;10:e14482. [PMID: 36523479 DOI: 10.7717/peerj.14482] [Reference Citation Analysis]
179 Yang Z, Huo Y, Zhou S, Guo J, Ma X, Li T, Fan C, Wang L. Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production. Cell Metab 2022;34:2018-2035.e8. [PMID: 36351432 DOI: 10.1016/j.cmet.2022.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Zhang Y, Lin C, Liu Z, Sun Y, Chen M, Guo Y, Liu W, Zhang C, Chen W, Sun J, Xia R, Hu Y, Yang X, Li J, Zhang Z, Cao W, Sun S, Wang X, Ji T. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metab 2022;34:1999-2017.e10. [PMID: 36395769 DOI: 10.1016/j.cmet.2022.10.012] [Reference Citation Analysis]
181 Shao X, Zhu J, Shi Y, Fang H, Chen J, Zhang Y, Wang J, Jian H, Lan S, Jiang F, Zhong F, Zhang Y, Cao C. Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Aging (Albany NY) 2022;14:9632-46. [PMID: 36470669 DOI: 10.18632/aging.204414] [Reference Citation Analysis]
182 Zhang K, Yu M, Liu H, Hui Z, Yang N, Bi X, Sun L, Lin R, Lü G. Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma. PeerJ 2022;10:e14415. [PMID: 36523478 DOI: 10.7717/peerj.14415] [Reference Citation Analysis]
183 Jiayu F, Jiang Y, Zhou X, Zhou M, Pan J, Ke Y, Zhen J, Huang D, Jiang W. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma. Aging (Albany NY) 2022;14:9550-78. [PMID: 36462500 DOI: 10.18632/aging.204312] [Reference Citation Analysis]
184 Zhou F, Chen L, Lu P, Cao Y, Deng C, Liu G. An integrative bioinformatics investigation and experimental validation of Chromobox family in Diffuse large B-cell lymphoma.. [DOI: 10.21203/rs.3.rs-2260064/v1] [Reference Citation Analysis]
185 Panatta E, Butera A, Celardo I, Leist M, Melino G, Amelio I. p53 regulates expression of nuclear envelope components in cancer cells. Biol Direct 2022;17:38. [PMID: 36461070 DOI: 10.1186/s13062-022-00349-3] [Reference Citation Analysis]
186 Wang M, Fu X, Wang W, Zhang Y, Jiang Z, Gu Y, Chu M, Shao Y, Li S. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer. Med Eng Phys 2022;110:103883. [PMID: 36075788 DOI: 10.1016/j.medengphy.2022.103883] [Reference Citation Analysis]
187 Luo J, Chen S, Chen J, Zhou Y, He F, Wang E. Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer. PLoS One 2022;17:e0278270. [PMID: 36454866 DOI: 10.1371/journal.pone.0278270] [Reference Citation Analysis]
188 Qing L, Li Q, Yang Y, Xu W, Dong Z. A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research. BMC Urol 2022;22. [DOI: 10.1186/s12894-022-01067-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Dai W, Duan Y, Yuan W, Wang S. circTUBGCP5 promotes liver cancer progression and glycolysis by up-regulating the expression of ACSL4. Appl Biol Chem 2022;65. [DOI: 10.1186/s13765-022-00723-9] [Reference Citation Analysis]
190 Song J, Zheng J, Liu X, Dong W, Yang C, Wang D, Ruan X, Zhao Y, Liu L, Wang P, Zhang M, Liu Y. A novel protein encoded by ZCRB1-induced circHEATR5B suppresses aerobic glycolysis of GBM through phosphorylation of JMJD5. J Exp Clin Cancer Res 2022;41:171. [DOI: 10.1186/s13046-022-02374-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Xie G, zhnaghan H, Zheng J, Fu Y, Ling J, Liu Z, Lin X, Dong X, Sun Y, Tan T, Guo Z. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.. [DOI: 10.21203/rs.3.rs-2292759/v1] [Reference Citation Analysis]
192 Taghehchian N, Farshchian M, Mahmoudian RA, Asoodeh A, Abbaszadegan MR. The expression of long non-coding RNA LINC01389, LINC00365, RP11-138J23.1, and RP11-354K4.2 in gastric cancer and their impacts on EMT. Mol Cell Probes 2022;66:101869. [PMID: 36208698 DOI: 10.1016/j.mcp.2022.101869] [Reference Citation Analysis]
193 Fang Y, Huang J, Wen J, Li J, Shen J, Zeng D, Pan Y, Huang H, Huang Z, Liu L, Chen G. AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer. PGPM 2022;Volume 15:999-1017. [DOI: 10.2147/pgpm.s360147] [Reference Citation Analysis]
194 Shang Q, Du H, Wu X, Guo Q, Zhang F, Gong Z, Jiao T, Guo J, Kong Y. FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma. J Exp Clin Cancer Res 2022;41:170. [DOI: 10.1186/s13046-022-02357-7] [Reference Citation Analysis]
195 Ferreira LC, Gomes CEM, Rodrigues-Neto JF, Jeronimo SMB. Genome-wide association studies of COVID-19: Connecting the dots. Infect Genet Evol 2022;106:105379. [PMID: 36280088 DOI: 10.1016/j.meegid.2022.105379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Rao MMV, Likith M, Kavya R, Hariprasad TPN. Plectin as a putative novel biomarker for breast cancer: an in silico study. Netw Model Anal Health Inform Bioinforma 2022;11:49. [DOI: 10.1007/s13721-022-00392-0] [Reference Citation Analysis]
197 Ullah MA, Araf Y, Sarkar B, Islam NN, Moin AT, Zohora US, Rahman MS. Exploring the prognostic significance of FOXM1 gene expression in human breast cancer by bioinformatics analysis. Gene Reports 2022;29:101693. [DOI: 10.1016/j.genrep.2022.101693] [Reference Citation Analysis]
198 Xu X, Chan AKN, Li M, Liu Q, Mattson N, Pangeni Pokharel S, Chang WH, Yuan YC, Wang J, Moore RE, Pirrotte P, Wu J, Su R, Müschen M, Rosen ST, Chen J, Yang L, Chen CW. ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Sci Adv 2022;8:eadc8911. [PMID: 36563143 DOI: 10.1126/sciadv.adc8911] [Reference Citation Analysis]
199 Li L, Chen L, Yu L, Zhang J, Chen L. Identification of FOXM1 and CXCR4 as key genes in breast cancer prevention and prognosis after intermittent energy restriction through bioinformatics and functional analyses. Adipocyte 2022;11:301-14. [PMID: 35481418 DOI: 10.1080/21623945.2022.2069311] [Reference Citation Analysis]
200 Yi W, Qiao T, Yang Z, Hu L, Sun M, Fan H, Xu Y, Lv Z. The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis. Materials Today Bio 2022;17:100470. [DOI: 10.1016/j.mtbio.2022.100470] [Reference Citation Analysis]
201 He Y, Li Y, Xiang J, Huang X, Zhao M, Wang Y, Chen R. TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1081519] [Reference Citation Analysis]
202 Guo L, Huai Q, Zhou B, Ying J, Guo W. Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma. Cancer Innovation 2022;1:328-343. [DOI: 10.1002/cai2.40] [Reference Citation Analysis]
203 Chellini L, Pieraccioli M, Sette C, Paronetto MP. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer. J Exp Clin Cancer Res 2022;41:178. [DOI: 10.1186/s13046-022-02384-4] [Reference Citation Analysis]
204 Zheng LL, Cai L, Zhang XQ, Lei Z, Yi CS, Liu XD, Yang JG. Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer. Curr Med Sci 2022;42:1285-96. [PMID: 36544038 DOI: 10.1007/s11596-022-2661-x] [Reference Citation Analysis]
205 Wang Z, Chen J, Sun F, Zhao X, Dong Y, Yu S, Li J, Liang H. LncRNA CRLM1 inhibits apoptosis and promotes metastasis through transcriptional regulation cooperated with hnRNPK in colorectal cancer. Cell Biosci 2022;12:120. [DOI: 10.1186/s13578-022-00849-9] [Reference Citation Analysis]
206 Zhao Y, Xu B, Wang F, Jiang F, Xu J, Yu D. nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer. Cancer Medicine 2022. [DOI: 10.1002/cam4.5260] [Reference Citation Analysis]
207 Suchanti S, Awasthi S, Singh G, Yadav PK, Singh A, Mishra R. In silico prediction of COVID-19 cytokine storm in lung cancer types. Biochemistry and Biophysics Reports 2022;32:101350. [DOI: 10.1016/j.bbrep.2022.101350] [Reference Citation Analysis]
208 Hu C, Dai Y, Zhou H, Zhang J, Xie D, Xu R, Yang M, Zhang R. Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach. Hereditas 2022;159:45. [PMID: 36451247 DOI: 10.1186/s41065-022-00258-5] [Reference Citation Analysis]
209 Wen Y, Ouyang D, Zou Q, Chen Q, Luo N, He H, Anwar M, Yi W. A literature review of the promising future of TROP2: a potential drug therapy target. Ann Transl Med 2022;10:1403. [PMID: 36660684 DOI: 10.21037/atm-22-5976] [Reference Citation Analysis]
210 Zhang J, Xu H, Cho WCS, Cheuk W, Li Y, Huang Q, Yang W, Xian Y, Lin Z. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway. J Exp Clin Cancer Res 2022;41:90. [DOI: 10.1186/s13046-022-02270-z] [Reference Citation Analysis]
211 Zhu H, Lv S, Yang B, Liu Z, Zhang D. CircGAK inhibits cell growth, migration, invasion, and angiogenesis of hepatocellular carcinoma via miR-1323/HHIP axis. Appl Biol Chem 2022;65. [DOI: 10.1186/s13765-022-00716-8] [Reference Citation Analysis]
212 Jamialahmadi O, Salehabadi E, Hashemi-Najafabadi S, Motamedian E, Bagheri F, Mancina RM, Romeo S. Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma. OMICS 2022;26:671-82. [PMID: 36508280 DOI: 10.1089/omi.2022.0122] [Reference Citation Analysis]
213 Wang Q, Liu J, Yin W, Sun D, Man Z, Jiang S, Ran X, Su Y, Wang Y, Dong J. Generation of multicellular tumor spheroids with micro-well array for anticancer drug combination screening based on a valuable biomarker of hepatocellular carcinoma. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1087656] [Reference Citation Analysis]
214 Zhang W, Tian W, Wang Y, Jin X, Guo H, Wang Y, Tang Y, Yao X. Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking. Comput Biol Med 2022;151:106293. [PMID: 36399857 DOI: 10.1016/j.compbiomed.2022.106293] [Reference Citation Analysis]
215 Ávila-López PA, Nuñez-Martínez HN, Peralta-Alvarez CA, Martinez-Calvillo S, Recillas-Targa F, Hernández-Rivas R. Interplay Between the Histone Variant H2A.Z and the Epigenome in Pancreatic Cancer. Arch Med Res 2022;53:840-58. [PMID: 36470770 DOI: 10.1016/j.arcmed.2022.11.010] [Reference Citation Analysis]
216 Mao C, Huang C, Hu Z, Qu S. Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells. MedComm 2022;3. [DOI: 10.1002/mco2.182] [Reference Citation Analysis]
217 Gresseau L, Roy ME, Duhamel S, Annabi B. A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres. Cancers (Basel) 2022;14. [PMID: 36497426 DOI: 10.3390/cancers14235944] [Reference Citation Analysis]
218 Karunakara SH, Puttahanumantharayappa LD, Sannappa Gowda NG, Shiragannavar VD, Santhekadur PK. Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective. Genes (Basel) 2022;13. [PMID: 36553522 DOI: 10.3390/genes13122254] [Reference Citation Analysis]
219 Zhao Q, Wang Y, Yu D, Leng JY, Zhao Y, Chu M, Xu Z, Ding H, Zhou J, Zhang T. Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation. BMC Cancer 2022;22:1229. [PMID: 36443709 DOI: 10.1186/s12885-022-10352-6] [Reference Citation Analysis]
220 Zwolak A, Chan SR, Harvilla P, Mahady S, Armstrong AA, Luistro L, Tamot N, Yamada D, Derebe M, Pomerantz S, Chiu M, Ganesan R, Chowdhury P. A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3. Sci Rep 2022;12:20538. [PMID: 36446890 DOI: 10.1038/s41598-022-24984-y] [Reference Citation Analysis]
221 Xu X, Zhang Z, Liu L, Che C, Li W. Exploring the Antiovarian Cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking. Comput Math Methods Med 2022;2022:7895246. [PMID: 36483919 DOI: 10.1155/2022/7895246] [Reference Citation Analysis]
222 Wu P, Pan X, Lu K, Gu N. Screening prognostic genes related to leucovorin, fluorouracil, and irinotecan treatment sensitivity by performing co-expression network analysis for colon cancer. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.928356] [Reference Citation Analysis]
223 Yuan Q, Zhang W, Shang W. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. Front Endocrinol (Lausanne) 2022;13:1045167. [PMID: 36518255 DOI: 10.3389/fendo.2022.1045167] [Reference Citation Analysis]
224 Wang Y, Wang C, Zhu Y. CARD9 contributes to ovarian cancer cell proliferation, cycle arrest, and cisplatin sensitivity. BMC Mol Cell Biol 2022;23:49. [PMID: 36443670 DOI: 10.1186/s12860-022-00447-0] [Reference Citation Analysis]
225 Li Y, Fu W, Geng Z, Song Y, Yang X, He T, Wu J, Wang B. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. PeerJ 2022;10:e14432. [PMID: 36518297 DOI: 10.7717/peerj.14432] [Reference Citation Analysis]
226 Yang P, Liu P, Li J. The Regulatory Network of Gastric Cancer Pathogenesis and Its Potential Therapeutic Active Ingredients of Traditional Chinese Medicine Based on Bioinformatics, Molecular Docking, and Molecular Dynamics Simulation. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-17. [DOI: 10.1155/2022/5005498] [Reference Citation Analysis]
227 Li K, Tan G, Zhang X, Lu W, Ren J, Si Y, Adu-Gyamfi EA, Li F, Wang Y, Xie B, Wang M. EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer. Biomolecules 2022;12. [PMID: 36551184 DOI: 10.3390/biom12121756] [Reference Citation Analysis]
228 Huang Q, Wu L, Wang Y, Kong X, Xiao X, Huang Q, Li M, Zhai Y, Shi F, Zhao R, Zhong J, Xiong L. Caveolin-1-deficient fibroblasts promote migration, invasion, and stemness via activating the TGF-β/Smad signaling pathway in breast cancer cells. Acta Biochim Biophys Sin (Shanghai) 2022;54:1587-98. [PMID: 36604141 DOI: 10.3724/abbs.2022150] [Reference Citation Analysis]
229 Taheri M, Safarzadeh A, Hussen BM, Ghafouri-Fard S, Baniahmad A. LncRNA/miRNA/mRNA Network Introduces Novel Biomarkers in Prostate Cancer. Cells 2022;11. [PMID: 36497036 DOI: 10.3390/cells11233776] [Reference Citation Analysis]
230 Kong F, Wang K, Wang L. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma. Discov Oncol 2022;13:131. [PMID: 36434140 DOI: 10.1007/s12672-022-00595-x] [Reference Citation Analysis]
231 Peng LS, Duan SL, Li RQ, Wang D, Han YY, Huang T, Yu YP, Ou CL, Wang JP. Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma. Front Oncol 2022;12:1043862. [PMID: 36505798 DOI: 10.3389/fonc.2022.1043862] [Reference Citation Analysis]
232 Screnci B, Stafford LJ, Barnes T, Shema K, Gilman S, Wright R, Al Absi S, Phillips T, Azuelos C, Slovik K, Murphy P, Harmon DB, Charpentier T, Doranz BJ, Rucker JB, Chambers R. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point. iScience 2022;25:105665. [PMID: 36505931 DOI: 10.1016/j.isci.2022.105665] [Reference Citation Analysis]
233 Gao H, Cai B, Lu Z, Wang G, Gao Y, Miao Y, Jiang K, Zhang K. Cancer‐testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. Cancer Medicine 2022. [DOI: 10.1002/cam4.5472] [Reference Citation Analysis]
234 Lee J, Keam B, Kim S, Heo JN, Joung E, Kim M, Kim TM, Kim DW, Heo DS. The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines. Transl Oncol 2022;27:101592. [PMID: 36436443 DOI: 10.1016/j.tranon.2022.101592] [Reference Citation Analysis]
235 Chen L, Wu Z, Guo J, Wang X, Zhao Z, Liang H, Zhang R, Deng J. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00952-8] [Reference Citation Analysis]
236 Ren D, Zhuang X, Lv Y, Zhang Y, Xu J, Gao F, Chen D, Wang Y. FAM84B promotes the proliferation of glioma cells through the cell cycle pathways. World J Surg Onc 2022;20:368. [DOI: 10.1186/s12957-022-02831-8] [Reference Citation Analysis]
237 Funato N, Yanagisawa H. TBX1 targets the miR-200-ZEB2 axis to induce epithelial differentiation and inhibit stem cell properties. Sci Rep 2022;12:20188. [PMID: 36418889 DOI: 10.1038/s41598-022-24604-9] [Reference Citation Analysis]
238 Wang J, Xia W, Huang Y, Li H, Tang Y, Li Y, Yi B, Zhang Z, Yang J, Cao Z, Zhou J. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer. Front Immunol 2022;13:1016612. [PMID: 36505458 DOI: 10.3389/fimmu.2022.1016612] [Reference Citation Analysis]
239 Gao Y, Cheng X, Han M. ZEB1-activated Notch1 promotes circulating tumor cell migration and invasion in lung squamous cell carcinoma. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-02993-7] [Reference Citation Analysis]
240 Pan Z, Chang S, Chen S, Zhao D, Zou Z, Dai L, Hou Y, Zhang Q, Yang Y, Chen Z, Zhang W, Zhao Y. Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma. PLoS One 2022;17:e0272542. [PMID: 36417422 DOI: 10.1371/journal.pone.0272542] [Reference Citation Analysis]
241 van Tienderen GS, Rosmark O, Lieshout R, Willemse J, de Weijer F, Elowsson Rendin L, Westergren-Thorsson G, Doukas M, Groot Koerkamp B, van Royen ME, van der Laan LJ, Verstegen MM. Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition. Acta Biomater 2022:S1742-7061(22)00763-2. [PMID: 36427688 DOI: 10.1016/j.actbio.2022.11.038] [Reference Citation Analysis]
242 He X, Wang X, Xiao Q, Liu D, Xu Q, Liu S. Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophageal squamous cell carcinoma via microRNA-133b/ENPEP axis. Cell Cycle 2022. [DOI: 10.1080/15384101.2022.2138416] [Reference Citation Analysis]
243 Ye Z, Kilic G, Dabelsteen S, Marinova IN, Thøfner JF, Song M, Rudjord-levann AM, Bagdonaite I, Vakhrushev SY, Brakebusch CH, Olsen JV, Wandall HH. Characterization of TGF-β signaling in a human organotypic skin model reveals that loss of TGF-βRII induces invasive tissue growth. Sci Signal 2022;15. [DOI: 10.1126/scisignal.abo2206] [Reference Citation Analysis]
244 Cui J, Du X, Yu X, Yu T, Yang X, Ke J, Yu L. Investigation of the prognostic biomarkers for thymoma.. [DOI: 10.21203/rs.3.rs-2281444/v1] [Reference Citation Analysis]
245 Feng Y, Li T, Lin Z, Li Y, Han X, Pei X, Fu Z, Wu Q, Shao D, Li C. Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma.. [DOI: 10.21203/rs.3.rs-2286692/v1] [Reference Citation Analysis]
246 Huang X, Chen Z, Xiang X, Liu Y, Long X, Li K, Qin M, Long C, Mo X, Tang W, Liu J. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine. EPMA J 2022;13:671-97. [PMID: 36505892 DOI: 10.1007/s13167-022-00305-1] [Reference Citation Analysis]
247 Dixit A, Sarver A, Zettervall J, Huang H, Zheng K, Brekken RA, Provenzano PP. Targeting TNF-α-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling. JCI Insight 2022;7:e153242. [PMID: 36256464 DOI: 10.1172/jci.insight.153242] [Reference Citation Analysis]
248 Jin W, Liu J, Yang J, Feng Z, Feng Z, Huang N, Yang T, Yu L. Identification of a key ceRNA network associated with ferroptosis in gastric cancer. Sci Rep 2022;12:20088. [PMID: 36418919 DOI: 10.1038/s41598-022-24402-3] [Reference Citation Analysis]
249 Bax HJ, Chauhan J, Stavraka C, Santaolalla A, Osborn G, Khiabany A, Grandits M, López-abente J, Palhares LCGF, Chan Wah Hak C, Robinson A, Pope A, Woodman N, Naceur-lombardelli C, Malas S, Coumbe JEM, Nakamura M, Laddach R, Mele S, Crescioli S, Black AM, Lombardi S, Canevari S, Figini M, Sayasneh A, Tsoka S, Fitzgerald K, Gillett C, Pinder S, Van Hemelrijck M, Kristeleit R, Ghosh S, Montes A, Spicer J, Karagiannis SN, Josephs DH. Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes. Br J Cancer 2022. [DOI: 10.1038/s41416-022-02031-x] [Reference Citation Analysis]
250 Yang L, Ma D, Tang S, Jiang T, Yu J, Wang L, Zou L. Comprehensive Genomic Analysis for Identifying FZD6 as a Novel Diagnostic Biomarker for Acute Myeloid Leukemia. Computational and Mathematical Methods in Medicine 2022;2022:1-14. [DOI: 10.1155/2022/9130958] [Reference Citation Analysis]
251 Huang Z, Cao J, Lao J, Deng W. A comprehensive expression profiles and prognostic values analysis of inosine 5'-monophosphate dehydrogenase type II (IMPDH2) in human tumors Running title: A pan-cancer analysis of IMPDH2.. [DOI: 10.21203/rs.3.rs-2265147/v1] [Reference Citation Analysis]
252 Song C, Gu X, Li R. Expression of IRAK1 in Hepatocellular Carcinoma, Its Clinical Significance, and Docking Characteristics with Selected Natural Compounds. Curr Oncol 2022;29:8904-16. [PMID: 36421353 DOI: 10.3390/curroncol29110700] [Reference Citation Analysis]
253 Pan YJ, Huo FC, Kang MJ, Liu BW, Wu MD, Pei DS. Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer. Clin Transl Med 2022;12:e1113. [PMID: 36394206 DOI: 10.1002/ctm2.1113] [Reference Citation Analysis]
254 Krug J, Rodrian G, Petter K, Yang H, Khoziainova S, Guo W, Bénard A, Merkel S, Gellert S, Maschauer S, Spermann M, Waldner M, Bailey P, Pilarsky C, Liebl A, Tripal P, Christoph J, Naschberger E, Croner R, Schellerer VS, Becker C, Hartmann A, Tüting T, Prante O, Grützmann R, Grivennikov SI, Stürzl M, Britzen-Laurent N. N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy. Gastroenterology 2022:S0016-5085(22)01294-X. [PMID: 36402190 DOI: 10.1053/j.gastro.2022.11.018] [Reference Citation Analysis]
255 Liu X, Liu D, Zhou S, Jiang W, Zhang J, Hu J, Liao G, Liao J, Guo Z, Li Y, Yang S, Li S, Chen H, Guo Y, Li M, Fan L, Li L, Zhao M, Liu Y. CARARIME: Interactive web server for comprehensive analysis of renal allograft rejection in immune microenvironment. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1026280] [Reference Citation Analysis]
256 Drouin M, Saenz J, Gauttier V, Evrard B, Teppaz G, Pengam S, Mary C, Desselle A, Thepenier V, Wilhelm E, Merieau E, Ligeron C, Girault I, Lopez M, Fourgeux C, Sinha D, Baccelli I, Moreau A, Louvet C, Josien R, Poschmann J, Poirier N, Chiffoleau E. CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy. Sci Adv 2022;8. [DOI: 10.1126/sciadv.abo7621] [Reference Citation Analysis]
257 Eid RA, Soltan MA, Eldeen MA, Shati AA, Dawood SA, Eissa M, Zaki MSA, Algahtani M, Theyab A, Abdel-Daim MM, Kim B. Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. Int J Mol Sci 2022;23. [PMID: 36430577 DOI: 10.3390/ijms232214102] [Reference Citation Analysis]
258 Oo JA, Pálfi K, Warwick T, Wittig I, Prieto-Garcia C, Matkovic V, Tomašković I, Boos F, Izquierdo Ponce J, Teichmann T, Petriukov K, Haydar S, Maegdefessel L, Wu Z, Pham MD, Krishnan J, Baker AH, Günther S, Ulrich HD, Dikic I, Leisegang MS, Brandes RP. Long non-coding RNA PCAT19 safeguards DNA in quiescent endothelial cells by preventing uncontrolled phosphorylation of RPA2. Cell Rep 2022;41:111670. [PMID: 36384122 DOI: 10.1016/j.celrep.2022.111670] [Reference Citation Analysis]
259 Heng Sun, Wenjie Han, Juyi Wen, Xue Ma. IL4I1 and tryptophan metabolites enhance AHR signals to facilitate colorectal cancer progression and immunosuppression. Am J Transl Res 2022;14. [PMID: 36505324] [Reference Citation Analysis]
260 Zhou X, Liu T, Deng S, Zhang T, Wu D, Xu Y. PAMR1 is a favorable diagnostic and prognostic biomarker in hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2114251/v1] [Reference Citation Analysis]
261 He Z, Lin J, Chen C, Chen Y, Yang S, Cai X, He Y, Liu S. Identification of BGN and THBS2 as metastasis-specific biomarkers and poor survival key regulators in human colon cancer by integrated analysis. Clin Transl Med 2022;12:e973. [PMID: 36377223 DOI: 10.1002/ctm2.973] [Reference Citation Analysis]
262 Chen H, He B, Ke F. Ceramide Synthase 6 Mediates Triple-Negative Breast Cancer Response to Chemotherapy Through RhoA- and EGFR-Mediated Signaling Pathways. J Breast Cancer 2022;25:500-12. [PMID: 36479603 DOI: 10.4048/jbc.2022.25.e47] [Reference Citation Analysis]
263 Fernández-palanca P, Payo-serafín T, San-miguel B, Méndez-blanco C, Tuñón MJ, González-gallego J, Mauriz JL. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation. Acta Pharmacol Sin 2022. [DOI: 10.1038/s41401-022-01021-2] [Reference Citation Analysis]
264 Zhang J, Yang H, Liu S, Islam MO, Zhu Y, Wang Z, Chen R. PCDH9 suppresses melanoma proliferation and cell migration. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.903554] [Reference Citation Analysis]
265 Chen K, Yong J, Zauner R, Wally V, Whitelock J, Sajinovic M, Kopecki Z, Liang K, Scott KF, Mellick AS. Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma. Cancers (Basel) 2022;14. [PMID: 36428658 DOI: 10.3390/cancers14225564] [Reference Citation Analysis]
266 Han M, Li Y, Guo Y, Zhu W, Jiang J. Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors. Int J Mol Sci 2022;23. [PMID: 36430477 DOI: 10.3390/ijms232213998] [Reference Citation Analysis]
267 Han J, Wan M, Ma Z, Yi H. Regulation of DNA‐PK activity promotes the progression of TNBC via enhancing the immunosuppressive function of myeloid‐derived suppressor cells. Cancer Medicine 2022. [DOI: 10.1002/cam4.5387] [Reference Citation Analysis]
268 Li L, Xiao Z, He P, Zou W, Deng Z, Zhang G, Liu R. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. BMC Gastroenterol 2022;22:454. [DOI: 10.1186/s12876-022-02552-y] [Reference Citation Analysis]
269 Sun X, Zhang J, Xiao C, Ge Z. Expression profile and prognostic values of LSM family in skin cutaneous melanoma. BMC Med Genomics 2022;15:238. [DOI: 10.1186/s12920-022-01395-6] [Reference Citation Analysis]
270 Zhang S, Zhang W, Wu B, Xia L, Li L, Jin K, Zou Y, Sun C. Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI. Medicine (Baltimore) 2022;101:e31418. [PMID: 36397358 DOI: 10.1097/MD.0000000000031418] [Reference Citation Analysis]
271 Wang C, Jiang X, Qi J, Xu J, Yang G, Mi C. PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1009056] [Reference Citation Analysis]
272 Xia M, Wang S, Qi Y, Long K, Li E, He L, Pan F, Guo Z, Hu Z. Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.993243] [Reference Citation Analysis]
273 Cao K, Ling X, Jiang X, Ma J, Zhu J. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Respir Res 2022;23:306. [DOI: 10.1186/s12931-022-02226-z] [Reference Citation Analysis]
274 Doughan A, Salifu SP. Genes associated with diagnosis and prognosis of Burkitt lymphoma. IET Syst Biol 2022;16:220-9. [PMID: 36354023 DOI: 10.1049/syb2.12054] [Reference Citation Analysis]
275 Ju G, Yao Z, Zhao Y, Zhao X, Liu F. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.. [DOI: 10.21203/rs.3.rs-1956294/v2] [Reference Citation Analysis]
276 Ji L, Yang T, Liu M, Li J, Si Q, Wang Y, Liu J, Dai L. Construction of lncRNA TYMSOS/hsa-miR-101-3p/CEP55 and TYMSOS/hsa-miR-195-5p/CHEK1 Axis in Non-small Cell Lung Cancer. Biochem Genet 2022. [DOI: 10.1007/s10528-022-10299-0] [Reference Citation Analysis]
277 Han H, Feng X, Guo Y, Cheng M, Cui Z, Guo S, Zhou W. Identification of potential target genes of breast cancer in response to Chidamide treatment. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.999582] [Reference Citation Analysis]
278 Zhang X, Mi Z. Breast cancer biomarkers identified in the Gene Expression Omnibus and The Cancer Genome Atlas.. [DOI: 10.21203/rs.3.rs-2162365/v1] [Reference Citation Analysis]
279 Hu F, Li H, Li L, Gale RP, Song Y, Chen S, Liang Y. Degree of stemness predicts micro-environmental response and clinical outcomes of diffuse large B-cell lymphoma and identifies a potential targeted therapy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1012242] [Reference Citation Analysis]
280 Tao Y, Luo J, Zhu H, Chu Y, Pei L. Chromosome 12 Open Reading Frame 49 Promotes Tumor Growth and Predicts Poor Prognosis in Colorectal Cancer. Dig Dis Sci 2022. [PMID: 36348128 DOI: 10.1007/s10620-022-07751-x] [Reference Citation Analysis]
281 Wang L, Zeng Q, Jiang S, Chen Z, Wang X, Li L, Li X. Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.987481] [Reference Citation Analysis]
282 Zhou Q, Yuan O, Cui H, Hu T, Xiao GG, Wei J, Zhang H, Wu C. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1007950] [Reference Citation Analysis]
283 Yang L, Yin H, Chen Y, Pan C, Hang H, Lu Y, Ma W, Li X, Gan W, Guo H, Li D. Low expression of PEBP1P2 promotes metastasis of clear cell renal cell carcinoma by post-transcriptional regulation of PEBP1 and KLF13 mRNA. Exp Hematol Oncol 2022;11:87. [DOI: 10.1186/s40164-022-00346-2] [Reference Citation Analysis]
284 Merulla AE, Stella M, Barbagallo C, Battaglia R, Caponnetto A, Broggi G, Altieri R, Certo F, Caltabiano R, Ragusa M, Barbagallo GMV, Di Pietro C, Purrello M, Barbagallo D. circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets, Insulin-like Growth Factor Binding Protein 2 (IGFBP2) and NRAS Proto-Oncogene, GTPase (NRAS) in Glioblastoma. Int J Mol Sci 2022;23. [PMID: 36430152 DOI: 10.3390/ijms232213676] [Reference Citation Analysis]
285 Ybañez W, Bagamasbad P. Krüppel-like factor 9 (KLF9) links hormone dysregulation and circadian disruption to breast cancer pathogenesis.. [DOI: 10.21203/rs.3.rs-2237040/v1] [Reference Citation Analysis]
286 Yang J, Tang Z, Ma Y, Dong W, Luo G, Yu F, Jiang F, Wang X, Liao W. Folate receptor genes were up-regulated in epithelial ovarian cancer and partly associated with patients’ prognosis. Pteridines 2022;33:69-77. [DOI: 10.1515/pteridines-2022-0043] [Reference Citation Analysis]
287 Cao L, Zhu L, Cheng L. ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis. BioMed Research International 2022;2022:1-23. [DOI: 10.1155/2022/5357114] [Reference Citation Analysis]
288 Liu L, Hou Y, Deng C, Tao Z, Chen Z, Hu J, Chen K. Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment. Nat Commun 2022;13:6740. [PMID: 36347860 DOI: 10.1038/s41467-022-34495-z] [Reference Citation Analysis]
289 Ye J, Li P, Zhang H, Wu Q, Yang D. Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma. Genes 2022;13:2059. [DOI: 10.3390/genes13112059] [Reference Citation Analysis]
290 Li J, Huang Y, Zuo H, Huang H, Lin Y, Huang H. Radix Sophorae Flavescentis (Kushen) inhibits NSCLC by targeting miR-183-5p/EGR1 and PTEN/AKt pathway.. [DOI: 10.21203/rs.3.rs-2227945/v1] [Reference Citation Analysis]
291 Zou X, Guo Y, Mo Z. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.905988] [Reference Citation Analysis]
292 Tang Y, Zhang H, Chen L, Zhang T, Xu N, Huang Z. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma. IJMS 2022;23:13590. [DOI: 10.3390/ijms232113590] [Reference Citation Analysis]
293 Zhen J, Pan J, Zhou X, Yu Z, Jiang Y, Gong Y, Ding Y, fang J, Liu Y, Huang D. FARSB Serves as a Novel Hypomethylated and Immune Cell Infiltration Related Prognostic Biomarker in Hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2171484/v1] [Reference Citation Analysis]
294 Fischer S, Trinh VT, Simon C, Weber LM, Formé I, Nist A, Bange G, Abendroth F, Stiewe T, Steinchen W, Liefke R, Vázquez O. Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells.. [DOI: 10.1101/2022.11.04.515028] [Reference Citation Analysis]
295 Chaib M, Hafeez BB, Mandil H, Daria D, Pingili AK, Kumari S, Sikander M, Kashyap VK, Chen GY, Anning E, Tripathi MK, Khan S, Behrman S, Yallapu MM, Jaggi M, Makowski L, Chauhan SC. Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Commun Biol 2022;5:1181. [PMID: 36333531 DOI: 10.1038/s42003-022-04102-4] [Reference Citation Analysis]
296 Mukherjee B, Tiwari A, Palo A, Pattnaik N, Samantara S, Dixit M. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF. Cell Death Discov 2022;8:442. [PMID: 36329016 DOI: 10.1038/s41420-022-01240-w] [Reference Citation Analysis]
297 Cai Z, Zhang W, Zhou R, Wang Y, Feng Y. Protein Phosphatase 2a Inhibits Gastric Cancer Cell Glycolysis by Reducing MYC Signaling. Cell Biochem Biophys 2022. [DOI: 10.1007/s12013-022-01112-1] [Reference Citation Analysis]
298 Hong KU, Tagnedji AH, Doll MA, Walls KM, Hein DW. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04436-w] [Reference Citation Analysis]
299 Chatterjee A, Bararia A, Ganguly D, Mondal PK, Roy P, Banerjee S, Ghosh S, Gulati S, Ghatak S, Chattopadhay BK, Basu P, Chatterjee A, Sikdar N. DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort. Cancer Cell Int 2022;22:334. [PMID: 36329447 DOI: 10.1186/s12935-022-02737-1] [Reference Citation Analysis]
300 Sinnett-Smith J, Anwar T, Reed EF, Teper Y, Eibl G, Rozengurt E. Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy. Mol Cancer Ther 2022;21:1652-62. [PMID: 35999654 DOI: 10.1158/1535-7163.MCT-21-0964] [Reference Citation Analysis]
301 Lin M, Zhu M, Ge T, Lu N, Fu X, Chang J. Prognostic potential and mechanism of SORT1 and its co‐expressed genes in hepatocellular carcinoma based on integrative analysis of multiple database. Precision Medical Sciences 2022. [DOI: 10.1002/prm2.12084] [Reference Citation Analysis]
302 Zhao W, Gao D, Ning L, Jiang Y, Li Z, Huang B, Chen A, Wang C, Liu Y. Prodigiosin inhibits the proliferation of glioblastoma by regulating the KIAA1524/PP2A signaling pathway. Sci Rep 2022;12:18527. [PMID: 36323805 DOI: 10.1038/s41598-022-23186-w] [Reference Citation Analysis]
303 Shi HZ, Xiong JS, Gan L, Zhang Y, Zhang CC, Kong YQ, Miao QJ, Tian CC, Li R, Liu JQ, Zhang EJ, Bu WB, Wang Y, Cheng XF, Sun JF, Chen H. N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3. Clin Transl Med 2022;12:e1075. [PMID: 36324258 DOI: 10.1002/ctm2.1075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Du T, Liu R, Zhang Q, Luo H, Liu Z, Sun S, Wang X. EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis. Biomolecules 2022;12:1617. [DOI: 10.3390/biom12111617] [Reference Citation Analysis]
305 Dutta R, Guruvaiah P, Reddi KK, Bugide S, Reddy Bandi DS, Edwards YJK, Singh K, Gupta R. UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress. NAR Cancer 2022;4:zcac035. [PMID: 36338541 DOI: 10.1093/narcan/zcac035] [Reference Citation Analysis]
306 Liao W, Chu P, Su C, Wu C, Li C. Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154215] [Reference Citation Analysis]
307 Fu J, Liu S, Tan Q, Liu Z, Qian J, Li T, Du J, Song B, Li D, Zhang L, He J, Guo K, Zhou B, Chen H, Fu S, Liu X, Cheng J, He T, Fu J. Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2. Molecules 2022;27:7413. [DOI: 10.3390/molecules27217413] [Reference Citation Analysis]
308 Li C, Chang C, Tsang Y, Fang S, Chen S, Chiang A. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma. International Immunopharmacology 2022;112:109273. [DOI: 10.1016/j.intimp.2022.109273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Song R, Huang J, Yang C, Li Y, Zhan G, Xiang B. ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis. IJGM 2022;Volume 15:8381-8398. [DOI: 10.2147/ijgm.s381188] [Reference Citation Analysis]
310 Fu T, Liu J, Xie J, Gao Z, Yang Z. LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis. BMJ Open 2022;12:e063682. [DOI: 10.1136/bmjopen-2022-063682] [Reference Citation Analysis]
311 Zhang Q, Nie H, Pan J, Xu H, Zhan Q. FMNL3 is Overexpressed in Tumor Tissues and Predicts an Immuno-Hot Phenotype in Pancreatic Cancer. IJGM 2022;Volume 15:8285-8298. [DOI: 10.2147/ijgm.s384195] [Reference Citation Analysis]
312 Xu X, Cui J, Wang H, Ma L, Zhang X, Guo W, Xue X, Wang Y, Qiu S, Tian X, Miao Y, Wu M, Yu Y, Xu Y, Wang J, Qiao Y. IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100503] [Reference Citation Analysis]
313 Pan X, Xue L, Sun Y. Spermine synthase (SMS) serves as a prognostic biomarker in head and neck squamous cell carcinoma: a bioinformatics analysis. Ann Transl Med 2022;10:1213. [PMID: 36544695 DOI: 10.21037/atm-22-5014] [Reference Citation Analysis]
314 Don Wai Luu L, Kaakoush NO, Castaño-Rodríguez N. The role of ATG16L2 in autophagy and disease. Autophagy 2022;18:2537-46. [PMID: 35239457 DOI: 10.1080/15548627.2022.2042783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
315 Wang J, Wu L, Lu W, Zhang H, Wu Y. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma. Genetic Testing and Molecular Biomarkers 2022;26:522-531. [DOI: 10.1089/gtmb.2022.0095] [Reference Citation Analysis]
316 Selkirk E, Patel R, Hoyle A, Lie-a-ling M, Smith D, Swift J, Lacaud G. SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11362] [Reference Citation Analysis]
317 Zhang F, Liang J, Lu Y, Tang Y, Liu S, Wu K, Zhang F, Lu Y, Liu Z, Wang X. Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma. JIR 2022;Volume 15:6275-6292. [DOI: 10.2147/jir.s375250] [Reference Citation Analysis]
318 Xu X, Zhang W, Gao H, Tan Y, Guo Y, He T. Polyadenylate-binding protein cytoplasmic 1 mediates alternative splicing events of immune-related genes in gastric cancer cells. Exp Biol Med (Maywood) 2022;247:1907-16. [PMID: 36112850 DOI: 10.1177/15353702221121631] [Reference Citation Analysis]
319 Ravi Prakash Yadav, Susanta Sadhukhan, Makhan Lal Saha, Sudakshina Ghosh, Madhusudan Das. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking. Sci Rep 2022;12:18413. [PMID: 36319798 DOI: 10.1038/s41598-022-18319-0] [Reference Citation Analysis]
320 Serhii K, Anastasiia H, Oksana M, Kyrylo L, Liubov S, Nataliia V, Iryna I, Rostyslav S, Alla R. Tristetraprolin expression levels and methylation status in breast cancer. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101718] [Reference Citation Analysis]
321 Zhu W, Tan L, Ma T, Yin Z, Gao J. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression. Dig Liver Dis 2022;54:1573-82. [PMID: 35354542 DOI: 10.1016/j.dld.2022.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
322 Wei Y, Liang D, Zhang M, Li Y, Sun H, Wang Q, Liang Y, Li Y, Wang R, Yang Z, Wang P, Xie S. WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1032850] [Reference Citation Analysis]
323 Li Z, Zhao J, Tong D, Yi C, Deng Z, Huang Z, Wuang Y, Tian X. Investigating the miRNA of the Chinese herb Gecko on the cross-species regulation network of hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2204354/v1] [Reference Citation Analysis]
324 Zhang Y, Ge M, Chen Y, Yang Y, Chen W, Wu D, Cai H, Chen X, Wu X. NDUFA4 promotes cell proliferation by enhancing oxidative phosphorylation in pancreatic adenocarcinoma. J Bioenerg Biomembr 2022. [DOI: 10.1007/s10863-022-09949-0] [Reference Citation Analysis]
325 Bulanenkova SS, Filyukova OB, Snezhkov EV, Akopov SB, Nikolaev LG. Suppression of the Testis-Specific Transcription of the <i>ZBTB32</i> and <i>ZNF473</i> Genes in Germ Cell Tumors. Acta Naturae 2022;14:85-94. [DOI: 10.32607/actanaturae.11620] [Reference Citation Analysis]
326 Cabarcas‐petroski S, Olshefsky G, Schramm L. BDP1 as a biomarker in serous ovarian cancer. Cancer Medicine 2022. [DOI: 10.1002/cam4.5388] [Reference Citation Analysis]
327 Liu X, Li L, Xie X, Zhuang D, Hu C. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma. THC 2022. [DOI: 10.3233/thc-220165] [Reference Citation Analysis]
328 Wang J, Zhu W, Tu J, Zheng Y. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation. J Microbiol Biotechnol 2022;32:1262-74. [PMID: 36224755 DOI: 10.4014/jmb.2207.07037] [Reference Citation Analysis]
329 Feng Y, Liu S, Zha R, Sun X, Li K, Wu D, Aryal UK, Koch M, Li BY, Yokota H. Prostate cancer-associated urinary proteomes differ before and after prostatectomy. Ther Adv Med Oncol 2022;14:17588359221131532. [PMID: 36324734 DOI: 10.1177/17588359221131532] [Reference Citation Analysis]
330 Zhen J, Ke Y, Pan J, Zhou M, Zeng H, Song G, Yu Z, Fu B, Liu Y, Huang D, Wu H. ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle. Aging 2022. [DOI: 10.18632/aging.204350] [Reference Citation Analysis]
331 Cao X, Zhou X, Chen C, Wang Z, Sun Q. Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.962389] [Reference Citation Analysis]
332 Liu Z, Liu L, Weng S, Xu H, Xing Z, Ren Y, Ge X, Wang L, Guo C, Li L, Cheng Q, Luo P, Zhang J, Han X. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors.. [DOI: 10.1101/2022.10.21.513300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Li Z, Cui Y, Duan Q, Zhang J, Shao D, Cao X, Gao Y, Wang S, Li J, Jones OD, Lei X, Wang L, Zhou X, Xu M, Ma J, Liu Y, Xu X. The Prognostic Significance of FKBP1A and Its Related Immune Infiltration in Liver Hepatocellular Carcinoma. IJMS 2022;23:12797. [DOI: 10.3390/ijms232112797] [Reference Citation Analysis]
334 Yang H, Zhou H, Wang G, Tian L, Li H, Zhang Y, Xue X. MELK is a prognostic biomarker and correlated with immune infiltration in glioma. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.977180] [Reference Citation Analysis]
335 Chen M, Zheng W, Fang L. Identifying liver metastasis-related hub genes in breast cancer and characterizing SPARCL1 as a potential prognostic biomarker.. [DOI: 10.21203/rs.3.rs-2183292/v1] [Reference Citation Analysis]
336 Sung J, Cheong J. Single Cell Analysis of Gastric Cancer Reveals Non-Defined Telomere Maintenance Mechanism. Cells 2022;11:3342. [DOI: 10.3390/cells11213342] [Reference Citation Analysis]
337 Kakar MU, Mehboob MZ, Akram M, Shah M, Shakir Y, Ijaz HW, Aziz U, Ullah Z, Ahmad S, Ali S, Yin Y, Li K. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4237633] [Reference Citation Analysis]
338 Ma M, Zhang C, Cao R, Tang D, Sang X, Zou S, Wang X, Xu H, Liu G, Dai L, Tian Y, Gao X, Fu X. UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. Oncogene 2022. [PMID: 36273042 DOI: 10.1038/s41388-022-02509-1] [Reference Citation Analysis]
339 Li H, Meng X, You X, Zhou W, Ouyang W, Pu X, Zhao R, Tang H. Increased expression of the RNA-binding protein Musashi-2 is associated with immune infiltration and predicts better outcomes in ccRCC patients. Front Oncol 2022;12:949705. [DOI: 10.3389/fonc.2022.949705] [Reference Citation Analysis]
340 Xiudan Han, Wei Long, Ying Liu, Jixiong Xu. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. Front Surg 2022;9:985034. [PMID: 36338652 DOI: 10.3389/fsurg.2022.985034] [Reference Citation Analysis]
341 Sun M, Qi S, Wu M, Xia W, Xiong H. Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. Front Genet 2022;13:909556. [DOI: 10.3389/fgene.2022.909556] [Reference Citation Analysis]
342 Xiao Q, Chen J, Zeng S, Cai H, Zhu G. An updated systematic review of the association between the TLR4 polymorphism rs4986790 and cancers risk. Medicine (Baltimore) 2022;101:e31247. [PMID: 36281200 DOI: 10.1097/MD.0000000000031247] [Reference Citation Analysis]
343 Dogan S, Leopold J, Hoffmann DT, Kubitschke H, Blauth E, Ficorella C, Zschau A, Schiller J, Käs JA. Identification of lipid droplet-associated genes in breast cancer patients.. [DOI: 10.21203/rs.3.rs-2157661/v1] [Reference Citation Analysis]
344 Reese RM, Helzer KT, Allen KO, Zheng C, Solodin N, Alarid ET. GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression. Mol Cell Biol 2022;42:e0019122. [PMID: 36036613 DOI: 10.1128/mcb.00191-22] [Reference Citation Analysis]
345 Li X, Tang L, Chen Q, Cheng X, Liu Y, Wang C, Zhu C, Xu K, Gao F, Huang J, Wang R, Guan X. Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer. Chin Med J (Engl) 2022;135:2436-45. [PMID: 36583862 DOI: 10.1097/CM9.0000000000002329] [Reference Citation Analysis]
346 Fu AB, Xiang SF, He QJ, Ying MD. Kelch-like proteins in the gastrointestinal tumors. Acta Pharmacol Sin 2022. [PMID: 36266566 DOI: 10.1038/s41401-022-01007-0] [Reference Citation Analysis]
347 Gamez-Belmonte R, Mahapatro M, Erkert L, Gonzalez-Acera M, Naschberger E, Yu Y, Tena-Garitaonaindia M, Patankar JV, Wagner Y, Podstawa E, Schödel L, Bubeck M, Neurath MF, Stürzl M, Becker C. Epithelial presenilin-1 drives colorectal tumour growth by controlling EGFR-COX2 signalling. Gut 2022:gutjnl-2022-327323. [PMID: 36261293 DOI: 10.1136/gutjnl-2022-327323] [Reference Citation Analysis]
348 Jiang Y, Zhang M, Zhang L, Wang L, Ma M, Jing M, Li J, Song R, Zhang Y, Yang Z, Zhang Y, Pu Y, Fan J. Identification of Biomarkers Related to Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma with Weighted gene co-expression network analysis.. [DOI: 10.21203/rs.3.rs-2160942/v1] [Reference Citation Analysis]
349 Li L, Liu Z, Wang H, Wang L, Ru G, Wang Y, Sakai E. ZNF521 Is Correlated with Tumor Immune Cell Infiltration and Act as a Valuable Prognostic Biomarker in Gastric Cancer. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/5288075] [Reference Citation Analysis]
350 Tsujimoto A, Matsuo N, Lai X, Inoue T, Yoda H, Lin J, Shinozaki Y, Watanabe T, Koshikawa N, Takatori A, Nagase H. Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Cancer Med 2022. [PMID: 36262061 DOI: 10.1002/cam4.5359] [Reference Citation Analysis]
351 Chen L, Huang Y, Dong B, Gu Y, Li Y, Cang W, Sun P, Xiang Y. Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration. J Inflamm Res 2022;15:5889-904. [PMID: 36274829 DOI: 10.2147/JIR.S384908] [Reference Citation Analysis]
352 Zuniga O, Byrum S, Wolfe AR. Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq. Cancer Drug Resist 2022;5:926-38. [PMID: 36627902 DOI: 10.20517/cdr.2022.60] [Reference Citation Analysis]
353 Ke B, Liang Z, Li B, Wang X, Liu N, Liang H, Zhang R. EDIL3 is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Gastric Cancer.. [DOI: 10.21203/rs.3.rs-2055502/v2] [Reference Citation Analysis]
354 Liu Y, Luo G, Yan Y, Peng J. A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values. Front Genet 2022;13:1038174. [DOI: 10.3389/fgene.2022.1038174] [Reference Citation Analysis]
355 Wang D, Xu W, Chen W, Li L, Yang S, Zhang J, Tang J, Stefan-van Staden R. Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/9133636] [Reference Citation Analysis]
356 Li X, Li X, Hu Y, Yang Q, Lin B, Liu O, Wang Y, Li S. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family based on bioinformatics analysis and in vitro validation.. [DOI: 10.21203/rs.3.rs-2111634/v1] [Reference Citation Analysis]
357 Necula L, Matei L, Dragu D, Pitica I, Neagu A, Bleotu C, Diaconu CC, Chivu-economescu M. Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer. IJMS 2022;23:12415. [DOI: 10.3390/ijms232012415] [Reference Citation Analysis]
358 Ma H, Yu H, Li Z, Cao Z, Du Y, Dai J, Zhi D, Xu Y, Li N, Wang J. β-Carboline dimers inhibit the tumor proliferation by the cell cycle arrest of sarcoma through intercalating to Cyclin-A2. Front Immunol 2022;13:922183. [DOI: 10.3389/fimmu.2022.922183] [Reference Citation Analysis]
359 Xiong Z, Wu S, Li F, Luo C, Jin Q, Connolly ID, Hayden Gephart M, You L. Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival. Genes 2022;13:1882. [DOI: 10.3390/genes13101882] [Reference Citation Analysis]
360 He S, Gu X, Yang J, Xu F, Hu J, Wang W, Huang Y, Lou B, Ding T, Zhou L, Ye D, Yu K, Dong J. Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage. Front Pharmacol 2022;13:902016. [DOI: 10.3389/fphar.2022.902016] [Reference Citation Analysis]
361 Guo L, Dou Y, Xiang Y, Luo L, Xu X, Wang Q, Zhang Y, Liang T. Systematic analysis of cancer‐specific synthetic lethal interactions provides insight into personalized anticancer therapy. The FEBS Journal 2022. [DOI: 10.1111/febs.16643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Yu W, Diao Y, Zhang Y, Shi Y, Lv X, Zhang C, Zhang K, Yao W, Huang D, Zhang J. Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer. Front Oncol 2022;12:1008100. [DOI: 10.3389/fonc.2022.1008100] [Reference Citation Analysis]
363 Zhang N, Cao S, Sun R, Wang Y, Liu L, Wang W, Meng X. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. PeerJ 2022;10:e14206. [PMID: 36275477 DOI: 10.7717/peerj.14206] [Reference Citation Analysis]
364 Song Q, Hou Y, Zhang Y, Liu J, Wang Y, Fu J, Zhang C, Cao M, Cui Y, Zhang X, Wang X, Zhang J, Liu C, Zhang Y, Wang P. Integrated multi-omics approach revealed cellular senescence landscape. Nucleic Acids Res 2022:gkac885. [PMID: 36243980 DOI: 10.1093/nar/gkac885] [Reference Citation Analysis]
365 Wu J, Yang D. Pancreatic Cancer-Derived Exosomes Promote the Proliferation, Invasion, and Metastasis of Pancreatic Cancer by the miR-3960/TFAP2A Axis. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/3590326] [Reference Citation Analysis]
366 Cui Y, Wu J, Zhou Z, Ma J, Dong L. Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC. Heliyon 2022;8:e11079. [PMID: 36311369 DOI: 10.1016/j.heliyon.2022.e11079] [Reference Citation Analysis]
367 Deng K, Lin S, Xu Z, Qin J, Yuan L, Sun Y, Wei J, Zheng T, Zheng Z, Qin F, Li S. A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma. Medicine 2022;101:e30982. [DOI: 10.1097/md.0000000000030982] [Reference Citation Analysis]
368 Liu Z, Liu H, Wang Y, Li Z. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma. BMC Gastroenterol 2022;22:435. [PMID: 36241983 DOI: 10.1186/s12876-022-02510-8] [Reference Citation Analysis]
369 Zhao J, Guo M, Song Y, Liu S, Liao R, Zhang Y, Zhang Y, Yang Q, Gu Y, Huang X. Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. Front Oncol 2022;12:992929. [DOI: 10.3389/fonc.2022.992929] [Reference Citation Analysis]
370 Yang J, Xu J, Gao Q, Wu F, Han W, Yu C, Shi Y, Qiu Y, Chen Y, Zhou X. Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment. Front Oncol 2022;12:1025195. [DOI: 10.3389/fonc.2022.1025195] [Reference Citation Analysis]
371 Zhu Z, Zhou Y, Chen Y, Zhou Z, Liu W, Zheng L, Pei Q, Tan F, Pei H, Li Y. m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA. Cancers (Basel) 2022;14:5025. [PMID: 36291811 DOI: 10.3390/cancers14205025] [Reference Citation Analysis]
372 Lin H, Han Q, Wang J, Zhong Z, Luo H, Hao Y, Jiang Y, Bu D. Methylation-Mediated Silencing of RBP7 Promotes Breast Cancer Progression through PPAR and PI3K/AKT Pathway. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/9039110] [Reference Citation Analysis]
373 Tian Y, Xie Y, Bai F, Zhang D. Biological clock genes are crucial and promising biomarkers for the therapeutic targets and prognostic assessment in gastric cancer.. [DOI: 10.21203/rs.3.rs-2142367/v1] [Reference Citation Analysis]
374 Liu S, Liu Y, Zhang X, Song X, Zhang B, Zhang Y. Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors. Front Genet 2022;13:1039440. [DOI: 10.3389/fgene.2022.1039440] [Reference Citation Analysis]
375 Kalantari S, Kazemi B, Roudi R, Zali H, D'Angelo A, Mohamadkhani A, Madjd Z, Pourshams A. RNA-sequencing for transcriptional profiling of whole blood in early stage and metastatic pancreatic cancer patients. Cell Biol Int 2022. [PMID: 36229929 DOI: 10.1002/cbin.11924] [Reference Citation Analysis]
376 Qiao H, Yin H, Feng Y, Tang H. Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors. Front Immunol 2022;13:1008778. [DOI: 10.3389/fimmu.2022.1008778] [Reference Citation Analysis]
377 Djokovic N, Djuric A, Ruzic D, Srdic Rajic T, Nikolic K. Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma.. [DOI: 10.1101/2022.10.10.511584] [Reference Citation Analysis]
378 Gao C, Zhou G, Cheng M, Feng L, Cao P, Zhou G. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Front Genet 2022;13:956094. [DOI: 10.3389/fgene.2022.956094] [Reference Citation Analysis]
379 Su X, Ma G, Bai X, Zhang J, Li M, Zhang F, Sun T, Ma D, Lu F, Ji C. The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia. Front Cell Dev Biol 2022;10:978786. [DOI: 10.3389/fcell.2022.978786] [Reference Citation Analysis]
380 Yang C, Wang T, Zhu S, Zong Z, Luo C, Zhao Y, Liu J, Li T, Liu X, Liu C, Deng H. Nicotinamide N -Methyltransferase Remodeled Cell Metabolism and Aggravated Proinflammatory Responses by Activating STAT3/IL1β/PGE 2 Pathway. ACS Omega. [DOI: 10.1021/acsomega.2c04286] [Reference Citation Analysis]
381 Liu J, Xie X, Xue M, Wang J, Chen Q, Zhao Z, Sheng X, Cigerci İH. A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/7676541] [Reference Citation Analysis]
382 Peng X, Yang R, Peng W, Zhao Z, Tu G, He B, Cai Q, Shi S, Yin W, Yu F, Tao Y, Wang X. Overexpression of LINC00551 promotes autophagy-dependent ferroptosis of lung adenocarcinoma via upregulating DDIT4 by sponging miR-4328. PeerJ 2022;10:e14180. [PMID: 36570007 DOI: 10.7717/peerj.14180] [Reference Citation Analysis]
383 Liu H, Tang T, Zhang H, Ting W, Zhou P, Luo Y, Qi H, Liu Y, Liu Y, Zhou M, Yin W, Lin J, Cigerci İH. Identification of a 5-Hydroxymethylation Signature in Circulating Cell-Free DNA for the Noninvasive Detection of Colorectal Cancer. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/3798741] [Reference Citation Analysis]
384 Yan D, Yu Y, Ni Q, Meng Q, Wu H, Ding S, Liu X, Tang C, Liu Q, Yang K. The overexpression and clinical significance of TBX15 in human gliomas.. [DOI: 10.21203/rs.3.rs-2133456/v1] [Reference Citation Analysis]
385 Rashid A, Fung HL, Tang AHN. Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression.. [DOI: 10.21203/rs.3.rs-1989444/v1] [Reference Citation Analysis]
386 Lu W, Mengxuan Z, Ming R, Zixu G, Yong Z, Simin Z, Yang Y, Leqi Q, Kangjie S, Yanlin L, Jia F, Yiteng D, Chuanyuan W, Jianying G, Han H. TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/1419179] [Reference Citation Analysis]
387 Hu Y, Zhu S, Xu R, Wang M, Chen F, Zhang Z, Feng B, Wang J, Chen Z, Wang J. Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway. Front Genet 2022;13:867872. [DOI: 10.3389/fgene.2022.867872] [Reference Citation Analysis]
388 Wang H, Zhang Y, Yan L, Lv Q, Lu J, Yun B. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221132986. [PMID: 36217828 DOI: 10.1177/03946320221132986] [Reference Citation Analysis]
389 Grimaldi AM, Affinito O, Salvatore M, Franzese M. CBX Family Members in Two Major Subtypes of Renal Cell Carcinoma: A Comparative Bioinformatic Analysis. Diagnostics (Basel) 2022;12:2452. [PMID: 36292141 DOI: 10.3390/diagnostics12102452] [Reference Citation Analysis]
390 Yang P, Liu H, Li Y, Gao Q, Chen X, Chang J, Li Y, Chen S, Dong R, Wu H, Liu C, Liu G. Overexpression of TCERG1 as a prognostic marker in hepatocellular carcinoma: A TCGA data-based analysis. Front Genet 2022;13:959832. [DOI: 10.3389/fgene.2022.959832] [Reference Citation Analysis]
391 Zhang H, Shan G, Jin X, Yu X, Bi G, Feng M, Wang H, Lin M, Zhan C, Wang Q, Li M. ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma. Transl Oncol 2022;26:101562. [PMID: 36228410 DOI: 10.1016/j.tranon.2022.101562] [Reference Citation Analysis]
392 Wu S, Qiu S, Chen W, Ding L, Wu L, Theocharis SE. Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/5081413] [Reference Citation Analysis]
393 Zhang J, Dong D, Wei Q, Ren L. CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma. BMC Cancer 2022;22:1052. [PMID: 36207693 DOI: 10.1186/s12885-022-10142-0] [Reference Citation Analysis]
394 Liu P, Zu F, Chen H, Yin X, Tan X. Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway. Cell Mol Biol Lett 2022;27:87. [PMID: 36209075 DOI: 10.1186/s11658-022-00390-0] [Reference Citation Analysis]
395 Yuan M, Hu X, Yao L, Liu P, Jiang Y, Li L. Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis. Front Mol Biosci 2022;9:1010160. [DOI: 10.3389/fmolb.2022.1010160] [Reference Citation Analysis]
396 Jong KXJ, Mohamed EHM, Ibrahim ZA. Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer. Apoptosis 2022. [PMID: 36207556 DOI: 10.1007/s10495-022-01774-5] [Reference Citation Analysis]
397 Hou J, Yang Y, Gao H, Ouyang T, Liu Q, Ding R, Kan H. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer. Medicine (Baltimore) 2022;101:e30888. [PMID: 36221371 DOI: 10.1097/MD.0000000000030888] [Reference Citation Analysis]
398 Tang M, Chen J, Zeng T, Ye DM, Li YK, Zou J, Zhang YP. Systemic analysis of the DNA replication regulator origin recognition complex in lung adenocarcinomas identifies prognostic and expression significance. Cancer Med 2022. [PMID: 36205357 DOI: 10.1002/cam4.5238] [Reference Citation Analysis]
399 Jiang Y, Qu X, Zhang M, Zhang L, Yang T, Ma M, Jing M, Zhang N, Song R, Zhang Y, Yang Z, Zhang Y, Pu Y, Fan J. Identification of a six-gene prognostic signature for bladder cancer associated macrophage. Front Immunol 2022;13:930352. [DOI: 10.3389/fimmu.2022.930352] [Reference Citation Analysis]
400 Yi L, Hu L, Huang K, Li Q, Wang Y, Wang J, Zhai Z. Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell-like diffuse large B-cell lymphoma cells. Anticancer Drugs 2022. [PMID: 36206105 DOI: 10.1097/CAD.0000000000001409] [Reference Citation Analysis]
401 Wang X, Huang Y, Li S, Zhang H. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma. Front Immunol 2022;13:1027154. [DOI: 10.3389/fimmu.2022.1027154] [Reference Citation Analysis]
402 Yi Q, Liang Q, Liu Y, Gong Z, Yan Y. Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma. Front Oncol 2022;12:998736. [DOI: 10.3389/fonc.2022.998736] [Reference Citation Analysis]
403 Zhu X, Zheng XY, Gong P, Xu X. Regulation of ATR-CHK1 signaling by ubiquitination of CLASPIN. Biochem Soc Trans 2022:BST20220729. [PMID: 36196914 DOI: 10.1042/BST20220729] [Reference Citation Analysis]
404 Fan X, Nie X, Huang J, Zhang L, Wang X, Lu M, Cheng Q. A Composite Bioinformatic Analysis to Explore Endoplasmic Reticulum Stress-Related Prognostic Marker and Potential Pathogenic Mechanisms in Glioma by Integrating Multiomics Data. Journal of Oncology 2022;2022:1-28. [DOI: 10.1155/2022/9886044] [Reference Citation Analysis]
405 Jiang W, Ou Z, Zhu Q, Zai H. RagC GTPase regulates mTOR to promote chemoresistance in senescence-like HepG2 cells. Front Physiol 2022;13:949737. [DOI: 10.3389/fphys.2022.949737] [Reference Citation Analysis]
406 Li Y, Li Y, Zhang X, Duan X, Feng H, Yu Z, Gao Y. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma. Front Oncol 2022;12:986827. [DOI: 10.3389/fonc.2022.986827] [Reference Citation Analysis]
407 Ge J, Mu S, Xiao E, Tian G, Tao L, Li D. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma. Front Genet 2022;13:1002673. [DOI: 10.3389/fgene.2022.1002673] [Reference Citation Analysis]
408 Han J, Wang Y, Zhou H, Ai S, Wan D, Sun J. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-17. [DOI: 10.1155/2022/6267851] [Reference Citation Analysis]
409 Cheng Y, Huang N, Yin Q, Cheng C, Chen D, Gong C, Xiong H, Zhao J, Wang J, Li X, Zhang J, Mao S, Qin K. LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells. Front Genet 2022;13:981030. [DOI: 10.3389/fgene.2022.981030] [Reference Citation Analysis]
410 Situ Y, Lu X, Cui Y, Xu Q, Deng L, Lin H, Shao Z, Chen J, Aziz AUR. Systematic Analysis of CXC Chemokine–Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis. BioMed Research International 2022;2022:1-19. [DOI: 10.1155/2022/5137301] [Reference Citation Analysis]
411 Shi F, Chen X, Wang Y, Xie Y, Zhong J, Su K, Li M, Li Y, Lin Q, Zhou Y, Wang J, Xiong L. HOTAIR/miR-203/CAV1 Crosstalk Influences Proliferation, Migration, and Invasion in the Breast Cancer Cell. IJMS 2022;23:11755. [DOI: 10.3390/ijms231911755] [Reference Citation Analysis]
412 Zhang W, Shi Y, Niu S, Li L, Lin L, Gao X, Cai W, Chen Y, Zhong Y, Tang D, Tang M, Dai Y. Integrated computer analysis and a self-built Chinese cohort study identified GSTM2 as one survival-relevant gene in human colon cancer potentially regulating immune microenvironment. Front Oncol 2022;12:881906. [DOI: 10.3389/fonc.2022.881906] [Reference Citation Analysis]
413 Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, Chen J, Qian Y, Lu X, Li L, Zheng G, Zhang Y, Zou X, Song F, Zheng C, Jiang L, Wang J, Tan Z, Huang P, Ge M. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Mol Cancer 2022;21:190. [PMID: 36192735 DOI: 10.1186/s12943-022-01658-x] [Reference Citation Analysis]
414 Zhang M, Xiang R, Glorieux C, Huang P. PLA2G2A Phospholipase Promotes Fatty Acid Synthesis and Energy Metabolism in Pancreatic Cancer Cells with K-ras Mutation. IJMS 2022;23:11721. [DOI: 10.3390/ijms231911721] [Reference Citation Analysis]
415 Sun Q, Gui Z, Zhao Z, Xu W, Zhu J, Gao C, Zhao W, Hu H, Yang D. Overexpression of LncRNA MNX1-AS1/PPFIA4 Activates AKT/HIF-1α Signal Pathway to Promote Stemness of Colorectal Adenocarcinoma Cells. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/8303409] [Reference Citation Analysis]
416 Valcarcel-Jimenez L, Rogerson C, Yong C, Schmidt C, Yang M, Cremades-Rodelgo M, Harle V, Offord V, Wong K, Mora A, Speed A, Caraffini V, Tran MGB, Maher ER, Stewart GD, Vanharanta S, Adams DJ, Frezza C. HIRA loss transforms FH-deficient cells. Sci Adv 2022;8:eabq8297. [PMID: 36269833 DOI: 10.1126/sciadv.abq8297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Poh AR, O’brien M, Chisanga D, He H, Baloyan D, Traichel J, Dijkstra C, Chopin M, Nutt S, Whitehead L, Boon L, Parkin A, Lowell C, Pajic M, Shi W, Nikfarjam M, Ernst M. Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis. Cell Reports 2022;41:111479. [DOI: 10.1016/j.celrep.2022.111479] [Reference Citation Analysis]
418 Xiong J, Wu R, He A, Hou P, Wang J, Zhang R, Liao W, Wu L, Li E. Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD. Tissue and Cell 2022;78:101900. [DOI: 10.1016/j.tice.2022.101900] [Reference Citation Analysis]
419 Jiaxin Li, Huan Wang, Fangli Cao, Yufeng Cheng. A bioinformatics analysis for diagnostic roles of the E2F family in esophageal cancer. J Gastrointest Oncol 2022;13. [PMID: 36388667 DOI: 10.21037/jgo-22-855] [Reference Citation Analysis]
420 Nam SE, Jin T, Park KS, Saindane M, Noh WC, Yoo YB, Park WS, Yun IJ. Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma. Ann Surg Treat Res 2022;103:183-94. [PMID: 36304189 DOI: 10.4174/astr.2022.103.4.183] [Reference Citation Analysis]
421 Cabiati M, Di Giorgi N, Salvadori C, Finamore F, Del Turco S, Cecchettini A, Rocchiccioli S, Del Ry S. Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles. Pathology - Research and Practice 2022;238:154088. [DOI: 10.1016/j.prp.2022.154088] [Reference Citation Analysis]
422 Qu L, Fang Q, Yin T, Yi H, Mei G, Hong Z, Qiu X, Zhou R, Dong H. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma. Cancer Immunol Immunother 2022;71:2449-2467. [DOI: 10.1007/s00262-022-03167-8] [Reference Citation Analysis]
423 Qiang W, Lei Y, Yuan L, Yuan J, Zhang J, Shan Y, Tian H, Shi B, Guo H. SGLT-2 as a potential target in pancreatic cancer: the preliminary clue from The Cancer Genome Atlas data. J Gastrointest Oncol 2022;13:2539-52. [PMID: 36388652 DOI: 10.21037/jgo-22-900] [Reference Citation Analysis]
424 Zhu T, Ge X, Gong S, Guo S, Tao Q, Guo J, Ma R. Prognostic value of lactate transporter SLC16A1 and SLC16A3 as oncoimmunological biomarkers associating tumor metabolism and immune evasion in glioma. Cancer Innovation 2022;1:229-239. [DOI: 10.1002/cai2.32] [Reference Citation Analysis]
425 Wang H, He M, Zhang Z, Yin W, Ren B, Lin Y, Muddassir Ali M. Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/1752827] [Reference Citation Analysis]
426 Taherkhani A, Dehto SS, Jamshidi S, Shojaei S. Pathogenesis and prognosis of primary oral squamous cell carcinoma based on microRNAs target genes: a systems biology approach. Genomics Inform 2022;20:e27. [DOI: 10.5808/gi.22038] [Reference Citation Analysis]
427 Takemoto K, Kobatake K, Miura K, Fukushima T, Babasaki T, Miyamoto S, Sekino Y, Kitano H, Goto K, Ikeda K, Hieda K, Hayashi T, Hinata N, Kaminuma O. BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity. Cancer Sci 2022. [PMID: 36178067 DOI: 10.1111/cas.15607] [Reference Citation Analysis]
428 Lei J, Fan Y, Yan C, Jiamaliding Y, Tang Y, Zhou J, Huang M, Ju G, Wu J, Peng C. Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer. Front Genet 2022;13:1007696. [PMID: 36171885 DOI: 10.3389/fgene.2022.1007696] [Reference Citation Analysis]
429 Li Q, Wu B, Daba M, Gao X, Chen B, Song G, Zeng K, Miao J, Yuan X, Liu J, Wang Z, Liu B, Xu G. Identification of Calcium Channel-Related Gene P2RX2 for Prognosis and Immune Infiltration in Prostate Cancer. Disease Markers 2022;2022:1-23. [DOI: 10.1155/2022/8058160] [Reference Citation Analysis]
430 Wen X, Chen S, Chen X, Qiu H, Wang W, Zhang N, Liu W, Wang T, Ding X, Zhang L. ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway. Front Oncol 2022;12:887068. [DOI: 10.3389/fonc.2022.887068] [Reference Citation Analysis]
431 Wu G, Hao Q, Liu B, Zhou J, Fan C, Liu R. Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme. Medicine (Baltimore) 2022;101:e30853. [PMID: 36181021 DOI: 10.1097/MD.0000000000030853] [Reference Citation Analysis]
432 Zhang F, Lin J, Feng D, Liang J, Lu Y, Liu Z, Wang X. Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma. Front Cell Dev Biol 2022;10:922995. [DOI: 10.3389/fcell.2022.922995] [Reference Citation Analysis]
433 Liu Z, Peng L, Sun Y, Lu Z, Wu B, Wang W, Zhang X, Hao H, Gong P. COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma. Front Pharmacol 2022;13:974107. [DOI: 10.3389/fphar.2022.974107] [Reference Citation Analysis]
434 Lin CY, Yu CJ, Shen CI, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target. Med Oncol 2022;39:242. [PMID: 36180600 DOI: 10.1007/s12032-022-01812-x] [Reference Citation Analysis]
435 Song S, Deng X, Jiang S, Tian C, Han J, Chai J, Li N, Yan Y, Luo Z. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. J Clin Lab Anal 2022;:e24662. [PMID: 36181310 DOI: 10.1002/jcla.24662] [Reference Citation Analysis]
436 Bhatia S, Gokhale P, Katte T, Acharya S, Rasalkar AA, Vidapanakal S, Manas R, Chinnam S, Narayanan P, Shettihalli AK, Kadappa V, Sirigiri DNR. Assessing the Vulnerability of Cancer Patients for COVID-19. ACS Omega. [DOI: 10.1021/acsomega.2c03764] [Reference Citation Analysis]
437 Chen B, Gao C, Wang H, Sun J, Han Z, Tao H. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes. Computational and Mathematical Methods in Medicine 2022;2022:1-16. [DOI: 10.1155/2022/3268386] [Reference Citation Analysis]
438 Chen B, Luo Y, Kang X, Sun Y, Jiang C, Yi B, Yan X, Chen Y, Shi R. Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes. Front Genet 2022;13:981222. [DOI: 10.3389/fgene.2022.981222] [Reference Citation Analysis]
439 Chen K, Wang Q, Liu X, Wang F, Ma Y, Zhang S, Shao Z, Yang Y, Tian X. Single Cell RNA-Seq Identifies Immune-Related Prognostic Model and Key Signature-SPP1 in Pancreatic Ductal Adenocarcinoma. Genes 2022;13:1760. [DOI: 10.3390/genes13101760] [Reference Citation Analysis]
440 Ashok G, Ramaiah S. A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery. Med Oncol 2022;39:206. [PMID: 36175717 DOI: 10.1007/s12032-022-01815-8] [Reference Citation Analysis]
441 Sun W, Huang R, Li Z, Zhu Y, Bai Y, Wu S, Wang J, Xiao Y, Xian S, Tong X, Zhang J, Guo Y, Ouyang Y. Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma. NPJ Genom Med 2022;7:56. [PMID: 36171217 DOI: 10.1038/s41525-022-00321-0] [Reference Citation Analysis]
442 Pan Y, Zhao Z, Li J, Li J, Luo Y, Li W, You W, Zhang Y, Li Z, Yang J, Xiao ZJ, Wang Y. Nuclear Beclin 1 Destabilizes Retinoblastoma Protein to Promote Cell Cycle Progression and Colorectal Cancer Growth. Cancers 2022;14:4735. [DOI: 10.3390/cancers14194735] [Reference Citation Analysis]
443 Wang H, Li B, Zuo L, Wang B, Yan Y, Tian K, Zhou R, Wang C, Chen X, Jiang Y, Zheng H, Qin F, Zhang B, Yu Y, Liu CP, Xu Y, Gao J, Qi Z, Deng W, Ji X. The transcriptional coactivator RUVBL2 regulates Pol II clustering with diverse transcription factors. Nat Commun 2022;13:5703. [PMID: 36171202 DOI: 10.1038/s41467-022-33433-3] [Reference Citation Analysis]
444 Yang X, Yu Y, Wang Z, Wu P, Su X, Wu Z, Gan J, Zhang D. NOX4 has the potential to be a biomarker associated with colon cancer ferroptosis and immune infiltration based on bioinformatics analysis. Front Oncol 2022;12:968043. [DOI: 10.3389/fonc.2022.968043] [Reference Citation Analysis]
445 Zeng J, Yi J, Tan S, Zeng Y, Zou L, Zhang C, Liu L, Yi P, Fan P, Yu J. GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. Front Endocrinol 2022;13:995972. [DOI: 10.3389/fendo.2022.995972] [Reference Citation Analysis]
446 Xiao W, Ahluwalia P, Wang L, Howard J, Kolhe R, Rojiani AM, Rojiani MV. TIMP-1 Dependent Modulation of Metabolic Profiles Impacts Chemoresistance in NSCLC. Cells 2022;11:3036. [DOI: 10.3390/cells11193036] [Reference Citation Analysis]
447 Li C, Chen S, Liu C, Mo C, Gong W, Hu J, He M, Xie L, Hou X, Tang J, Ou M. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Hereditas 2022;159:37. [PMID: 36167571 DOI: 10.1186/s41065-022-00251-y] [Reference Citation Analysis]
448 Long F, Tian L, Chai Z, Li J, Tang Y, Liu M. Identification of stage-associated exosome miRNAs in colorectal cancer by improved robust and corroborative approach embedded miRNA-target network. Front Med 2022;9. [DOI: 10.3389/fmed.2022.881788] [Reference Citation Analysis]
449 Jia Z, Long D, Yu Y. Dynamic Expression of Palmitoylation Regulators across Human Organ Development and Cancers Based on Bioinformatics. CIMB 2022;44:4472-4489. [DOI: 10.3390/cimb44100306] [Reference Citation Analysis]
450 Sarni D, Barroso S, Shtrikman A, Irony-Tur Sinai M, Oren YS, Aguilera A, Kerem B. Topoisomerase 1-dependent R-loop deficiency drives accelerated replication and genomic instability. Cell Rep 2022;40:111397. [PMID: 36170822 DOI: 10.1016/j.celrep.2022.111397] [Reference Citation Analysis]
451 Zeng Y, Fan R. Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis. Sci Rep 2022;12:16153. [PMID: 36167975 DOI: 10.1038/s41598-022-20615-8] [Reference Citation Analysis]
452 Xiong F, Liu W, Wang X, Wu G, Wang Q, Guo T, Huang W, Wang B, Chen Y. HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway. Cell Death Dis 2022;13:829. [PMID: 36167790 DOI: 10.1038/s41419-022-05279-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
453 Zhang Y, Wang H, Wang F, Ma W, Li N, Bo C, Zhao Y, He L, Liu M, Elmouki I. A Four-Gene Signature Associated with Radioresistance in Head and Neck Squamous Cell Carcinoma Identified by Text Mining and Data Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-19. [DOI: 10.1155/2022/5693806] [Reference Citation Analysis]
454 Zeng J, Hua S, Liu J, Mungur R, He Y, Feng J. Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma. Front Genet 2022;13:928407. [DOI: 10.3389/fgene.2022.928407] [Reference Citation Analysis]
455 Hasan MM, Nabi AN, Yasmin T. Comprehensive analysis predicting effects of deleterious SNPs of human progesterone receptor gene on its structure and functions: a computational approach. J Biomol Struct Dyn 2022;:1-16. [PMID: 36166622 DOI: 10.1080/07391102.2022.2127908] [Reference Citation Analysis]
456 Gao L, Ren R, Shen J, Hou J, Ning J, Feng Y, Wang M, Wu L, Sun Y, Wang H, Wang D, Cao J. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. BMC Cancer 2022;22:1016. [PMID: 36162993 DOI: 10.1186/s12885-022-10102-8] [Reference Citation Analysis]
457 Li X, Dai Z, Liu J, Sun Z, Li N, Jiao G, Cao H. Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer. Front Genet 2022;13:969856. [DOI: 10.3389/fgene.2022.969856] [Reference Citation Analysis]
458 Zhang C, Yang Y, Wang K, Chen M, Lu M, Hu C, Du X, Xing B, Liu X, Zhang J. The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/2466006] [Reference Citation Analysis]
459 Cui X, Song S, Zhang W, Wang D, Fang Z. Bioinformatic-based identification of 3 immune-related genes for prognostic in breast invasive carcinoma.. [DOI: 10.1101/2022.09.23.509179] [Reference Citation Analysis]
460 Ren L, Wen X, Liu M, Xiao Y, Leng P, Luo H, Tao P, Xie L, Wei L. Comprehensive Analysis of the Molecular Characteristics and Prognosis value of AT II-associated Genes in Non-small Cell Lung Cancer. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/3106688] [Reference Citation Analysis]
461 Chen Y, Qian J, Ding P, Wang W, Li X, Tang X, Tang C, Yang Y, Gu C. Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation. Cell Death Dis 2022;13:822. [PMID: 36163342 DOI: 10.1038/s41419-022-05272-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Ye S, Yang B, Zhang T, Wei W, Li Z, Chen J, Li X. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses. Cells 2022;11:3000. [DOI: 10.3390/cells11193000] [Reference Citation Analysis]
463 Ahmadi-beni R, Shahbazi S, Khoshnevisan A. An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas. Diagn Pathol 2022;17. [DOI: 10.1186/s13000-022-01253-0] [Reference Citation Analysis]
464 Bhuvaneswari MS, Priyadharsini S, Balaganesh N, Theenathayalan R, Hailu TA, Rethinam S. Investigating the Lung Adenocarcinoma Stem Cell Biomarker Expressions Using Machine Learning Approaches. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/3518190] [Reference Citation Analysis]
465 Rafia C, Loizeau C, Renoult O, Harly C, Pecqueur C, Joalland N, Scotet E. A dramatic impairment of the antitumor activity of human Vγ9Vδ2 T cells is induced by TGF-β through significant phenotype, transcriptomic and metabolic changes.. [DOI: 10.1101/2022.09.22.509026] [Reference Citation Analysis]
466 Sung JY, Kim JH, Kang HG, Park JW, Park S, Park B, Kim Y. ICSBP-induced PD-L1 enhances osteosarcoma cell growth. Front Oncol 2022;12:918216. [DOI: 10.3389/fonc.2022.918216] [Reference Citation Analysis]
467 Goes JVC, Carvalho LG, de Oliveira RTG, Melo MMDL, Novaes LAC, Moreno DA, Gonçalves PG, Montefusco-pereira CV, Pinheiro RF, Ribeiro Junior HL. Role of Sirtuins in the Pathobiology of Onco-Hematological Diseases: A PROSPERO-Registered Study and In Silico Analysis. Cancers 2022;14:4611. [DOI: 10.3390/cancers14194611] [Reference Citation Analysis]
468 Huang X, Wang X, Huang G, Li R, Liu X, Cao L, Ye J, Zhang P. Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis. Medicine 2022;101:e30678. [DOI: 10.1097/md.0000000000030678] [Reference Citation Analysis]
469 Yin X, Lyu C, Li Z, Wang Q, Ding Y, Wang Y, Qiu Y, Cui S, Guo D, Xu R. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia. Journal of Healthcare Engineering 2022;2022:1-15. [DOI: 10.1155/2022/2669114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Lv S, An Y, Dong H, Xie L, Zheng H, Cheng X, Zhang L, Teng T, Wang Q, Yan Z, Guo X, Zhao J. High APLN Expression Predicts Poor Prognosis for Glioma Patients. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/8393336] [Reference Citation Analysis]
471 Zhang J, Ren Z, Zheng D, Song Z, Lin J, Luo Y, Zou X, Pan Y, Qi N, Li A, Liu X. AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma. Cancers 2022;14:4600. [DOI: 10.3390/cancers14194600] [Reference Citation Analysis]
472 Liu P, Guo W, Su Y, Chen C, Ma Y, Ma P, Chen C, Lv X. Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer. Cancers 2022;14:4595. [DOI: 10.3390/cancers14194595] [Reference Citation Analysis]
473 Marrugo-padilla A, Márquez-lázaro J, Álviz-amador A. Identification of prognostic biomarkers of invasive ductal carcinoma by an integrated bioinformatics approach. F1000Res 2022;11:1075. [DOI: 10.12688/f1000research.123714.1] [Reference Citation Analysis]
474 Mithu E, Joshi M, Raval I, Joshi C, Dasgupta A, Majumdar S, Shah SA. RNASeq as a tool to understand dysregulation of potential biomarkers in HNSC.. [DOI: 10.1101/2022.09.20.508683] [Reference Citation Analysis]
475 Fan T, Xue L, Dong B, He H, Zhang W, Hao L, Ma W, Zang G, Han C, Dong Y. CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration. BMC Urol 2022;22:156. [PMID: 36131343 DOI: 10.1186/s12894-022-01103-7] [Reference Citation Analysis]
476 Deng H, Chen Y, Wang J, An R. HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling. PLoS ONE 2022;17:e0274897. [DOI: 10.1371/journal.pone.0274897] [Reference Citation Analysis]
477 Wang HQ, Qian CH, Guo ZY, Li PM, Qiu ZJ. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression via targeting miR-299-3p. World J Gastroenterol 2022; 28(35): 5141-5153 [DOI: 10.3748/wjg.v28.i35.5141] [Reference Citation Analysis]
478 Shen Y, He W, Wang D, Cao D, Mei H, Luan T, Hu Y, Zhang Z. Identification of Gene Coexpression Modules and Prognostic Genes Associated with Papillary Thyroid Cancer. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/9025198] [Reference Citation Analysis]
479 Huang S, Wang X, Luo K, Zhang X, Liu Z, Li R, Liang S. Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/1129062] [Reference Citation Analysis]
480 Zhang Z, Liang Z, Gao W, Yu S, Hou Z, Li K, Zeng P. Identification of circadian clock genes as regulators of immune infiltration in Hepatocellular Carcinoma. J Cancer 2022;13:3199-208. [PMID: 36118525 DOI: 10.7150/jca.71925] [Reference Citation Analysis]
481 Alam MS, Sultana A, Sun H, Wu J, Guo F, Li Q, Ren H, Hao Z, Zhang Y, Wang G. Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer. Front Pharmacol 2022;13:942126. [DOI: 10.3389/fphar.2022.942126] [Reference Citation Analysis]
482 Hu T, Wang X, Xia Y, Wu L, Ma Y, Zhou R, Zhao Y. Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer. Chin Med J (Engl) 2022;135:2218-31. [PMID: 36113844 DOI: 10.1097/CM9.0000000000002025] [Reference Citation Analysis]
483 Shao Y, Zheng Z, Li S, Yang G, Qi F, Fei F, Zheng M. Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/5185202] [Reference Citation Analysis]
484 Wen H, Shu M, Chen J, Li X, Zhu Q, Zhang J, Tian Y, Lu X, Zhu W. Histone methyltransferase GLP epigenetically activates GPCPD1 to sustain cancer cell metastasis and invasion. GENOME INSTAB DIS 2022. [DOI: 10.1007/s42764-022-00083-0] [Reference Citation Analysis]
485 Qin J, Liu X, Wang X, Wang G, Liang Q, Dong Y, Pang K, Hao L, Xue L, Zhao Y, Hu Z, Li R, Lv Q, Chao L, Meng F, Shi Z, Han C. Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker. Front Genet 2022;13:984279. [DOI: 10.3389/fgene.2022.984279] [Reference Citation Analysis]
486 Yu C, Rao D, Wang T, Song J, Zhang L, Huang W. Emerging roles of TRIM27 in cancer and other human diseases. Front Cell Dev Biol 2022;10:1004429. [DOI: 10.3389/fcell.2022.1004429] [Reference Citation Analysis]
487 Huang S, Hou Y, Hu M, Hu J, Liu X. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma. BMC Cancer 2022;22:995. [PMID: 36123627 DOI: 10.1186/s12885-022-10087-4] [Reference Citation Analysis]
488 Saddozai UAK, Wang F, Khattak S, Akbar MU, Badar M, Khan NH, Zhang L, Zhu W, Xie L, Li Y, Ji X, Guo X. Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma. Cells 2022;11:2924. [PMID: 36139498 DOI: 10.3390/cells11182924] [Reference Citation Analysis]
489 Kurtović M, Piteša N, Bartoniček N, Ozretić P, Musani V, Čonkaš J, Petrić T, King C, Sabol M. RNA-seq and ChIP-seq Identification of Unique and Overlapping Targets of GLI Transcription Factors in Melanoma Cell Lines. Cancers (Basel) 2022;14:4540. [PMID: 36139698 DOI: 10.3390/cancers14184540] [Reference Citation Analysis]
490 Ju G, Zhang L, Guo W, Wang H, Zhang X, Mu Z, Sun Y, Sun D, Diao H, Miao S, Chen Y, Xing T, Liang J, Lin Y, Zhong WL. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma. Disease Markers 2022;2022:1-20. [DOI: 10.1155/2022/1686316] [Reference Citation Analysis]
491 Zhou Q, Shaya M, Kugeluke Y, Fu Q, Li S, Dilimulati Y. A circular RNA derived from GLIS3 accelerates the proliferation of glioblastoma cells through competitively binding with miR-449c-5p to upregulate CAPG and GLIS3. BMC Neurosci 2022;23. [DOI: 10.1186/s12868-022-00736-6] [Reference Citation Analysis]
492 Liu T, Wang Y, Wang Y, Cheung SK, Or PM, Wong CW, Guan J, Li Z, Yang W, Tu Y, Wang J, Ho WL, Gu H, Cheng AS, Tsui SK, Chan AM. The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma. Cancer Lett 2022;549:215914. [PMID: 36116740 DOI: 10.1016/j.canlet.2022.215914] [Reference Citation Analysis]
493 Chen E, Yi J, Ren Q, Mi Y, Gan Z, Liu J. Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/7853168] [Reference Citation Analysis]
494 Wang G, Zhou X, Li Y, Zhao M, Zou Y, Lu Q, Wu Y, Zhong WL. Comprehensive Multiomics Analysis Identified IQGAP3 as a Potential Prognostic Marker in Pan-Cancer. Disease Markers 2022;2022:1-33. [DOI: 10.1155/2022/4822964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
495 Xu K, Wu Y, Chi H, Li Y, She Y, Yin X, Liu X, He B, Li X, Du H. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics. Medicine (Baltimore) 2022;101:e30270. [PMID: 36123895 DOI: 10.1097/MD.0000000000030270] [Reference Citation Analysis]
496 Hermawan A, Putri H. Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy. BMC Genom Data 2022;23:72. [DOI: 10.1186/s12863-022-01086-2] [Reference Citation Analysis]
497 Fu L, Wang Z, Jiang F, Wei G, Sun L, Guo C, Wu J, Zhu J, Granito A. High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer. Journal of Oncology 2022;2022:1-25. [DOI: 10.1155/2022/9342283] [Reference Citation Analysis]
498 Wang C, Zhang L. Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis. Medicine (Baltimore) 2022;101:e30619. [PMID: 36123948 DOI: 10.1097/MD.0000000000030619] [Reference Citation Analysis]
499 Yang H, Yue GG, Leung PC, Wong CK, Zhang YJ, Lau CB. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition. Pharmacol Res 2022;184:106457. [PMID: 36116708 DOI: 10.1016/j.phrs.2022.106457] [Reference Citation Analysis]
500 Yang X, Xu Y, Zhu Q. SPOP Expression Is Associated with tumor-infiltrating lymphocytes in Pancreatic Cancer.. [DOI: 10.21203/rs.3.rs-2059152/v1] [Reference Citation Analysis]
501 Li R, Wang Y, Wang S, Li X, Chen Y, Li Z, He J, Zhou Z, Li J, Guo X, Wang X, Wu Y, Ren Y, Zhang W, Wang X, Guo G. GBP2 as a potential prognostic predictor with immune-related characteristics in glioma. Front Genet 2022;13:956632. [DOI: 10.3389/fgene.2022.956632] [Reference Citation Analysis]
502 Cui K, Yao X, Wei Z, yang Y, Liu X, Huang Z, Huo H, Tang J, Xie Y. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma. Front Genet 2022;13:917344. [DOI: 10.3389/fgene.2022.917344] [Reference Citation Analysis]
503 Hoang NTD, Hassan G, Suehiro T, Mine Y, Matsuki T, Fujii M. BMP and activin membrane-bound inhibitor regulate connective tissue growth factor controlling mesothelioma cell proliferation. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-10080-x] [Reference Citation Analysis]
504 Zhang G. Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment. Front Immunol 2022;13:975762. [DOI: 10.3389/fimmu.2022.975762] [Reference Citation Analysis]
505 Kocatürk B. Identification of thioredoxin domain containing family members' expression pattern and prognostic value in diffuse gliomas via in silico analysis. Cancer Medicine. [DOI: 10.1002/cam4.5169] [Reference Citation Analysis]
506 Cui M, Zhang H, Han S, Huo F, Shen Z, Ding D. Screening of biomarkers associated with diagnosis and prognosis of colorectal cancer. Genes Genet Syst 2022. [PMID: 36104170 DOI: 10.1266/ggs.21-00072] [Reference Citation Analysis]
507 Mir MA. Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors.. [DOI: 10.21203/rs.3.rs-2053542/v1] [Reference Citation Analysis]
508 Ke B, Liang Z, Li B, Wang X, Liu N, Liang H, Zhang R. Expression and Prognostic Significance of EDIL3 in Gastric Cancer.. [DOI: 10.21203/rs.3.rs-2055502/v1] [Reference Citation Analysis]
509 Guo Q, Qiu P, Yao Q, Chen J, Lin J, Falzone L. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/4964793] [Reference Citation Analysis]
510 Cai J, Ye Z, Hu Y, Wang Y, Ye L, Gao L, sun Q, Tong S, Sun Z, Yang J, Chen Q. FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration. Front Oncol 2022;12:998336. [DOI: 10.3389/fonc.2022.998336] [Reference Citation Analysis]
511 Cheng J, Fu J, Tan Q, Liu Z, Guo K, Zhang L, He J, Zhou B, Liu X, Li D, Fu J. The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals. Front Immunol 2022;13:958898. [DOI: 10.3389/fimmu.2022.958898] [Reference Citation Analysis]
512 Kour B, Shukla N, Bhargava H, Sharma D, Sharma A, Valadi J, Sadasukhi T, Vuree S, Suravajhala P. Identification of plausible candidates in Prostate Cancer using integrated machine learning approaches.. [DOI: 10.21203/rs.3.rs-2028971/v1] [Reference Citation Analysis]
513 Zhou M, Zhang P, Da M, Yang R, Ma Y, Zhao J, Ma T, Xia J, Shen G, Chen Y, Chen D. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment. Front Oncol 2022;12:925537. [DOI: 10.3389/fonc.2022.925537] [Reference Citation Analysis]
514 Mengyan X, Kun D, Xinming J, Yutian W, Yongqian S. Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis. Front Pharmacol 2022;13:997842. [DOI: 10.3389/fphar.2022.997842] [Reference Citation Analysis]
515 Chen M, Zhao Z, Wu L, Huang J, Yu P, Qian J, Ni T, Zhao C. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. Cell Death Dis 2022;13:784. [PMID: 36096885 DOI: 10.1038/s41419-022-05222-9] [Reference Citation Analysis]
516 Li L, Lu S, Ma C. Anti-proliferative and pro-apoptotic effects of curcumin on skin cutaneous melanoma: Bioinformatics analysis and in vitro experimental studies. Front Genet 2022;13:983943. [DOI: 10.3389/fgene.2022.983943] [Reference Citation Analysis]
517 Chen S, Li Y, Ouyang Z, Fu W, Li Q, You X. Candidate biomarkers for diagnosis and prognosis of prostate cancer based on bioinformatics methods.. [DOI: 10.21203/rs.3.rs-2031095/v1] [Reference Citation Analysis]
518 Su H, Hailin Z, Dongdong L, Jiang Y, Shuncheng H, Shun Z, Dan L, Biao P. Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p. J Neurooncol 2022. [PMID: 36094613 DOI: 10.1007/s11060-022-04113-5] [Reference Citation Analysis]
519 Meng X, Li W, Yuan H, Dong W, Xiao W, Zhang X. KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion. Biol Proced Online 2022;24:12. [PMID: 36096734 DOI: 10.1186/s12575-022-00174-y] [Reference Citation Analysis]
520 Wang J, Li T, Wei S, Zhao G, Ye C, Ma Q, Ma J, Cheng X, Zheng M. Identification of Novel Hypoxia Subtypes for Prognosis Based on Machine Learning Algorithms. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/1508113] [Reference Citation Analysis]
521 You S, Zhu X, Yang Y, Du X, Song K, Zheng Q, Zeng P, Yao Q, Muthu M. SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells. Journal of Oncology 2022;2022:1-21. [DOI: 10.1155/2022/5864826] [Reference Citation Analysis]
522 Hermawan A, Putri H. Computational analysis of G-protein-coupled receptor kinase family members as potential targets for colorectal cancer therapy. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00349-y] [Reference Citation Analysis]
523 Xiao Y, Zhang B, Cloyd JM, Xu G, Du S, Mao Y, Pawlik TM. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. Surg Oncol 2022;44:101849. [PMID: 36116415 DOI: 10.1016/j.suronc.2022.101849] [Reference Citation Analysis]
524 Chen Y, Zhang J, Yang Y, Xiang K, Li H, Sun D, Chen L. Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression. Journal Cellular Physiology. [DOI: 10.1002/jcp.30876] [Reference Citation Analysis]
525 Huang Q, Han Y, Shen E, Feng Z, Peng Y, Gao L, Gao Y, Liu Y, Li W, Liu P, Chen Y, Guo C, Zeng S, Cai C, Shen H. MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma. iScience 2023;26:105095. [PMID: 36713263 DOI: 10.1016/j.isci.2022.105095] [Reference Citation Analysis]
526 Fang J, Zhen J, Gong Y, Ke Y, Fu B, Jiang Y, Xie J, Liu Y, Ding Y, Huang D, Xiao F. MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma. Aging. [DOI: 10.18632/aging.204280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
527 Hu D, Zhang W, Shi Z, Zhang M, Li R, Wang Q, Ji X, Qu Y. FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC. Front Genet 2022;13:937069. [DOI: 10.3389/fgene.2022.937069] [Reference Citation Analysis]
528 Chen X, Jiang J, Liu H, Li A, Wang W, Ni Z, Lin M. MSR1 characterized by chromatin accessibility mediates M2 macrophage polarization to promote gastric cancer progression. Int Immunopharmacol 2022;112:109217. [PMID: 36095948 DOI: 10.1016/j.intimp.2022.109217] [Reference Citation Analysis]
529 Zhang F, Lin J, Zhu D, Tang Y, Lu Y, Liu Z, Wang X. Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma. Front Oncol 2022;12:970208. [DOI: 10.3389/fonc.2022.970208] [Reference Citation Analysis]
530 Zhu Z, Kiang KM, Li N, Liu J, Zhang P, Jin L, He X, Zhang S, Leung GK. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma. Cancer Lett 2022;549:215903. [PMID: 36089117 DOI: 10.1016/j.canlet.2022.215903] [Reference Citation Analysis]
531 Wei H, Li W, Yang M, Fang Q, Nian J, Huang Y, Wei Q, Huang Z, Liu G, Xu Z, Hu A, Pu J. ZNNT1/osteopontin/S100A9 feedback loop promote hepatocellular carcinoma progression via mediating crosstalk between hepatocellular carcinoma cells and macrophages.. [DOI: 10.21203/rs.3.rs-2034019/v1] [Reference Citation Analysis]
532 Zhou C, Lin A, Zhang J, Luo P. MOAHIT: a web tool for visualizing tumor multi-omics data with human anatomy heatmaps.. [DOI: 10.1101/2022.09.07.506938] [Reference Citation Analysis]
533 Chen K, Gong S, Fang X, Li Q, Ye M, Li J, Huang S, Zhao Y, Liu N, Li Y, Ma J. Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer. Front Immunol 2022;13:920136. [DOI: 10.3389/fimmu.2022.920136] [Reference Citation Analysis]
534 Meškytė EM, Pezzè L, Forcato M, Bocci IA, Bisio A, Bicciato S, Baltriukienė D, Ciribilli Y. ETV7 reduces inflammatory responses in breast cancer cells by repressing TNFR1/NF-κB axis.. [DOI: 10.1101/2022.09.06.506542] [Reference Citation Analysis]
535 Yang C, Song D, Zhao F, Wu J, Zhang B, Ren H, Sun Q, Qin S. Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer. Front Oncol 2022;12:936952. [DOI: 10.3389/fonc.2022.936952] [Reference Citation Analysis]
536 Shi H, Cheng Y, Shi Q, Liu W, Yang X, Wang S, Wei L, Chen X, Fang H. Myoferlin disturbs redox equilibrium to accelerate gastric cancer migration. Front Oncol 2022;12:905230. [DOI: 10.3389/fonc.2022.905230] [Reference Citation Analysis]
537 Dilmac S, Kuscu N, Caner A, Yildirim S, Yoldas B, Farooqi AA, Tanriover G. SIRT1/FOXO Signaling Pathway in Breast Cancer Progression and Metastasis. IJMS 2022;23:10227. [DOI: 10.3390/ijms231810227] [Reference Citation Analysis]
538 Chen W, Yang Z, Chen Y, Trivanovic D. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma. Disease Markers 2022;2022:1-20. [DOI: 10.1155/2022/3594901] [Reference Citation Analysis]
539 Li H, Zhu R, Liu X, Zhao K, Hong D, Li T. Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/3341038] [Reference Citation Analysis]
540 Zhang Y, Kong X, Xin S, Bi L, Sun X, Jia S. Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/8227806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
541 Wen J, Aili A, Yan YX, Lai Y, Niu S, He S, Zhang X, Zhang G, Li J. OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism. Front Oncol 2022;12:977348. [DOI: 10.3389/fonc.2022.977348] [Reference Citation Analysis]
542 Du Y, He L, Ye X, Chen S, Li G, Yu Y, Ye E, Huang Y, Zhou Y, Zhang W, Yang C, B S. To Explore the Molecular Mechanism of Acupuncture Alleviating Inflammation and Treating Obesity Based on Text Mining. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/3133096] [Reference Citation Analysis]
543 Qian S, Lin S, Xu X, Bai H, Yeerken A, Ying X, Li Z, Fei X, Yang J, Tang M, Wang J, Jin M, Chen K. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis. Clin Epigenetics 2022;14:111. [PMID: 36064442 DOI: 10.1186/s13148-022-01328-1] [Reference Citation Analysis]
544 Zhang K, Yu C, Tian R, Zhang W, Tang S, Wang G. Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase : PAX3 downregulation inhibits melanoma progression. Mol Biol Rep 2022. [PMID: 36057879 DOI: 10.1007/s11033-022-07706-5] [Reference Citation Analysis]
545 Guo S, Wang X, Zhou H, Gao Y, Wang P, Zhi H, Sun Y, Zhang Y, Gan J, Xiao Y, Ning S. PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity. Biomolecules 2022;12:1226. [PMID: 36139065 DOI: 10.3390/biom12091226] [Reference Citation Analysis]
546 Yu W, He G, Zhang W, Ye Z, Zhong Z, Huang S. INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer. Front Genet 2022;13:933862. [DOI: 10.3389/fgene.2022.933862] [Reference Citation Analysis]
547 Doepner M, Lee I, Natale CA, Brathwaite R, Venkat S, Kim SH, Wei Y, Vakoc CR, Capell BC, Katzenellenbogen JA, Katzenellenbogen BS, Feigin ME, Ridky TW. Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling. Sci Adv 2022;8:eabn4007. [PMID: 36054350 DOI: 10.1126/sciadv.abn4007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Chen W, Wang Y, Wang L, Zhao H, Li X, Hu S. CKAP2L Promotes Esophageal Squamous Cell Carcinoma Progression and Drug-Resistance by Modulating Cell Cycle. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/2378253] [Reference Citation Analysis]
549 Liu Y, Yang J, Ke RS, Wu L, Hong Z, Guo P, Feng L, Li Z. LINC02875 Upregulation Contributed to Poor Prognosis for the Hepatocellular Carcinoma and Progression for the Cancerous Cells. Horm Metab Res 2022. [PMID: 36055279 DOI: 10.1055/a-1913-8223] [Reference Citation Analysis]
550 Ghafouri-fard S, Safarzadeh A, Akhavan-bahabadi M, Hussen BM, Taheri M, Dilmaghani NA. Expression pattern of non-coding RNAs in non-functioning pituitary adenoma. Front Oncol 2022;12:978016. [DOI: 10.3389/fonc.2022.978016] [Reference Citation Analysis]
551 Wang K, Xu H, Wang Y, Mao J, Liu D, Zhu X, Cong Y, Wang M. Ufl1 deficiency causes skin pigmentation by up-regulation of Endothelin-1. Front Cell Dev Biol 2022;10:961675. [DOI: 10.3389/fcell.2022.961675] [Reference Citation Analysis]
552 Mesquita FP, Souza PFN, da Silva EL, Lima LB, de Oliveira LLB, Moreira-nunes CA, Zuercher WJ, Burbano RMR, de Moraes MEA, Montenegro RC. Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer. Pharmaceutics 2022;14:1841. [DOI: 10.3390/pharmaceutics14091841] [Reference Citation Analysis]
553 Wu R, Chen X, Wu H, Hu Y, Wang G, Wang H, Yang B, Fu J, Gao Y, Pi J, Xu Y. Nrf2 activation contributes to hepatic tumor-augmenting effects of developmental arsenic exposure. Sci Total Environ 2022;837:155685. [PMID: 35523338 DOI: 10.1016/j.scitotenv.2022.155685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
554 Li G, Yang M, Ran L, Jin F. Expression profile of radiotherapy sensitive genes and tumor-associated immune cell infiltration and prognosis in multiple human cancers. Journal of Radiation Research and Applied Sciences 2022;15:5-11. [DOI: 10.1016/j.jrras.2022.05.016] [Reference Citation Analysis]
555 Tan L, Lu Y. Expression Pattern and Clinical Significance of E2F Transcription Factors in Skin Cutaneous Melanoma.. [DOI: 10.21203/rs.3.rs-1946063/v1] [Reference Citation Analysis]
556 Mehdi Raei, Mahdi Bagheri, Safieh Aghaabdollahian, Masoud Ghorbani, Afshin Sadeghi. Ionizing Radiation Promotes Epithelial-Mesenchymal Transition Phenotype and Stem Cell Marker in The Lung adenocarcinoma: In Vitro and Bioinformatic Studies. Cell J 2022;24. [PMID: 36274205 DOI: 10.22074/cellj.2022.8403] [Reference Citation Analysis]
557 López-cade I, García-barberán V, Cabañas Morafraile E, Díaz-tejeiro C, Saiz-ladera C, Sanvicente A, Pérez Segura P, Pandiella A, Győrffy B, Ocaña A. Genomic mapping of copy number variations influencing immune response in breast cancer. Front Oncol 2022;12:975437. [DOI: 10.3389/fonc.2022.975437] [Reference Citation Analysis]
558 Jia Y, Cheng X, Liang W, Lin S, Li P, Yan Z, Zhang M, Ma W, Hu C, Wang B, Liu Z. CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis. Curr Res Transl Med 2022;70:103345. [PMID: 35487167 DOI: 10.1016/j.retram.2022.103345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
559 Gao L, Zhou W, Xie N, Qiu J, Huang J, Zhang Z, Hong M, Xia J, Xu J, Zhao P, Fu L, Luo Y, Jiang J, Gong H, Wang J, Dai Y, Luo D, Zou C. Yin Yang 1 promotes aggressive cell growth in high-grade breast cancer by directly transactivating kinectin 1. MedComm (2020) 2022;3:e133. [PMID: 35811688 DOI: 10.1002/mco2.133] [Reference Citation Analysis]
560 Jian F, Yanhong J, Limeng W, Guoping N, Yiqin T, Hao L, Zhaoji P. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer. International Immunopharmacology 2022;110:109008. [DOI: 10.1016/j.intimp.2022.109008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
561 Ullah MA, Farzana M, Islam MS, Moni R, Zohora US, Rahman MS. Identification of the prognostic and therapeutic values of cyclin E1 (CCNE1) gene expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: A database mining approach. Heliyon 2022;8:e10367. [DOI: 10.1016/j.heliyon.2022.e10367] [Reference Citation Analysis]
562 Ullah MA, Islam NN, Sarkar B, Araf Y, Zohora US, Rahman MS. Bioinformatics analysis on the prognostic significance of SOX9 gene and its transcriptional product in colorectal cancer. Human Gene 2022;33:201043. [DOI: 10.1016/j.humgen.2022.201043] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
563 Lu T, Xu H, Dong W, Dong H. Expression and prognosis analysis of PAQR5 in kidney cancer. Front Oncol 2022;12:955510. [DOI: 10.3389/fonc.2022.955510] [Reference Citation Analysis]
564 Tang F, Liu Z, Chen X, Yang J, Wang Z, Li Z. Current knowledge of protein palmitoylation in gliomas. Mol Biol Rep 2022. [PMID: 36044113 DOI: 10.1007/s11033-022-07809-z] [Reference Citation Analysis]
565 Zhao S, An L, Yang X, Wei Z, Zhang H, Wang Y. Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma. Front Oncol 2022;12:820587. [DOI: 10.3389/fonc.2022.820587] [Reference Citation Analysis]
566 Liu W, Liu C, You J, Chen Z, Qian C, Lin W, Yu L, Ye L, Zhao L, Zhou R. Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker. Front Cell Dev Biol 2022;10:954214. [DOI: 10.3389/fcell.2022.954214] [Reference Citation Analysis]
567 Gan J, Liu S, Zhang Y, He L, Bai L, Liao R, Zhao J, Guo M, Jiang W, Li J, Li Q, Mu G, Wu Y, Wang X, Zhang X, Zhou D, Lv H, Wang Z, Zhang Y, Qian C, Feng M, Chen H, Meng Q, Huang X. MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis. Exp Mol Med 2022. [PMID: 36042375 DOI: 10.1038/s12276-022-00837-6] [Reference Citation Analysis]
568 Song Y, Wang Z, He L, Sun F, Zhang B, Wang F, Pan J. Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC. Journal of Oncology 2022;2022:1-22. [DOI: 10.1155/2022/4714931] [Reference Citation Analysis]
569 Yang H, Che D, Gu Y, Cao D. Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma. Front Genet 2022;13:940306. [DOI: 10.3389/fgene.2022.940306] [Reference Citation Analysis]
570 Jia Y, Liu Z, Cheng X, Liu R, Li P, Kong D, Liang W, Liu B, Wang H, Bu X, Gao Y. DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients. J Mol Neurosci 2022. [PMID: 36040678 DOI: 10.1007/s12031-022-02054-2] [Reference Citation Analysis]
571 Kong F, Wang K. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-1992254/v1] [Reference Citation Analysis]
572 Li Y, Fan T, Li X, Liu L, Mao F, Li Y, Miao Z, Zeng C, Song W, Pan J, Zhou S, Wang H, Wang Y, Sun ZS. Npas3 deficiency impairs cortical astrogenesis and induces autistic-like behaviors. Cell Rep 2022;40:111289. [PMID: 36044858 DOI: 10.1016/j.celrep.2022.111289] [Reference Citation Analysis]
573 Zong W, Liu C, Zhang Y, Zhang S, Qu W, Luo X, Pan J. Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/8615949] [Reference Citation Analysis]
574 Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W, Liu H, Chu Y, Cao J, Jiang M, Yang S, Shi Y, Xie X, Chen F, Han Y, Qin W, Xu B, Liang J. Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death Dis 2022;13:742. [PMID: 36038548 DOI: 10.1038/s41419-022-05192-y] [Reference Citation Analysis]
575 Chen R, Chai C, Ma S, Guan Q, Wu D. The bioinformatics and experimental analysis of CD276 for prognosis and immune infiltrates in colon adenocarcinoma.. [DOI: 10.21203/rs.3.rs-1987050/v1] [Reference Citation Analysis]
576 Xu Q, Yang H, Fan G, Zhang B, Yu J, Zhang Z, Jia G. Clinical importance of PLA2R1 and RASSF9 in thyroid cancer and their inhibitory roles on the Wnt/β-catenin pathway and thyroid cancer cell malignant behaviors. Pathol Res Pract 2022;238:154092. [PMID: 36049438 DOI: 10.1016/j.prp.2022.154092] [Reference Citation Analysis]
577 Yu Q, Ge X, Wang Z, Ding S, Jin Y, Chen L, Zhang Z. Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/3588117] [Reference Citation Analysis]
578 Penugurti V, Mishra YG, Manavathi B. AMPK: An odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene. Biochim Biophys Acta Rev Cancer 2022;1877:188785. [PMID: 36031088 DOI: 10.1016/j.bbcan.2022.188785] [Reference Citation Analysis]
579 Zhang G, Sun J. Endoplasmic Reticulum Stress-Related Signature for Predicting Prognosis and Immune Features in Hepatocellular Carcinoma. J Immunol Res 2022;2022:1366508. [PMID: 36003068 DOI: 10.1155/2022/1366508] [Reference Citation Analysis]
580 Mattes A, Gamez MP, Martin E, Boryn L, Baskaran P, Huber HJ, Schuler M, Park JE, Swee LK. Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells.. [DOI: 10.1101/2022.08.26.505456] [Reference Citation Analysis]
581 Zhao Y, Feng X, Zhao Y, Yang H, Zhang C. Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3. Mol Biotechnol 2022. [PMID: 36030355 DOI: 10.1007/s12033-022-00536-7] [Reference Citation Analysis]
582 Zhou C, Chen Z, Xiao B, Xiang C, Li A, Zhao Z, Li H. Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma. Front Cell Dev Biol 2022;10:951363. [DOI: 10.3389/fcell.2022.951363] [Reference Citation Analysis]
583 Alhammad R. Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer. Diagnostics 2022;12:2067. [DOI: 10.3390/diagnostics12092067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
584 Fu J, Sun H, Xu F, Chen R, Wang X, Ding Q, Xia T. RUNX regulated immune-associated genes predicts prognosis in breast cancer. Front Genet 2022;13:960489. [DOI: 10.3389/fgene.2022.960489] [Reference Citation Analysis]
585 Yang S, Zhang Y, Hua Y, Cui M, Wang M, Gao J, Liu Q, Liao Q. GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma. Front Oncol 2022;12:968610. [DOI: 10.3389/fonc.2022.968610] [Reference Citation Analysis]
586 Puzanov GA. Identification of key genes of the ccRCC subtype with poor prognosis. Sci Rep 2022;12:14588. [PMID: 36028558 DOI: 10.1038/s41598-022-18620-y] [Reference Citation Analysis]
587 Tu J, Tang M, Li G, Chen L, Wang Y, Huang Y, Zheng M. Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and its Role in Evaluation of Prognosis. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/4181658] [Reference Citation Analysis]
588 Li C, Gao Y, Lu C, Guo M. Identification of potential biomarkers for colorectal cancer by bioinformatics analysis and analysis of associated survival by Kaplan-Meier curves.. [DOI: 10.21203/rs.3.rs-1702249/v1] [Reference Citation Analysis]
589 Xu J, Chen S, Liang J, Hao T, Wang H, Liu G, Jin X, Li H, Zhang J, Zhang C, He Y. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Front Immunol 2022;13:922138. [DOI: 10.3389/fimmu.2022.922138] [Reference Citation Analysis]
590 Nagar G, Mittal P, Gupta SRR, Pahuja M, Sanger M, Mishra R, Singh A, Singh IK. Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting. Brief Funct Genomics 2022:elac026. [PMID: 36003055 DOI: 10.1093/bfgp/elac026] [Reference Citation Analysis]
591 Li C, Chen S, Jia W, Li W, Wei D, Cao S, Qian Y, Guan R, Liu H, Lei D. Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma. Front Immunol 2022;13:955614. [DOI: 10.3389/fimmu.2022.955614] [Reference Citation Analysis]
592 Huang R, Huang D, Wang S, Xian S, Liu Y, Jin M, Zhang X, Chen S, Yue X, Zhang W, Lu J, Liu H, Huang Z, Zhang H, Yin H. Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis. Front Genet 2022;13:952162. [DOI: 10.3389/fgene.2022.952162] [Reference Citation Analysis]
593 Xie L, Zhang Y, Xu Y, Hu F, Zheng C, Wu C, Xu J. A Pan-Cancer Analysis of SRD5A1, a Potential New Carcinogenic Indicator Related to Immune Infiltration and Prognosis of UCEC.. [DOI: 10.21203/rs.3.rs-1951445/v1] [Reference Citation Analysis]
594 Wang Z, Ge X, Shi J, Lu B, Zhang X, Huang J, shi W. SPTSSA Is a Prognostic Marker for Glioblastoma Associated with Tumor-Infiltrating Immune Cells and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/6711085] [Reference Citation Analysis]
595 Liu N, Zhang GD, Bai P, Su L, Tian H, He M. Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study. World J Clin Oncol 2022; 13(8): 675-687 [PMID: 36160462 DOI: 10.5306/wjco.v13.i8.675] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
596 Wang J, Qiao S, Liang S, Qian C, Dong Y, Pei M, Wang H, Wan G. TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM. Front Mol Biosci 2022;9:985434. [DOI: 10.3389/fmolb.2022.985434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
597 Chen X, Wang X, Zhu F, Qian C, Xu F, Huang X, Zhang W, Sun B, Bonam SR. HBV Infection-Related PDZK1 Plays an Oncogenic Role by Regulating the PI3K-Akt Pathway and Fatty Acid Metabolism and Enhances Immunosuppression. Journal of Immunology Research 2022;2022:1-18. [DOI: 10.1155/2022/8785567] [Reference Citation Analysis]
598 You Y, Wen D, Zeng L, Lu J, Xiao X, Chen Y, Song H, Liu Z. ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression. Int J Biol Sci 2022;18:5001-18. [PMID: 35982895 DOI: 10.7150/ijbs.70149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
599 Hao X, Zhang M, Gu M, Wang Z, Zhou S, Li W, Xu S. Long non-coding RNA BZRAP1-AS1 functions in malignancy and prognosis for non-small-cell lung cancer. PeerJ 2022;10:e13871. [PMID: 36032951 DOI: 10.7717/peerj.13871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
600 Heo H, Kim JH, Lim HJ, Kim JH, Kim M, Koh J, Im JY, Kim BK, Won M, Park JH, Shin YJ, Yun MR, Cho BC, Kim YS, Kim SY, Kim M. DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy. Exp Mol Med 2022. [PMID: 35999456 DOI: 10.1038/s12276-022-00836-7] [Reference Citation Analysis]
601 Geng R, Chen T, Zhong Z, Ni S, Bai J, Liu J. The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer. Cancers (Basel) 2022;14:4056. [PMID: 36011053 DOI: 10.3390/cancers14164056] [Reference Citation Analysis]
602 Mesbah G, Namazi F, T. Shamsabadi F, Maleki Z, Nasirikenari M, Shahbazi M. In vivo assessment of simultaneous G1 cyclins silencing by a tumor-specific bidirectional promoter on the mammary tumor in nude mice. Front Vet Sci 2022;9. [DOI: 10.3389/fvets.2022.914311] [Reference Citation Analysis]
603 Cheng L, Wang Z, Nie L, Yang C, Huang H, Lin J, Zhuo D. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Int Immunopharmacol 2022;111:109169. [PMID: 36007389 DOI: 10.1016/j.intimp.2022.109169] [Reference Citation Analysis]
604 Wang X, Sun R, Hong X, Chen C, Ding Y, Zhang Z. KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/9799346] [Reference Citation Analysis]
605 Verma A, Arya R, Brahmachari V. Identification of a polycomb responsive region in human HoxA cluster and its long-range interaction with polycomb enriched genomic regions. Gene 2022;:146832. [PMID: 36007803 DOI: 10.1016/j.gene.2022.146832] [Reference Citation Analysis]
606 Ju G, Yao Z, Zhao Y, Zhao X, Liu F. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.. [DOI: 10.21203/rs.3.rs-1956294/v1] [Reference Citation Analysis]
607 Yan P, Li Z, Xian S, Wang S, Fu Q, Zhu J, Yue X, Zhang X, Chen S, Zhang W, Lu J, Yin H, Huang R, Huang Z. Construction of the prognostic enhancer RNA regulatory network in osteosarcoma. Transl Oncol 2022;25:101499. [PMID: 36001923 DOI: 10.1016/j.tranon.2022.101499] [Reference Citation Analysis]
608 Liu C, Liu J, Shao J, Huang C, Dai X, Shen Y, Hou W, Shen Y, Yu Y. MAGED4B Promotes Glioma Progression via Inactivation of the TNF-α-induced Apoptotic Pathway by Down-regulating TRIM27 Expression. Neurosci Bull . [DOI: 10.1007/s12264-022-00926-6] [Reference Citation Analysis]
609 Wang Y, Shen Z, Mo S, Dai L, Song B, Gu W, Ding X, Zhang X. Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma. Transl Oncol 2022;25:101519. [PMID: 35998436 DOI: 10.1016/j.tranon.2022.101519] [Reference Citation Analysis]
610 Tian L, Liao Y. Identification of G6PC as a potential prognostic biomarker in hepatocellular carcinoma based on bioinformatics analysis. Medicine (Baltimore) 2022;101:e29548. [PMID: 35984176 DOI: 10.1097/MD.0000000000029548] [Reference Citation Analysis]
611 Li JW, Huang QR, Mo LG. CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas. Medicine (Baltimore) 2022;101:e30044. [PMID: 35984129 DOI: 10.1097/MD.0000000000030044] [Reference Citation Analysis]
612 Liu E, Wu X, Wang L, Huo Y, Wu H, Li L, Cheng L. DSCN: Double-target selection guided by CRISPR screening and network. PLoS Comput Biol 2022;18:e1009421. [DOI: 10.1371/journal.pcbi.1009421] [Reference Citation Analysis]
613 Yu H, Zou D, Ni N, Zhang S, Zhang Q, Yang L. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway. J Ovarian Res 2022;15. [DOI: 10.1186/s13048-022-01030-z] [Reference Citation Analysis]
614 Sunami Y, Chen Y, Trojanowicz B, Sommerer M, Hämmerle M, Eils R, Kleeff J. Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients. Cells 2022;11:2583. [PMID: 36010660 DOI: 10.3390/cells11162583] [Reference Citation Analysis]
615 Rudjord-levann A, Ye Z, Hafkenscheid L, Horn S, Wiegertjes R, Nielsen M, Mathiesen C, Stoop J, Stowell S, Straten P, lefler H, Vakhrushev S, Dabelsteen S, Olsen J, Wandall H. Galectin-1 upregulates IDO1 and PD-L1 and induces a tolerogenic tumor-associated macrophage phenotype.. [DOI: 10.21203/rs.3.rs-1936493/v1] [Reference Citation Analysis]
616 Li S, Wu Z, Li Q, Liang Q, Zhou H, Shi Y, Zhang R, Pan H. The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-16. [DOI: 10.1155/2022/1150390] [Reference Citation Analysis]
617 Li S, Jiang X, Guan M, Zhang Y, Cao Y, Zhang L. The overexpression of GPX8 is correlated with poor prognosis in GBM patients. Front Genet 2022;13:898204. [DOI: 10.3389/fgene.2022.898204] [Reference Citation Analysis]
618 Wang X, Fang J, Wang A, Zhu W. TMEM201 overexpression is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-1841990/v1] [Reference Citation Analysis]
619 Hermawan A, Wulandari F, Hanif N, Utomo RY, Jenie RI, Ikawati M, Tafrihani AS. Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study. Sci Rep 2022;12:13928. [PMID: 35977996 DOI: 10.1038/s41598-022-18348-9] [Reference Citation Analysis]
620 Wei M, Li M, Li C, Zhang X, Ma H, Du X, Wang Q, Zhao H. A risk model including eight tumor microenvironment-related genes for prediction of lung cancer prognosis.. [DOI: 10.21203/rs.3.rs-1940330/v1] [Reference Citation Analysis]
621 Santos NJ, Camargo ACL, Carvalho HF, Justulin LA, Felisbino SL. Prostate Cancer Secretome and Membrane Proteome from Pten Conditional Knockout Mice Identify Potential Biomarkers for Disease Progression. IJMS 2022;23:9224. [DOI: 10.3390/ijms23169224] [Reference Citation Analysis]
622 Chen H, Zhou L, Li J, Hu K. ALKBH family members as novel biomarkers and prognostic factors in human breast cancer. Aging (Albany NY) 2022;14. [PMID: 35980268 DOI: 10.18632/aging.204231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Piipponen M, Riihilä P, Knuutila JS, Kallajoki M, Kähäri V, Nissinen L. Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma. Cancers 2022;14:3980. [DOI: 10.3390/cancers14163980] [Reference Citation Analysis]
624 Wei W, Zhang Y. PSEN1 is associated with colon cancer development via potential influences on PD-L1 nuclear translocation and tumor-immune interactions. Front Immunol 2022;13:927474. [DOI: 10.3389/fimmu.2022.927474] [Reference Citation Analysis]
625 Cheng T, Wu Y, Liu Z, Yu Y, Sun S, Guo M, Sun B, Huang C. CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. Front Immunol 2022;13:970950. [DOI: 10.3389/fimmu.2022.970950] [Reference Citation Analysis]
626 Fang Z, Wang F, Zhang M, Huang H, Lin Z. Identification of Co-Expression Modules and Genes Associated With Tumor Progression in Oral Squamous Cell Carcinoma. Pathol Oncol Res 2022;28:1610481. [DOI: 10.3389/pore.2022.1610481] [Reference Citation Analysis]
627 Wang D, Wang Z, Tao Y. Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma. Biomed Res Int 2022;2022:8360481. [PMID: 36017386 DOI: 10.1155/2022/8360481] [Reference Citation Analysis]
628 Gupta P, Strange K, Telange R, Guo A, Hatch H, Sobh A, Elie J, Carter AM, Totenhagen J, Tan C, Sonawane YA, Neuzil J, Natarajan A, Ovens AJ, Oakhill JS, Wiederhold T, Pacak K, Ghayee HK, Meijer L, Reddy S, Bibb JA. Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer. Cell Rep 2022;40:111218. [PMID: 35977518 DOI: 10.1016/j.celrep.2022.111218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Hussein M, Mueller L, Issa PP, Haidari M, Trinh L, Toraih E, Kandil E. Latency Trend Analysis as a Guide to Screening Malignancy Survivors for Second Primary Thyroid Cancer. Biomedicines 2022;10:1984. [DOI: 10.3390/biomedicines10081984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
630 Koumarianou P, Fernández-méndez C, Fajardo-delgado D, Mielu LM, Santisteban P, De la Vieja A. Basolateral Sorting of the Sodium/Iodide Symporter Is Mediated by Adaptor Protein 1 Clathrin Adaptor Complexes. Thyroid 2022. [DOI: 10.1089/thy.2022.0163] [Reference Citation Analysis]
631 Wang Y, Sun Z, Lu S, Zhang X, Xiao C, Li T, Wu J. Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma. Front Oncol 2022;12:834524. [DOI: 10.3389/fonc.2022.834524] [Reference Citation Analysis]
632 Kong F, Xiong Y, Ye Q. Comprehensive Analysis of Prognosis and Immune Function of CD70-CD27 Signaling Axis in Pan-Cancer.. [DOI: 10.21203/rs.3.rs-1949691/v1] [Reference Citation Analysis]
633 Chikhaoui A, Jones M, Režen T, Ben Ahmed M, Naouali C, Komel R, Zghal M, Boubaker S, Abdelhak S, Yacoub-Youssef H. Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma. Sci Rep 2022;12:13854. [PMID: 35974070 DOI: 10.1038/s41598-022-17928-z] [Reference Citation Analysis]
634 Wang C, Zong X, Wu F, Leung RWT, Hu Y, Qin J. DNA- and RNA-Binding Proteins Linked Transcriptional Control and Alternative Splicing Together in a Two-Layer Regulatory Network System of Chronic Myeloid Leukemia. Front Mol Biosci 2022;9:920492. [DOI: 10.3389/fmolb.2022.920492] [Reference Citation Analysis]
635 Deng Y, Yang X, Hua H, Zhang C. IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer. Int J Gen Med 2022;15:6485-97. [PMID: 35966504 DOI: 10.2147/IJGM.S370576] [Reference Citation Analysis]
636 Wei L, Wang W, Yao J, Cui Z, Xu Z, Ding H, Wu X, Wang D, Luo J, Ke ZJ. PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation. Oncogene 2022. [PMID: 35974143 DOI: 10.1038/s41388-022-02431-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
637 Huang Q, Li XM, Sun JP, Zhou Y. Tumor-derived endomucin promotes colorectal cancer proliferation and metastasis. Cancer Med 2022. [PMID: 35971319 DOI: 10.1002/cam4.5055] [Reference Citation Analysis]
638 Zhang YJ, Zhao LY, He X, Yao RF, Lu F, Lu BN, Pang ZR. CBXs-related prognostic gene signature correlates with immune microenvironment in gastric cancer. Aging. [DOI: 10.18632/aging.204214] [Reference Citation Analysis]
639 Zhu W, Wang J, Liu X, Xu Y, Zhai R, Zhang J, Wang M, Wang M, Liu L. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell Death Dis 2022;13:703. [PMID: 35963855 DOI: 10.1038/s41419-022-05157-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
640 Pan Z, Chen Y, Pang H, Wang X, Zhang Y, Xie X, He G. Design, synthesis, and biological evaluation of novel dual inhibitors of heat shock protein 90/mammalian target of rapamycin (Hsp90/mTOR) against bladder cancer cells. Eur J Med Chem 2022;242:114674. [PMID: 35987020 DOI: 10.1016/j.ejmech.2022.114674] [Reference Citation Analysis]
641 Zhang G, Lv X, Yang Q, Liu H. Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma. BMC Cancer 2022;22:888. [PMID: 35964022 DOI: 10.1186/s12885-022-09987-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
642 Zhang D, Cui F, Peng L, Wang M, Yang X, Xia C, Li K, Yin H, Zhang Y, Yu Q, Jin Z, Huang H. Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma. Aging (Albany NY) 2022;14. [PMID: 35963640 DOI: 10.18632/aging.204221] [Reference Citation Analysis]
643 Fujii M, Suehiro T, Hoang N, Matsuki T, Mine Y, Nikawa H, Asano K. PDGF regulates proliferation of malignant mesothelioma cells via CTGF protein control.. [DOI: 10.21203/rs.3.rs-1905395/v1] [Reference Citation Analysis]
644 Chen X, Lin Q, Jiang Y, Wang C, Min F, Ou Y, Xia Y, Yu G, Liu R, Ali HH. Identification of Potential Biomarkers of Platelet RNA in Glioblastoma by Bioinformatics Analysis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/2488139] [Reference Citation Analysis]
645 Zou Z, Sun Y, Wang L, Ma S, Sun C, Zhou Y, Yang G. GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma. Medicine (Baltimore) 2022;101:e29645. [PMID: 35960100 DOI: 10.1097/MD.0000000000029645] [Reference Citation Analysis]
646 Baczewska M, Supruniuk E, Bojczuk K, Guzik P, Milewska P, Konończuk K, Dobroch J, Chabowski A, Knapp P. Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications. IJMS 2022;23:8968. [DOI: 10.3390/ijms23168968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 Caruso FP, D'Andrea MR, Coppola L, Landriscina M, Condelli V, Cerulo L, Giordano G, Porras A, Pancione M. Lymphocyte antigen 6G6D-mediated modulation through p38α MAPK and DNA methylation in colorectal cancer. Cancer Cell Int 2022;22:253. [PMID: 35953834 DOI: 10.1186/s12935-022-02672-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
648 Niu N, Li Y, Yu H, Guo L, Guo Z, Lan S, Liu Q, Zhang Y, Gui J, Wu D. The oncogenic function and potential mechanism of basic transcription factor 3 in melanoma.. [DOI: 10.21203/rs.3.rs-1946197/v1] [Reference Citation Analysis]
649 Ahmed MM, Shafat Z, Tazyeen S, Ali R, Almashjary MN, Al-raddadi R, Harakeh S, Alam A, Haque S, Ishrat R. Identification of pathogenic genes associated with CKD: An integrated bioinformatics approach. Front Genet 2022;13:891055. [DOI: 10.3389/fgene.2022.891055] [Reference Citation Analysis]
650 Ran Z, Yang J, Liu Y, Chen X, Ma Z, Wu S, Huang Y, Song Y, Gu Y, Zhao S, Fa M, Lu J, Chen Q, Cao Z, Li X, Sun S, Yang T. GlioMarker: An integrated database for knowledge exploration of diagnostic biomarkers in gliomas. Front Oncol 2022;12:792055. [DOI: 10.3389/fonc.2022.792055] [Reference Citation Analysis]
651 Zeng Z, Zhang J, Li J, Li Y, Huang Z, Han L, Xie C, Gong Y. SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma. Front Genet 2022;13:935601. [DOI: 10.3389/fgene.2022.935601] [Reference Citation Analysis]
652 Jin Y, Wang Z, Xiang K, Zhu Y, Cheng Y, Cao K, Jiang J. Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma. Front Genet 2022;13:900911. [DOI: 10.3389/fgene.2022.900911] [Reference Citation Analysis]
653 Dai L, Mugaanyi J, Cai X, Dong M, Lu C, Lu C. Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model. Sci Rep 2022;12:13639. [PMID: 35948625 DOI: 10.1038/s41598-022-17954-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
654 Houghton-gisby J, Kerslake R, Karteris E, Mokbel K, Harvey AJ. ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells. IJMS 2022;23:8881. [DOI: 10.3390/ijms23168881] [Reference Citation Analysis]
655 He D, Qin Z, Liu Z, Ji X, Gao J, Guo H, Yang F, Fan H, Wei Y, Wang Z, Liu Q, Pang Q. Comprehensive Analysis of the Prognostic Value and Immune Infiltration of Butyrophilin Subfamily 2/3 (BTN2/3) Members in Pan-Glioma. Front Oncol 2022;12:816760. [DOI: 10.3389/fonc.2022.816760] [Reference Citation Analysis]
656 Wei S, Zhao Q, Zheng K, Liu P, Sha N, Li Y, Ma C, Li J, Zhuo L, Liu G, Liang W, Jiang Y, Chen T, Zhong N. GFAT1-linked TAB1 glutamylation sustains p38 MAPK activation and promotes lung cancer cell survival under glucose starvation. Cell Discov 2022;8:77. [PMID: 35945223 DOI: 10.1038/s41421-022-00423-0] [Reference Citation Analysis]
657 Li X, Li J, Zhao L, Wang Z, Zhang P, Xu Y, Wu G, Chen L. Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-33. [DOI: 10.1155/2022/2465598] [Reference Citation Analysis]
658 Zhang C, Xu H, Sui X, Wu T, Chen B, Wang S, Wang X, Wang F. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-27. [DOI: 10.1155/2022/7073472] [Reference Citation Analysis]
659 Wang T, Bai J, Zhang Y, Xue Y, Peng Q. N6-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma. Front Immunol 2022;13:918522. [DOI: 10.3389/fimmu.2022.918522] [Reference Citation Analysis]
660 Rao D, Yu C, Wang T, Sheng J, Lv E, Liang H, Huang W, Dong H. Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker. Int Immunopharmacol 2022;111:109091. [PMID: 35952516 DOI: 10.1016/j.intimp.2022.109091] [Reference Citation Analysis]
661 Xu M, Ren P, Tian J, Xiao L, Hu P, Chen P, Li W, Xue L. dGLYAT modulates Gadd45-mediated JNK activation and cell invasion. Cell Div 2022;17. [DOI: 10.1186/s13008-022-00080-5] [Reference Citation Analysis]
662 Rodríguez TC, Kwan SY, Smith JL, Dadafarin S, Wu CH, Sontheimer EJ, Xue W. Multiomics characterization of mouse hepatoblastoma identifies yes-associated protein 1 target genes. Hepatology 2022. [PMID: 35932276 DOI: 10.1002/hep.32713] [Reference Citation Analysis]
663 Wang QQ, Zhou YC, Zhou Ge YJ, Qin G, Yin TF, Zhao DY, Tan C, Yao SK. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer. World J Clin Cases 2022; 10(22): 7686-7697 [DOI: 10.12998/wjcc.v10.i22.7686] [Reference Citation Analysis]
664 Jiao Y, Li S, Wang X, Yi M, Wei H, Rong S, Zheng K, Zhang L. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer. Front Immunol 2022;13:929846. [DOI: 10.3389/fimmu.2022.929846] [Reference Citation Analysis]
665 Liu K, Cui L, Li C, Tang C, Niu Y, Hao J, Bu Y, Chen B. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker. Front Genet 2022;13:922472. [DOI: 10.3389/fgene.2022.922472] [Reference Citation Analysis]
666 Zhang C, Zeng Y, Guo X, Shen H, Zhang J, Wang K, Ji M, Huang S. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front Genet 2022;13:923737. [DOI: 10.3389/fgene.2022.923737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
667 Jiang Y, Wang X, Li L, He J, Jin Q, Long D, Liu C, Zhou W, Liu K. A systematic analysis of C5ORF46 in gastrointestinal tumors as a potential prognostic and immunological biomarker. Front Genet 2022;13:926943. [DOI: 10.3389/fgene.2022.926943] [Reference Citation Analysis]
668 López-mejía JA, Tallabs-utrilla LF, Salazar-sojo P, Mantilla-ollarves JC, Sánchez-carballido MA, Rocha-zavaleta L. c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment. IJMS 2022;23:8702. [DOI: 10.3390/ijms23158702] [Reference Citation Analysis]
669 Khalaji A, Haddad S, Yazdani Y, Moslemi M, Alizadeh L, Baradaran B. A bioinformatics-based study on the Cisplatin-resistant lung cancer cells; what are the orchestrators of this phenom? Gene 2022;834:146668. [PMID: 35690284 DOI: 10.1016/j.gene.2022.146668] [Reference Citation Analysis]
670 Xu N, Xiao W, Meng X, Li W, Wang X, Zhang X, Yang H. Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT. Cell Death Discov 2022;8:351. [PMID: 35927229 DOI: 10.1038/s41420-022-01145-8] [Reference Citation Analysis]
671 Wu Q, Hu Q, Hai Y, Li Y, Gao Y. METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A/HN1L positive feedback circuit. J Cell Commun Signal 2022. [PMID: 35925508 DOI: 10.1007/s12079-022-00687-x] [Reference Citation Analysis]
672 Wang J, Akter R, Shahriar MF, Uddin MN. Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer. Pathol Oncol Res 2022;28:1610350. [PMID: 35991839 DOI: 10.3389/pore.2022.1610350] [Reference Citation Analysis]
673 Zhang M, Li J, Lin W, Qi L, Yao C, Zheng Z, Chen C, Duan S, Qi Y. EPAS1 Promoter Hypermethylation is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Genet Test Mol Biomarkers 2022. [PMID: 35920832 DOI: 10.1089/gtmb.2021.0305] [Reference Citation Analysis]
674 Ning X, Zhao J, He F, Yuan Y, Li B, Ruan J, Chen G. lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/3299336] [Reference Citation Analysis]
675 Sung J, Cheong J. Single Cell Analysis Reveals Reciprocal Tumor-Macrophage Intercellular Communications Related with Metabolic Reprogramming in Stem-like Gastric Cancer. Cells 2022;11:2373. [DOI: 10.3390/cells11152373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
676 Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer. Clin Transl Oncol 2022. [PMID: 35917055 DOI: 10.1007/s12094-022-02881-0] [Reference Citation Analysis]
677 Cai Y, He Q, Liu W, Liang Q, Peng B, Li J, Zhang W, Kang F, Hong Q, Yan Y, Peng J, Xu Z, Bai N. Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers. Front Oncol 2022;12:952129. [DOI: 10.3389/fonc.2022.952129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
678 Sahu SK, Agirre E, Inayatullah M, Mahesh A, Tiwari N, Lavin DP, Singh A, Strand S, Diken M, Luco RF, Belmonte JCI, Tiwari VK. A complex epigenome-splicing crosstalk governs epithelial-to-mesenchymal transition in metastasis and brain development. Nat Cell Biol 2022;24:1265-77. [PMID: 35941369 DOI: 10.1038/s41556-022-00971-3] [Reference Citation Analysis]
679 Zhang S, Jin K, Li T, Zhou M, Yang W. Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer. Exp Biol Med (Maywood) 2022;247:1317-29. [PMID: 35521936 DOI: 10.1177/15353702221085203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
680 Sun Y, Lin C, Ding Q, Dai Y. Overexpression of FOXC1 Promotes Tumor Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer. Dig Dis Sci 2022;67:3742-52. [PMID: 34427817 DOI: 10.1007/s10620-021-07226-5] [Reference Citation Analysis]
681 Wu BK, Mei SC, Chen EH, Zheng Y, Pan D. YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis. Nat Genet 2022;54:1202-13. [PMID: 35835915 DOI: 10.1038/s41588-022-01119-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
682 Zhu S, Ding W, Chen Y, Wang W, Xu R, Liu C, Liu X, Deng H. High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells. Genomics Proteomics Bioinformatics 2022;20:657-69. [PMID: 33647481 DOI: 10.1016/j.gpb.2019.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
683 Huang C, Wang N, Zhang N, Chen Z, Ni Z, Liu X, Xiong H, Xie H, Lin B, Ge B, Huang Q, Du B. Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic data. Open Biol 2022;12:210375. [PMID: 35946310 DOI: 10.1098/rsob.210375] [Reference Citation Analysis]
684 Ware AP, Kabekkodu SP, Chawla A, Paul B, Satyamoorthy K. Diagnostic and prognostic potential clustered miRNAs in bladder cancer. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03225-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
685 Nam SE, Ko YS, Park KS, Jin T, Yoo YB, Yang JH, Kim WY, Han HS, Lim SD, Lee SE, Kim WS. Overexpression of FRAT1 protein is closely related to triple-negative breast cancer. Ann Surg Treat Res 2022;103:63-71. [PMID: 36017142 DOI: 10.4174/astr.2022.103.2.63] [Reference Citation Analysis]
686 Duan J, Jin M, Qiao B. Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma. Translational Oncology 2022;22:101453. [DOI: 10.1016/j.tranon.2022.101453] [Reference Citation Analysis]
687 Xu J, Guo Z, Yuan S, Li H, Luo S. Upregulation of B3GNT3 is associated with immune infiltration and activation of NF-κB pathway in gynecologic cancers. Journal of Reproductive Immunology 2022;152:103658. [DOI: 10.1016/j.jri.2022.103658] [Reference Citation Analysis]
688 Yang X, Liu Z, Yin X, Zeng Y, Guo G. Inhibition MNK-eIF4E-β-catenin preferentially sensitizes gastric cancer to chemotherapy. Fundam Clin Pharmacol 2022;36:712-20. [PMID: 35048413 DOI: 10.1111/fcp.12759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
689 Ding F, Li F, Tang D, Wang B, Liu J, Mao X, Yin J, Xiao H, Wang J, Liu Z. Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202203546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
690 Xiao T, Lin F, Zhou J, Tang Z. The Expression and Role of Tubulin Polymerization-Promoting Protein 3 in Oral Squamous Cell Carcinoma. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105519] [Reference Citation Analysis]
691 Huang Y, Lu S, Chen Y, Qing Y, Wu R, Ma T, Zhang Z, Wang Y, Li K. Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation. Heliyon 2022;8:e10081. [PMID: 36033322 DOI: 10.1016/j.heliyon.2022.e10081] [Reference Citation Analysis]
692 Wang M, Wei Y, Li Y, Li H, Jin J, Lu Y, Li Q. Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism. Immun Inflamm Dis 2022;10:e626. [PMID: 35894707 DOI: 10.1002/iid3.626] [Reference Citation Analysis]
693 Huang C, Yi H, Zhou Y, Zhang Q, Yao X. Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK Pathway. Cancers 2022;14:3735. [DOI: 10.3390/cancers14153735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
694 Zhang Y, Zheng S, Ma L, Lin P, Shang-guan H, Lin Y, Kang D, Yao P. Elevated Hexose-6-Phosphate Dehydrogenase Regulated by OSMR-AS1/hsa-miR-516b-5p Axis Correlates with Poor Prognosis and Dendritic Cells Infiltration of Glioblastoma. Brain Sciences 2022;12:1012. [DOI: 10.3390/brainsci12081012] [Reference Citation Analysis]
695 Li G, Xu Z, Peng J, Yan Y, Liu Y, Zhang X, Qiu Y, Fu C. The RIPK family: expression profile and prognostic value in lung adenocarcinoma. Aging (Albany NY) 2022;14. [PMID: 35907206 DOI: 10.18632/aging.204195] [Reference Citation Analysis]
696 Ren L, Yi J, Yang Y, Li W, Zheng X, Liu J, Li S, Yang H, Zhang Y, Ge B, Zhang S, Fu W, Dong D, Du G, Wang X, Wang J. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. Pharmacol Res 2022;:106376. [PMID: 35914680 DOI: 10.1016/j.phrs.2022.106376] [Reference Citation Analysis]
697 Liang W, Deng L, Mo C, Chen W, Sha Y, Shi J, Hou X, Zhang Y, Yang M, Ou M. Microarray and bioinformatic analysis reveal the parental genes of m6A modified circRNAs as novel prognostic signatures in colorectal cancer. Front Oncol 2022;12:939790. [DOI: 10.3389/fonc.2022.939790] [Reference Citation Analysis]
698 Wang Y, Shen X, Gong L, Zhao Y, Xiong X. Functional characterization of FBXL7 as a novel player in human cancers. Cell Death Discov 2022;8:342. [PMID: 35906197 DOI: 10.1038/s41420-022-01143-w] [Reference Citation Analysis]
699 Hu H, Zhong T, Jiang S. H2AFX might be a prognostic biomarker for hepatocellular carcinoma. Cancer Rep (Hoboken) 2023;6:e1684. [PMID: 35903980 DOI: 10.1002/cnr2.1684] [Reference Citation Analysis]
700 Perelroizen R, Philosof B, Budick-Harmelin N, Chernobylsky T, Ron A, Katzir R, Shimon D, Tessler A, Adir O, Gaoni-Yogev A, Meyer T, Krivitsky A, Shidlovsky N, Madi A, Ruppin E, Mayo L. Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity. Brain 2022:awac222. [PMID: 35899587 DOI: 10.1093/brain/awac222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
701 Zhu J, Weng Y, Wang F, Zhao J. LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma. Open Med (Wars) 2022;17:1259-74. [PMID: 35892083 DOI: 10.1515/med-2022-0478] [Reference Citation Analysis]
702 Guo L, Kang Y, Xiong Y, Jia L, Yan X, Xia D, Yu J, Wang J, Liang T. A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma. Comput Struct Biotechnol J 2022;20:3839-50. [PMID: 35891787 DOI: 10.1016/j.csbj.2022.07.020] [Reference Citation Analysis]
703 Li P, Yuan W, Wu R, Zeng C, Li K, Lu L. Androgens in Patients With Luminal B and HER2 Breast Cancer Might Be a Biomarker Promoting Anti-PD-1 Efficacy. Front Oncol 2022;12:917400. [PMID: 35880165 DOI: 10.3389/fonc.2022.917400] [Reference Citation Analysis]
704 Zhang K, Zhou J, Wu T, Tian Q, Liu T, Wang W, Zhong H, Chen Z, Xiao X, Wu G. Combined analysis of expression, prognosis and immune infiltration of GINS family genes in human sarcoma. Aging (Albany NY) 2022;14. [PMID: 35896011 DOI: 10.18632/aging.204191] [Reference Citation Analysis]
705 Liu L, Matsumoto M, Matsui-watanabe M, Ochiai K, Callens BKK, Nguyen LC, Kozuki Y, Tanaka M, Nishizawa H, Igarashi K. BACH1 Expression Is Promoted by Tank Binding Kinase 1 (TBK1) in Pancreatic Cancer Cells to Increase Iron and Reduce the Expression of E-Cadherin. Antioxidants 2022;11:1460. [DOI: 10.3390/antiox11081460] [Reference Citation Analysis]
706 Liu S, Sun Z, Zhu M, Liu M, Wei M, Pan X, Huang S. Prognostic value and potential mechanism of long non-coding RNA Lnc-SMIM20-1 in acute myeloid leukemia. Expert Rev Anticancer Ther 2022;:1-11. [PMID: 35894677 DOI: 10.1080/14737140.2022.2093720] [Reference Citation Analysis]
707 Wang X, Liang B, Li J, Pi X, Zhang P, Zhou X, Chen X, Zhou S, Yang R. Identification and characterization of four immune-related signatures in keloid. Front Immunol 2022;13:942446. [DOI: 10.3389/fimmu.2022.942446] [Reference Citation Analysis]
708 Zhang T, Wang B, Su F, Gu B, Xiang L, Gao L, Zheng P, Li XM, Chen H. TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. Int J Biol Sci 2022;18:4560-77. [PMID: 35864968 DOI: 10.7150/ijbs.69933] [Reference Citation Analysis]
709 Chen J, Ge J, Zhang W, Xie X, Zhong X, Tang S. NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma. Front Genet 2022;13:764957. [DOI: 10.3389/fgene.2022.764957] [Reference Citation Analysis]
710 Wang T, Zhu T, Zhang Y, Bai J, Xue Y, Xu G, Lu L, Peng Q. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): friend or foe? Gene 2022;:146765. [PMID: 35905855 DOI: 10.1016/j.gene.2022.146765] [Reference Citation Analysis]
711 Nahacka Z, Novak J, Zobalova R, Neuzil J. Miro proteins and their role in mitochondrial transfer in cancer and beyond. Front Cell Dev Biol 2022;10:937753. [DOI: 10.3389/fcell.2022.937753] [Reference Citation Analysis]
712 Wang J, Yang Q, Tang M, Liu W. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer. Front Oncol 2022;12:911316. [DOI: 10.3389/fonc.2022.911316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
713 Kühn JP, Bochen F, Körner S, Schick B, Wagner M, Smola S, Berkó-Göttel B, Morris LGT, Wang J, Bozzato A, Linxweiler M. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients. Int J Biol Markers 2022;:3936155221105524. [PMID: 35880270 DOI: 10.1177/03936155221105524] [Reference Citation Analysis]
714 Ji J, Li H, Wang W, Yuan B, Shen T. ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression. Human Cell. [DOI: 10.1007/s13577-022-00754-w] [Reference Citation Analysis]
715 Brandt EF, Baues M, Wirtz TH, May J, Fischer P, Beckers A, Schüre B, Sahin H, Trautwein C, Lammers T, Berres M. Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma. IJMS 2022;23:8112. [DOI: 10.3390/ijms23158112] [Reference Citation Analysis]
716 Pan Z, Chang S, Chen S, Zhao D, Zou Z, Dai L, Hou Y, Zhang Q, Yang Y, Chen Z, Zhang W, Zhao Y. Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma.. [DOI: 10.1101/2022.07.22.501084] [Reference Citation Analysis]
717 Liu M, Xu Y, Bukhari I. Gene Identification and Potential Drug Therapy for Drug-Resistant Melanoma with Bioinformatics and Deep Learning Technology. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/2461055] [Reference Citation Analysis]
718 Wang S, Fu Y, Kuerban K, Liu J, Huang X, Pan D, Chen H, Zhu Y, Ye L. Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. Front Immunol 2022;13:933165. [DOI: 10.3389/fimmu.2022.933165] [Reference Citation Analysis]
719 Chen H, Zhang J, Sun X, Wang Y, Qian Y. Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma. Front Cell Dev Biol 2022;10:901207. [DOI: 10.3389/fcell.2022.901207] [Reference Citation Analysis]
720 Li R, Lu C, Li X, Chen X, Huang G, Wen Z, Li H, Tao L, Hu Y, Zhao Z, Chen Z, Lai Y. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma. Front Genet 2022;13:897827. [DOI: 10.3389/fgene.2022.897827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
721 Hou W, Pan M, Xiao Y, Ge W. Serum Extracellular Vesicle Stratifin Is a Biomarker of Perineural Invasion in Patients With Colorectal Cancer and Predicts Worse Prognosis. Front Oncol 2022;12:912584. [DOI: 10.3389/fonc.2022.912584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
722 Huang C, Han W, Wu Y, Shen G. Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma. Front Genet 2022;13:817656. [DOI: 10.3389/fgene.2022.817656] [Reference Citation Analysis]
723 Zhang R, Zhao J, Zhao L. TRKB acts as a prognostic predictive marker in Her-2 positive breast cancer. Ann Diagn Pathol 2022;60:152017. [PMID: 35905534 DOI: 10.1016/j.anndiagpath.2022.152017] [Reference Citation Analysis]
724 Su Z, Shu K, Li G. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration. CBM 2022. [DOI: 10.3233/cbm-210482] [Reference Citation Analysis]
725 Zhou X, Zhou R, Rao X, Hong J, Li Q, Jie X, Wang J, Xu Y, Zhu K, Li Z, Wu G. Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer. Cell Death Dis 2022;13:636. [PMID: 35864117 DOI: 10.1038/s41419-022-05079-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
726 Siddique AB, Ebrahim HY, Tajmim A, King JA, Abdelwahed KS, Abd Elmageed ZY, El Sayed KA. Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2. Cancers 2022;14:3542. [DOI: 10.3390/cancers14143542] [Reference Citation Analysis]
727 Leung JH, Ng B, Lim W. Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer. Cells 2022;11:2257. [DOI: 10.3390/cells11142257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
728 Bai X, Li Y, Li Y, Li F, Che N, Ni C, Zhao N, Zhao X, Liu T. GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer. Clin Med Insights Oncol 2022;16:11795549221109511. [PMID: 35898391 DOI: 10.1177/11795549221109511] [Reference Citation Analysis]
729 Mishra D, Mishra A, Singh M. Identification of prognostic biomarkers for suppressing tumorigenesis and metastasis of Hepatocellular carcinoma through transcriptome analysis.. [DOI: 10.1101/2022.07.20.500640] [Reference Citation Analysis]
730 Meng S, Liu Y, Wang X, Wu X, Xie W, Kang X, Liu X, Guo L, Wang C. The prognostic value and biological significance of gap junction beta protein 2 (GJB2 or Cx26) in cervical cancer. Front Oncol 2022;12:907960. [DOI: 10.3389/fonc.2022.907960] [Reference Citation Analysis]
731 Ye Z, Yang Y, Wei Y, Li L, Wang X, Zhang J. PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1. Cell Death Dis 2022;13:633. [PMID: 35864095 DOI: 10.1038/s41419-022-05087-y] [Reference Citation Analysis]
732 Wang P, Zhang J, Zhang H, Zhang F. The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling. Mol Cell Biochem 2022. [PMID: 35857251 DOI: 10.1007/s11010-022-04517-x] [Reference Citation Analysis]
733 Wang Y, Xie Y, Dong B, Xue W, Chen S, Mitsuo S, Zou H, Feng Y, Ma K, Dong Q, Cao J, Zhu C. The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC. Int J Biol Sci 2022;18:4053-70. [PMID: 35844789 DOI: 10.7150/ijbs.73009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
734 Wang YL, Liu H, Wan LL, Pan KH, Ni JX, Hu Q, Bin X, Chen M. Characterization and function of biomarkers in sunitinib-resistant renal carcinoma cells. Gene 2022;832:146514. [PMID: 35550407 DOI: 10.1016/j.gene.2022.146514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
735 Ning S, He C, Guo Z, Zhang H, Mo Z. [VIPR1 promoter methylation promotes transcription factor AP-2α binding to inhibit VIPR1 expression and promote hepatocellular carcinoma cell growth in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2022;42:957-65. [PMID: 35869757 DOI: 10.12122/j.issn.1673-4254.2022.07.01] [Reference Citation Analysis]
736 Zhu H, Chen K, Chen Y, Liu J, Zhang X, Zhou Y, Liu Q, Wang B, Chen T, Cao X. RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis. Signal Transduct Target Ther 2022;7:240. [PMID: 35853866 DOI: 10.1038/s41392-022-01033-8] [Reference Citation Analysis]
737 Liu J, Liu Q, Shen H, Liu Y, Wang Y, Wang G, Du J. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. Front Genet 2022;13:838624. [DOI: 10.3389/fgene.2022.838624] [Reference Citation Analysis]
738 Dang HH, Ta HDK, Nguyen TTT, Anuraga G, Wang C, Lee K, Le NQK. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation. Funct Integr Genomics. [DOI: 10.1007/s10142-022-00883-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
739 Lv Y, Feng QY, Zhang ZY, Zheng P, Zhu DX, Lin Q, Chen SM, Mao YH, Xu YQ, Ji ML, Xu JM, He GD. Low ferroptosis score predicts chemotherapy responsiveness and immune-activation in colorectal cancer. Cancer Med 2023;12:2033-45. [PMID: 35855531 DOI: 10.1002/cam4.4956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
740 Liu R, Liu Z, Zhao Y, Cheng X, Liu B, Wang Y, Wang J, Lian X, Zhu Y, Gao Y. GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma. Front Oncol 2022;12:726556. [DOI: 10.3389/fonc.2022.726556] [Reference Citation Analysis]
741 Yu Z, Liu Z, Lian X, Cheng X, Liu B, Zhang B, Wang H, Wang J, Li A, Ren Z, Pang B, Qian R, Gao Y. High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes. Cell Cycle. [DOI: 10.1080/15384101.2022.2096715] [Reference Citation Analysis]
742 Hu X, Zhou J, Zhang Y, Zeng Y, Jie G, Wang S, Yang A, Zhang M. Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments. Front Genet 2022;13:942454. [DOI: 10.3389/fgene.2022.942454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
743 Lu Y, Yu J, Dong Q, Du Y, Liang Z. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis. Int J Gen Med 2022;15:6127-43. [PMID: 35846794 DOI: 10.2147/IJGM.S357096] [Reference Citation Analysis]
744 Hu D, Zhang T, Yan Z, Wang L, Wang Y, Meng N, Tu B, Teng Y, Li Z, Lou X, Lei Y, Ren X, Zou Y, Wang F. Multimolecular characteristics of cell-death related hub genes in human cancers: a comprehensive pan-cancer analysis. Cell Cycle 2022;:1-11. [PMID: 35848940 DOI: 10.1080/15384101.2022.2101337] [Reference Citation Analysis]
745 Zheng X, Wang X, He Y, Ge H. Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer. Front Mol Biosci 2022;9:844618. [DOI: 10.3389/fmolb.2022.844618] [Reference Citation Analysis]
746 Treeck O, Weber F, Fritsch J, Skrzypczak M, Schüler-toprak S, Buechler C, Ortmann O. DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile. Biomedicines 2022;10:1727. [DOI: 10.3390/biomedicines10071727] [Reference Citation Analysis]
747 Loureiro JP, Cruz MS, Cardoso AP, Oliveira MJ, Macedo MF. Human iNKT Cells Modulate Macrophage Survival and Phenotype. Biomedicines 2022;10:1723. [DOI: 10.3390/biomedicines10071723] [Reference Citation Analysis]
748 Zhong Z, Xu X, Han S, Shao Y, Yi Y. Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma. J Healthc Eng 2022;2022:2929695. [PMID: 35832140 DOI: 10.1155/2022/2929695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
749 Ma W, Liao Y, Gao Z, Zhu W, Liu J, She W. Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Clin Med Insights Oncol 2022;16:11795549221109493. [PMID: 35837368 DOI: 10.1177/11795549221109493] [Reference Citation Analysis]
750 Liu J, Yin J, Wang Y, Cai L, Geng R, Du M, Zhong Z, Ni S, Huang X, Yu H, Bai J. A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma. Biol Proced Online 2022;24:9. [PMID: 35836132 DOI: 10.1186/s12575-022-00172-0] [Reference Citation Analysis]
751 Li Y, Yuan SL, Yin JY, Yang K, Zhou XG, Xie W, Wang Q. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis. World J Gastrointest Oncol 2022; 14(7): 1265-1280 [DOI: 10.4251/wjgo.v14.i7.1265] [Reference Citation Analysis]
752 Lin J, Chen L, Wu D, Lin J, Liu B, Guo C. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining. Comput Math Methods Med 2022;2022:1372879. [PMID: 35813444 DOI: 10.1155/2022/1372879] [Reference Citation Analysis]
753 Mao G, Li L, Shan C, Liang B, Ma L, Zhang S. High expression of RRM2 mediated by non-coding RNAs correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. Front Med 2022;9. [DOI: 10.3389/fmed.2022.833301] [Reference Citation Analysis]
754 Sadeghipour N, Kumar SU, Massoud TF, Paulmurugan R. A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models. Sci Rep 2022;12:12017. [PMID: 35835978 DOI: 10.1038/s41598-022-16219-x] [Reference Citation Analysis]
755 Dong Y, Miao Q, Li D, Chen L. Screening of Prognostic Markers for Hepatocellular Carcinoma Patients Based on Multichip Combined Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/6881600] [Reference Citation Analysis]
756 Guo T, You K, Chen X, Sun Y, Wu Y, Wu P, Jiang Y. RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator. Cell Death Discov 2022;8:320. [PMID: 35831298 DOI: 10.1038/s41420-022-01112-3] [Reference Citation Analysis]
757 KrishnaPriya S, Omer S, Banerjee S, Karunagaran D, Suraishkumar GK. An integrated approach to understand fluid shear stress-driven and reactive oxygen species-mediated metastasis of colon adenocarcinoma through mRNA-miRNA-lncRNA-circRNA networks. Mol Genet Genomics 2022. [PMID: 35831469 DOI: 10.1007/s00438-022-01924-z] [Reference Citation Analysis]
758 Vetrivel P, Nachimuthu S, Abuyaseer A, Bhosale PB, Ha SE, Kim HH, Park MY, Kim GS. Investigation on the cellular mechanism of Prunetin evidenced through next generation sequencing and bioinformatic approaches against gastric cancer. Sci Rep 2022;12:11852. [PMID: 35831348 DOI: 10.1038/s41598-022-15826-y] [Reference Citation Analysis]
759 Dai L, Mugaanyi J, Cai X, Lu C, Lu C. Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Sci Rep 2022;12:11944. [PMID: 35831362 DOI: 10.1038/s41598-022-16155-w] [Reference Citation Analysis]
760 Wang N, Zhou X, Wang X, Zhu X. Identification of Grb2-associated binding protein 3 expression to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma. J Biochem Mol Toxicol 2022;:e23166. [PMID: 35822560 DOI: 10.1002/jbt.23166] [Reference Citation Analysis]
761 Wang Z, Li J, Zhang P, Zhao L, Huang B, Xu Y, Wu G, Xia Q. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. Front Genet 2022;13:862210. [DOI: 10.3389/fgene.2022.862210] [Reference Citation Analysis]
762 Yu D, Liu S, Chen Y, Yang L. Integrative Bioinformatics Analysis Reveals CHEK1 and UBE2C as Luminal A Breast Cancer Subtype Biomarkers. Front Genet 2022;13:944259. [DOI: 10.3389/fgene.2022.944259] [Reference Citation Analysis]
763 Lan T, Wang Y, Miao J, Guo H, Wang Z, Wang J, Zhang C, Yang P, Zhang Z, Dunmall LC, Wang Y. Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer. Front Mol Biosci 2022;9:887059. [DOI: 10.3389/fmolb.2022.887059] [Reference Citation Analysis]
764 Liu JY, Zhang H, Ravindranathan S, Owonikoko TK, El‐rayes BF, Liu Y, Waller EK. Comparing VIP and PD‐L1 expression as cancer biomarkers. ImmunoMedicine 2022. [DOI: 10.1002/imed.1033] [Reference Citation Analysis]
765 Tang TY, Huang X, Zhang G, Lu MH, Liang TB. mRNA vaccine development for cholangiocarcinoma: a precise pipeline. Mil Med Res 2022;9:40. [PMID: 35821067 DOI: 10.1186/s40779-022-00399-8] [Reference Citation Analysis]
766 Lu L, Wang H, Fang J, Zheng J, Liu B, Xia L, Li D. Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer. Front Oncol 2022;12:944194. [DOI: 10.3389/fonc.2022.944194] [Reference Citation Analysis]
767 Cheung A, Chenoweth AM, Quist J, Sow HS, Malaktou C, Ferro R, Hoffmann RM, Osborn G, Sachouli E, French E, Marlow R, Lacy KE, Papa S, Grigoriadis A, Karagiannis SN. CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models. Cancers 2022;14:3361. [DOI: 10.3390/cancers14143361] [Reference Citation Analysis]
768 Wang Y, Wang Z, Li K, Xiang W, Chen B, Jin L, Hao K. lncRNAs Functioned as ceRNA to Sponge miR-15a-5p Affects the Prognosis of Pancreatic Adenocarcinoma and Correlates With Tumor Immune Infiltration. Front Genet 2022;13:874667. [DOI: 10.3389/fgene.2022.874667] [Reference Citation Analysis]
769 Chen Y, Zhou M, Gu X, Wang L, Wang C, Sun Y. High Expression of TACC3 Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients. Disease Markers 2022;2022:1-22. [DOI: 10.1155/2022/8789515] [Reference Citation Analysis]
770 Warrier NM, Krishnan RK, Prabhu V, Hariharapura RC, Agarwal P, Kumar P. Survivin Inhibition by Piperine Sensitizes Glioblastoma Cancer Stem Cells and Leads to Better Drug Response. Int J Mol Sci 2022;23:7604. [PMID: 35886952 DOI: 10.3390/ijms23147604] [Reference Citation Analysis]
771 Maia R, Santos GAD, Reis S, Viana NI, Pimenta R, Guimarães VR, Recuero S, Romão P, Leite KRM, Srougi M, Passerotti CC. Can we use Ki67 expression to predict prostate cancer aggressiveness? Rev Col Bras Cir 2022;49:e20223200. [PMID: 35792806 DOI: 10.1590/0100-6991e-20223200-en] [Reference Citation Analysis]
772 Cao Y, Duan H, Su A, Xu L, Lai B. A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker. Aging (Albany NY) 2022;14. [PMID: 35802774 DOI: 10.18632/aging.204171] [Reference Citation Analysis]
773 Tu Y, Fang P, Zhang L, Sun K. Analysis of the Effect of SNAI Family in Breast Cancer and Immune Cell. Front Cell Dev Biol 2022;10:906885. [DOI: 10.3389/fcell.2022.906885] [Reference Citation Analysis]
774 Tian Y, Bai F, Zhang D, Isaguliants M. HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/1246267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
775 Zhao Y, Zuo J, Shen Y, Yan D, Chen J, Qi X. Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis. Symmetry 2022;14:1403. [DOI: 10.3390/sym14071403] [Reference Citation Analysis]
776 Faria AVS, Fonseca EMB, Fernandes-Oliveira PS, de Lima TI, Clerici SP, Justo GZ, Silveira LR, Durán N, Ferreira-Halder CV. Violacein switches off low molecular weight tyrosine phosphatase and rewires mitochondria in colorectal cancer cells. Bioorg Chem 2022;127:106000. [PMID: 35853296 DOI: 10.1016/j.bioorg.2022.106000] [Reference Citation Analysis]
777 Skolastika S, Hanif N, Ikawati M, Hermawan A. Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-18. [DOI: 10.1155/2022/4172531] [Reference Citation Analysis]
778 Chen J, Wen Y, Su H, Yu X, Hong R, Chen C, Su C. Deciphering Prognostic Value of TTN and Its Correlation With Immune Infiltration in Lung Adenocarcinoma. Front Oncol 2022;12:877878. [DOI: 10.3389/fonc.2022.877878] [Reference Citation Analysis]
779 Yang X, Yang F, Lan L, Wen N, Li H, Sun X. Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer. Medicine (Baltimore) 2022;101:e29628. [PMID: 35801800 DOI: 10.1097/MD.0000000000029628] [Reference Citation Analysis]
780 Hu X, Yang Y, Wang Y, Ren S, Li X. Identifying an Immune-Related Gene ST8SIA1 as a Novel Target in Patients With Clear-Cell Renal Cell Carcinoma. Front Pharmacol 2022;13:901518. [DOI: 10.3389/fphar.2022.901518] [Reference Citation Analysis]
781 Li Y, Wang H, Wan J, Ma Q, Qi Y, Gu Z. The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma. Front Oncol 2022;12:845931. [DOI: 10.3389/fonc.2022.845931] [Reference Citation Analysis]
782 Zhong J, Xiang D, Ma X, Shen Y. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/2309339] [Reference Citation Analysis]
783 You A, Tian W, Yuan H, Gu L, Zhou J, Deng D. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern. Oncogene 2022. [PMID: 35798874 DOI: 10.1038/s41388-022-02402-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
784 Huang S, Luo Q, Huang J, Wei J, Wang S, Hong C, Qiu P, Li C. A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma. Front Genet 2022;13:902064. [DOI: 10.3389/fgene.2022.902064] [Reference Citation Analysis]
785 Cucielo MS, Cesário RC, Silveira HS, Gaiotte LB, dos Santos SAA, de Campos Zuccari DAP, Seiva FRF, Reiter RJ, de Almeida Chuffa LG. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation. Molecules 2022;27:4350. [DOI: 10.3390/molecules27144350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
786 Xie J, Chen R, Wang Q, Mao H. Exploration and validation of Taraxacum mongolicum anti-cancer effect. Comput Biol Med 2022;148:105819. [PMID: 35810695 DOI: 10.1016/j.compbiomed.2022.105819] [Reference Citation Analysis]
787 Wang F, Yuan C, Liu B, Yang Y, Wu H. Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03504-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
788 Tecalco-Cruz AC, Velasco-Loyden G, Robles-Villarruel L, Cortes-González CC, Zepeda-Cervantes J, Pineda B, Chagoya de Sánchez V. Interferon-stimulated gene 15 and ISGylation are upregulated in glioblastoma. Biochem Biophys Res Commun 2022;621:144-50. [PMID: 35834923 DOI: 10.1016/j.bbrc.2022.07.011] [Reference Citation Analysis]
789 Hou G, Lu Z, Yang Z, Jiang J. Prognostic value of metabolic genes in lung adenocarcinoma via integrative analyses. Genomics 2022;114:110425. [PMID: 35803451 DOI: 10.1016/j.ygeno.2022.110425] [Reference Citation Analysis]
790 Liu L, Yang L, Liu X, Liu M, Liu J, Feng X, Nie Z, Luo J. SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03500-w] [Reference Citation Analysis]
791 Shi W, Ling L, Li C, Wu R, Zhang M, Shao F, Wang Y. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway. J Cancer Res Clin Oncol 2022. [PMID: 35792913 DOI: 10.1007/s00432-022-04152-5] [Reference Citation Analysis]
792 Wang Y, Nie H, Li H, Liao Z, Yang X, He X, Ma J, Zhou J, Ou C. The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer. Front Med 2022;9. [DOI: 10.3389/fmed.2022.888093] [Reference Citation Analysis]
793 Mohan DR, Borges KS, Finco I, Lapensee CR, Rege J, Solon AL, Little DW, Else T, Almeida MQ, Dang D, Haggerty-skeans J, Apfelbaum AA, Vinco M, Wakamatsu A, Mariani BM, Amorin L, Latronico AC, Mendonca BB, Zerbini MCN, Lawlor ER, Ohi R, Auchus RJ, Rainey WE, Marie SKN, Giordano TJ, Venneti S, Fragoso MCBV, Breault DT, Lerario AM, Hammer GD. β-catenin programs a tissue-specific epigenetic vulnerability in aggressive adrenocortical carcinoma.. [DOI: 10.1101/2022.07.02.497654] [Reference Citation Analysis]
794 Feng Z, Hom ME, Bearrood TE, Rosenthal ZC, Fernández D, Ondrus AE, Gu Y, McCormick AK, Tomaske MG, Marshall CR, Kline T, Chen CH, Mochly-Rosen D, Kuo CJ, Chen JK. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. Nat Chem Biol 2022. [PMID: 35788181 DOI: 10.1038/s41589-022-01048-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
795 Boieri M, Malishkevich A, Guennoun R, Marchese E, Kroon S, Trerice KE, Awad M, Park JH, Iyer S, Kreuzer J, Haas W, Rivera MN, Demehri S. CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation. J Exp Med 2022;219:e20201963. [PMID: 35657353 DOI: 10.1084/jem.20201963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
796 Zhang T, Sheng P, Jiang Y. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35780396 DOI: 10.1007/s00432-022-04150-7] [Reference Citation Analysis]
797 Wu H, Feng H, Miao X, Ma J, Liu C, Zhang L, Yang L. Construction and validation of a prognostic model based on 11 lymph node metastasis-related genes for overall survival in endometrial cancer. Cancer Med 2022;11:4641-55. [PMID: 35778922 DOI: 10.1002/cam4.4844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
798 Inoue K, Schanne DH, Matsui A, Lei P, Klein S, Aoki S, Taniguchi H, Kikuchi H, Chen J, Liu Z, Tsai SQ, Schmidt TC, Iwasaki M, Geidel G, Koch A, Huang P, Fukumura D, Shioda T, Munn LL, Castillo CF, Hong TS, Jain RK, Liss A, Bardeesy N, Duda DG. IFNA pathway drives the more aggressive phenotype of KRASG12D-mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation.. [DOI: 10.1101/2022.06.29.497540] [Reference Citation Analysis]
799 Sahar N, Qadir J, Riaz SK, Bagabir SA, Muneer Z, Sheikh AK, Waqar SH, Pellicano R, Fagoonee S, Haque S, Malik MF. Dysregulated expression of suppressor loop of circadian rhythm genes in colorectal cancer pathogenesis. Minerva Med 2022;113. [DOI: 10.23736/s0026-4806.22.07981-2] [Reference Citation Analysis]
800 Wang G, Zhuang Z, Cheng J, Yang F, Zhu D, Jiang Z, Du W, Shen S, Huang J, Hua L, Chen Y. Overexpression of SHARPIN promotes tumor progression in ovarian cancer. Experimental and Molecular Pathology 2022. [DOI: 10.1016/j.yexmp.2022.104806] [Reference Citation Analysis]
801 Zhong F, Chen T, Li B. Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.07.046] [Reference Citation Analysis]
802 Ye J, Chen X, Jiang X, Dong Z, Hu S, Xiao M. RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner. J Clin Lab Anal 2022;36:e24514. [PMID: 35689537 DOI: 10.1002/jcla.24514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
803 Mehraj U, Aisha S, Sofi S, Mir MA. Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis. Advances in Cancer Biology - Metastasis 2022;4:100037. [DOI: 10.1016/j.adcanc.2022.100037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
804 Wang X, Wang J, Lyu L, Gao X, Cai Y, Tang B. Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis. Sci Rep 2022;12:11161. [PMID: 35778520 DOI: 10.1038/s41598-022-15205-7] [Reference Citation Analysis]
805 Li L, Liu J, Huang W. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription. Dig Liver Dis 2022;54:937-45. [PMID: 34583905 DOI: 10.1016/j.dld.2021.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
806 Qi W, Bai Y, Wang Y, Liu L, Zhang Y, Yu Y, Chen H. BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma. APMIS 2022;130:371-82. [PMID: 35255180 DOI: 10.1111/apm.13219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
807 Miao X, Zou H, Pan L, Cheng J, Wu Y, Chen R, Su Y, Du H, Ding X. Circ_0110940 Exerts an Antiapoptotic and Pro-Proliferative Effect in Gastric Cancer Cells via the miR-1178-3p/SLC38A6 Axis. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/3494057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
808 Ge L, Sun Q, Xia L, Xu X. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases. Medicine (Baltimore) 2022;101:e29802. [PMID: 35777029 DOI: 10.1097/MD.0000000000029802] [Reference Citation Analysis]
809 Sun X, Xin S, Li W, Zhang Y, Ye L. Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer. Front Genet 2022;13:928778. [DOI: 10.3389/fgene.2022.928778] [Reference Citation Analysis]
810 Zhang X, Chen Q, Li Y, Chen H, Jiang Q, Hu Q, Xu Y. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM). BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/3233004] [Reference Citation Analysis]
811 Ma T, Li H, Zhang X. Discovering single-cell eQTLs from scRNA-seq data only. Gene 2022;829:146520. [PMID: 35452708 DOI: 10.1016/j.gene.2022.146520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
812 Liu J, Zhu X, Gao L, Geng R, Tao X, Xu H, Chen Z. Expression and Prognostic Role of Glia Maturation Factor-γ in Gliomas. Front Mol Neurosci 2022;15:906762. [DOI: 10.3389/fnmol.2022.906762] [Reference Citation Analysis]
813 Sun EC, Dong SS, Li ZJ, Li CX. Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma. Dis Markers 2022;2022:7300593. [PMID: 35756492 DOI: 10.1155/2022/7300593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
814 Kok V, Tang JY, Eng G, Tan SY, Chin J, Quek C, Lai WX, Lim TK, Lin Q, Chua J, Cheong J. SFPQ promotes RAS-mutant cancer cell growth by modulating 5′-UTR mediated translational control of CK1α. NAR Cancer 2022;4. [DOI: 10.1093/narcan/zcac027] [Reference Citation Analysis]
815 Chen L, Fang B, Qiao L, Zheng Y. Discovery of Anticancer Activity of Amentoflavone on Esophageal Squamous Cell Carcinoma: Bioinformatics, Structure-Based Virtual Screening, and Biological Evaluation. J Microbiol Biotechnol 2022;32:718-29. [PMID: 35484963 DOI: 10.4014/jmb.2203.03050] [Reference Citation Analysis]
816 Song L, Wu J, Fu H, Wu C, Tong X, Zhang M. Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma. Front Pharmacol 2022;13:921963. [PMID: 35754466 DOI: 10.3389/fphar.2022.921963] [Reference Citation Analysis]
817 Zois CE, Hendriks AM, Haider S, Pires E, Bridges E, Kalamida D, Voukantsis D, Lagerholm BC, Fehrmann RSN, den Dunnen WFA, Tarasov AI, Baba O, Morris J, Buffa FM, McCullagh JSO, Jalving M, Harris AL. Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation. Cell Death Dis 2022;13:573. [PMID: 35764612 DOI: 10.1038/s41419-022-05005-2] [Reference Citation Analysis]
818 Li H, Ma T, Hao M, Wei L, Zhang X. Decoding functional cell–cell communication events by multi-view graph learning on spatial transcriptomics.. [DOI: 10.1101/2022.06.22.496105] [Reference Citation Analysis]
819 Liu J, Jia J, Wang S, Zhang J, Xian S, Zheng Z, Deng L, Feng Y, Zhang Y, Zhang J. Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer. Molecules 2022;27:4108. [DOI: 10.3390/molecules27134108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
820 Sun K, Fei X, Xu M, Xu R, Xu M, Mumtaz S. FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/9499317] [Reference Citation Analysis]
821 Wang Y, Liu M, Jiang H, Yu Y, Gurzu S. Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5848823] [Reference Citation Analysis]
822 Wang L, Hensley CR, Howell ME, Ning S. Bioinformatics-Driven Identification of p62 as A Crucial Oncogene in Liver Cancer. Front Oncol 2022;12:923009. [DOI: 10.3389/fonc.2022.923009] [Reference Citation Analysis]
823 Zhang C, Xu C, Ma C, Zhang Q, Bu S, Zhang D, Yu L, Wang H. TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets. Front Mol Biosci 2022;9:915409. [DOI: 10.3389/fmolb.2022.915409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
824 Bai Y, Yuan F, Yu J, Si Y, Zheng Y, Li D. A BIRC5High COD1Low Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients. Cancer Inform 2022;21:11769351221096655. [PMID: 35734521 DOI: 10.1177/11769351221096655] [Reference Citation Analysis]
825 Meng X, Liu Z, Zhang L, He Y. Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma. Front Oncol 2022;12:919436. [DOI: 10.3389/fonc.2022.919436] [Reference Citation Analysis]
826 Ravindran F, Jain A, Desai S, Menon N, Srivastava K, Bawa PS, Sateesh K, Srivatsa N, Raghunath SK, Srinivasan S, Choudhary B. Whole-exome sequencing of Indian prostate cancer reveals a novel therapeutic target: POLQ. J Cancer Res Clin Oncol 2022. [PMID: 35737091 DOI: 10.1007/s00432-022-04111-0] [Reference Citation Analysis]
827 Gong Y, Xu F, Deng L, Peng L, Teekaraman Y. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/2244228] [Reference Citation Analysis]
828 Li Y, Ge Y, Qian Y, Chen K, Zhao F, Qin Z, Zhou L, Xu L, Xu Z, Dou Q, Jia R. The Role of P4HA1 in Multiple Cancer Types and its Potential as a Target in Renal Cell Carcinoma. Front Genet 2022;13:848456. [DOI: 10.3389/fgene.2022.848456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
829 Salmerón-Bárcenas EG, Zacapala-Gómez AE, Ortiz-Ortiz J, Torres-Rojas FI, Ávila-López PA. Integrated bioinformatics analysis reveals that EZH2-rich domains promote transcriptional repression in cervical cancer. EXCLI J 2022;21:852-68. [PMID: 36172073 DOI: 10.17179/excli2022-5029] [Reference Citation Analysis]
830 Cruz-de la Rosa MI, Jiménez-wences H, Alarcón-millán J, Romero-lópez MJ, Castañón-sánchez CA, Salmerón-bárcenas EG, Fernández-tilapa G. miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer. IJMS 2022;23:6993. [DOI: 10.3390/ijms23136993] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
831 You W, Ke J, Chen Y, Cai Z, Huang ZP, Hu P, Wu X. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. Front Immunol 2022;13:864244. [PMID: 35720314 DOI: 10.3389/fimmu.2022.864244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
832 Wang K, Deng H, Song B, He J, Liu S, Fu J, Zhang L, Li D, Balaji KS, Mei Z, Cheng J, Fu J. The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis. Front Immunol 2022;13:923516. [PMID: 35720350 DOI: 10.3389/fimmu.2022.923516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
833 Saed L, Jeleń A, Mirowski M, Sałagacka-kubiak A. Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis. IJMS 2022;23:6933. [DOI: 10.3390/ijms23136933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
834 Li Y, Luo Y, Tian Q, Lai Y, Xu L, Yun H, Liang Y, Liao D, Gu R, Liu L, Yuan M, Li Y, Li Y, Lu M, Yong X, Zhang H. Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma. J Oncol 2022;2022:9080460. [PMID: 35726219 DOI: 10.1155/2022/9080460] [Reference Citation Analysis]
835 Chen J, Ji K, Gu L, Fang Y, Pan M, Tian S, Zhang ZG. HMGA1 Promotes Macrophage Recruitment via Activation of NF-κB-CCL2 Signaling in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/4727198] [Reference Citation Analysis]
836 Guan L, Tang Y, Li G, Qin Z, Li S. Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer. Front Oncol 2022;12:921710. [DOI: 10.3389/fonc.2022.921710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
837 Zang H. A malignant prognostic indicator of Uterine Corpus Endometrial Carcinoma: CDKN2A. HSET 2022;2:15-23. [DOI: 10.54097/hset.v2i.550] [Reference Citation Analysis]
838 Chang K, Jiang L, Sun Y, Li H. Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update. Mol Diagn Ther 2022. [PMID: 35732878 DOI: 10.1007/s40291-022-00593-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
839 Wang X, Miao J, Wang S, Shen R, Zhang S, Tian Y, Li M, Zhu D, Yao A, Bao W, Zhang Q, Tang X, Wang X, Li J. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells. Mol Cancer 2022;21:133. [PMID: 35733218 DOI: 10.1186/s12943-022-01596-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
840 Mishra D, Mishra A, Singh M. Demystifying the role of prognostic biomarkers in breast cancer through integrated transcriptome and pathway enrichment analyses.. [DOI: 10.1101/2022.06.20.496785] [Reference Citation Analysis]
841 Heo J, Lee J, Nam YJ, Kim Y, Yun H, Lee S, Ju H, Ryu CM, Jeong SM, Lee J, Lim J, Cho YM, Jeong EM, Hong B, Son J, Shin DM. The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer. Exp Mol Med 2022. [PMID: 35729325 DOI: 10.1038/s12276-022-00786-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
842 Li X, Yuan Y, Pal M, Jiang X. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator. Front Oncol 2022;12:929655. [PMID: 35719962 DOI: 10.3389/fonc.2022.929655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
843 Liu H, Wu W, Sun G, Chia T, Cao L, Liu X, Guan J, Fu F, Yao Y, Wu Z, Zhou S, Wang J, Lu J, Kuang Z, Wu M, He L, Shao Z, Wu D, Chen B, Xu W, Wang Z, He K. Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity. Cell Rep Med 2022;3:100660. [PMID: 35732156 DOI: 10.1016/j.xcrm.2022.100660] [Reference Citation Analysis]
844 Xiao Y, Li S, Zhang M, Liu X, Ju G, Hou J. A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma. Evid Based Complement Alternat Med 2022;2022:5490644. [PMID: 35722147 DOI: 10.1155/2022/5490644] [Reference Citation Analysis]
845 Xu S, Liu D, Cui M, Zhang Y, Zhang Y, Guo S, Zhang H, Li C. Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma. BioMed Research International 2022;2022:1-21. [DOI: 10.1155/2022/1893351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
846 Gao LJ, Li JL, Yang RR, He ZM, Yan M, Cao X, Cao JM. Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer. Front Oncol 2022;12:884334. [PMID: 35719943 DOI: 10.3389/fonc.2022.884334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
847 Cheng R, Ji L, Su H, Wang L, Jia D, Yao X, Ji H, Chen Y. Silencing of Long Noncoding RNA HLA Complex P5 (HCP5) Suppresses Glioma Progression through the HCP5-miR-205-Vascular Endothelial Growth Factor A Feedback Loop. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/3092063] [Reference Citation Analysis]
848 Chen R, Wang X, Deng X, Chen L, Liu Z, Li D. CPDR: An R Package of Recommending Personalized Drugs for Cancer Patients by Reversing the Individual’s Disease-Related Signature. Front Pharmacol 2022;13:904909. [DOI: 10.3389/fphar.2022.904909] [Reference Citation Analysis]
849 Ding F, Li F, Tang D, Wang B, Liu J, Mao X, Yin J, Xiao H, Wang J, Liu Z. Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition. Angewandte Chemie. [DOI: 10.1002/ange.202203546] [Reference Citation Analysis]
850 Muccioli S, Ciaccio R, Brillo V, Leanza L. Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma. Cell Death Discov 2022;8:294. [PMID: 35725560 DOI: 10.1038/s41420-022-01087-1] [Reference Citation Analysis]
851 Zhang X, Xu H, Zhang Y, Sun C, Li Z, Hu C, Zhao D, Guo C. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer. Front Oncol 2022;12:878546. [PMID: 35712475 DOI: 10.3389/fonc.2022.878546] [Reference Citation Analysis]
852 Calvo G, Céspedes M, Casas A, Di Venosa G, Sáenz D. Hydrogen sulfide decreases photodynamic therapy outcome through the modulation of the cellular redox state. Nitric Oxide 2022;125-126:57-68. [PMID: 35728762 DOI: 10.1016/j.niox.2022.06.006] [Reference Citation Analysis]
853 Gu X, Li X, Zhang X, Feng R, Zheng M, Liu L, Yang J, Sun H, Zhang Q, Bian T, Zhao H, Liu Y. MicroRNA-mediated high expression of PDIA3 was correlated with poor prognosis of patients with LUAD. Genomics 2022;114:110417. [PMID: 35724731 DOI: 10.1016/j.ygeno.2022.110417] [Reference Citation Analysis]
854 Bao G, Guan X, Liang J, Yao Y, Xiang Y, Li T, Zhong X. A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients. Front Oncol 2022;12:855305. [PMID: 35712480 DOI: 10.3389/fonc.2022.855305] [Reference Citation Analysis]
855 Gong Y, Zhou L, Ding L, Zhao J, Wang Z, Ren G, Zhang J, Mao Z, Zhou R. KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry. Medicine (Baltimore) 2022;101:e29312. [PMID: 35713434 DOI: 10.1097/MD.0000000000029312] [Reference Citation Analysis]
856 Zhang L, Zhao X, Chu H, Zhao H, Lai X, Li J, Lv T. Serum Free Fatty Acids and G-Coupled Protein Receptors Are Associated With the Prognosis of Epithelial Ovarian Cancer. Front Oncol 2022;12:777367. [DOI: 10.3389/fonc.2022.777367] [Reference Citation Analysis]
857 Qian C, Xiufu W, Jianxun T, Zihao C, Wenjie S, Jingfeng T, Kahlert UD, Renfei D. A Novel Extracellular Matrix Gene-Based Prognostic Model to Predict Overall Survive in Patients With Glioblastoma. Front Genet 2022;13:851427. [DOI: 10.3389/fgene.2022.851427] [Reference Citation Analysis]
858 Zou Z, Li Y, Guo W, Zhang J, Li Y. Serglycin: the Role in Liver Hepatocellular Carcinoma shown by Bioinformatics and Association with Tumor Microenvironment.. [DOI: 10.1101/2022.06.15.495916] [Reference Citation Analysis]
859 Chen J, Hu S, Wang H, Zhao T, Song Y, Zhong X, Luo Q, Xu M, He L, Chen Q, Du B, Xiao J, Wang K. Integrated analysis reveals the pivotal interactions between immune cells in the melanoma tumor microenvironment. Sci Rep 2022;12:10040. [PMID: 35710862 DOI: 10.1038/s41598-022-14319-2] [Reference Citation Analysis]
860 Gao T, Zhao L, Zhang F, Cao C, Fan S, Shi X. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors. World J Surg Oncol 2022;20:207. [PMID: 35710427 DOI: 10.1186/s12957-022-02652-9] [Reference Citation Analysis]
861 Zhang D, Lindstrom A, Kim EJ, Hwang CI, Hall ML, Lin TY, Li Y. SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment. Front Oncol 2022;12:890154. [PMID: 35785187 DOI: 10.3389/fonc.2022.890154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
862 Xie D, Chen Y, Wan X, Li J, Pei Q, Luo Y, Liu J, Ye T. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer. Front Endocrinol 2022;13:916469. [DOI: 10.3389/fendo.2022.916469] [Reference Citation Analysis]
863 Rahnama N, Jahangir M, Alesaeid S, Kahrizi MS, Adili A, Mohammed RN, Aslaminabad R, Akbari M, Özgönül AM. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives. Pathol Res Pract 2022;236:153982. [PMID: 35779293 DOI: 10.1016/j.prp.2022.153982] [Reference Citation Analysis]
864 Zhao L, Liang J, Zhong W, Han C, Liu D, Chen X. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma. Gene 2022;827:146461. [PMID: 35358652 DOI: 10.1016/j.gene.2022.146461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
865 Shi YX, Zhang WD, Dai PH, Deng J, Tan LH. Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma. Sci Rep 2022;12:9938. [PMID: 35705627 DOI: 10.1038/s41598-022-14250-6] [Reference Citation Analysis]
866 Ma X, Jin W, Zhao C, Wang X, Wang K. CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies. Mol Ther Nucleic Acids 2022;28:190-201. [PMID: 35402077 DOI: 10.1016/j.omtn.2022.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
867 Xiang Z, Lv Q, Zhang Y, Chen X, Guo R, Liu S, Peng X. Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC. Mol Ther Nucleic Acids 2022;28:601-12. [PMID: 35614994 DOI: 10.1016/j.omtn.2022.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
868 Almasabi S, Boyd R, Ahmed AU, Williams BRG. Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity. Front Oncol 2022;12:836005. [PMID: 35692780 DOI: 10.3389/fonc.2022.836005] [Reference Citation Analysis]
869 Lan C, Ni B, Zhao T, Li Z, Wang J, Ma Y, Li W, Wang X. An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers. Front Genet 2022;13:866702. [PMID: 35685435 DOI: 10.3389/fgene.2022.866702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
870 Cai D, Ma X, Guo H, Zhang H, Bian A, Yu H, Cheng W. Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration. J Orthop Surg Res 2022;17:305. [PMID: 35689249 DOI: 10.1186/s13018-022-03193-3] [Reference Citation Analysis]
871 Huynh NC, Huang TT, Nguyen CT, Lin FK. Comprehensive Integrated Single-Cell Whole Transcriptome Analysis Revealed the p-EMT Tumor Cells-CAFs Communication in Oral Squamous Cell Carcinoma. Int J Mol Sci 2022;23:6470. [PMID: 35742914 DOI: 10.3390/ijms23126470] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
872 Yin L, Tang Y, Xiao M, Li M, Huang Fu ZM, Wang YL. The role of histone chaperone spty2d1 in human colorectal cancer. Mol Cell Probes 2022;64:101832. [PMID: 35691597 DOI: 10.1016/j.mcp.2022.101832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
873 Li W, Xu W, Sun K, Wang F, Wong TW, Kong AN. Identification of novel biomarkers in prostate cancer diagnosis and prognosis. J Biochem Mol Toxicol 2022;:e23137. [PMID: 35686336 DOI: 10.1002/jbt.23137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
874 Zhang Y, Fang Y, Tang Y, Han S, Jia J, Wan X, Chen J, Yuan Y, Zhao B, Fang D. SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters. Nat Commun 2022;13:3190. [PMID: 35680905 DOI: 10.1038/s41467-022-30940-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
875 Zhang H, Wu P, Guo C, Zhang C, Zhao Y, Tan D, An J, Shi C. Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine. Biochem Biophys Rep 2022;31:101291. [PMID: 35669987 DOI: 10.1016/j.bbrep.2022.101291] [Reference Citation Analysis]
876 Zhang J, Tong Y, Lu X, Dong F, Ma X, Yin S, He Y, Liu Y, Liu Q, Fan D. A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma. Life Sci 2022;304:120698. [PMID: 35690105 DOI: 10.1016/j.lfs.2022.120698] [Reference Citation Analysis]
877 Zhao J, Chang L, Tu J, Sun B, Wei X, Anand V. Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell Carcinoma. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/8748434] [Reference Citation Analysis]
878 Liu Y, Fu B, Yu Z, Song G, Zeng H, Gong Y, Ding Y, Huang D. Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2022;9:497-516. [PMID: 35669909 DOI: 10.2147/JHC.S363862] [Reference Citation Analysis]
879 Liu H, Zhang X, Zhao Z, Zhu H, Li D, Yang Y, Zhao W, Zhang F, Wang Y, Zhu L, Ding Z, Li X. CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML. Front Pharmacol 2022;13:888243. [PMID: 35662693 DOI: 10.3389/fphar.2022.888243] [Reference Citation Analysis]
880 Wang F, Bi J, Yi C, Zhang Y, Zhang Y, Yue Q. Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma. Contrast Media Mol Imaging 2022;2022:7376588. [PMID: 35655721 DOI: 10.1155/2022/7376588] [Reference Citation Analysis]
881 Fei X, Kong L, Shi C, Wang G, Liu C, Wang C, Liu P, Tan X, Bu D. Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer. Journal of Oncology 2022;2022:1-21. [DOI: 10.1155/2022/7117014] [Reference Citation Analysis]
882 Song S, Zhou J, Li Y, Liu J, Li J, Shu P. Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix-Amomi Fructus against gastric cancer. Sci Rep 2022;12:9401. [PMID: 35672352 DOI: 10.1038/s41598-022-13223-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
883 Zhong F, Liu J, Gao C, Chen T, Li B. Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma. Front Oncol 2022;12:816070. [PMID: 35664780 DOI: 10.3389/fonc.2022.816070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
884 Zhang D, Ye L, Hu S, Zhu Q, Li C, Zhu C, Wang F. Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer. Journal of Immunology Research 2022;2022:1-26. [DOI: 10.1155/2022/7623654] [Reference Citation Analysis]
885 Valcarcel-jimenez L, Rogerson C, Yong C, Schmidt C, Yang M, Harle V, Offord V, Wong K, Mora A, Speed A, Caraffini V, Tran MGB, Maher ER, Stewart GD, Vanharanta S, Adams DJ, Frezza C. HIRA loss transforms FH-deficient cells.. [DOI: 10.1101/2022.06.04.492123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
886 Hu L, Liu J, Shimada H, Ito M, Sugimoto K, Hiwasa T, Zhou Q, Li J, Shen S, Wang H. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis. Front Oncol 2022;12:870086. [PMID: 35656505 DOI: 10.3389/fonc.2022.870086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
887 Yang J, Huang J, Wang H, Liu Y, Tang Y, Lin C, Zhou Q, Chen C. Expression of the Cavin Family in Childhood Leukemia and Its Implications in Subtype Diagnosis and Prognosis Evaluation. Front Pediatr 2022;10:815421. [DOI: 10.3389/fped.2022.815421] [Reference Citation Analysis]
888 Zhang M, Liu Y, Yin Y, Sun Z, Wang Y, Zhang Z, Li F, Chen X. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis. Mol Med 2022;28:62. [PMID: 35658829 DOI: 10.1186/s10020-022-00489-2] [Reference Citation Analysis]
889 Huang Y, Xia L, Tan X, Zhang J, Zeng W, Tan B, Yu X, Fang W, Yang Z. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis. Cell Mol Biol Lett 2022;27:43. [PMID: 35658874 DOI: 10.1186/s11658-022-00343-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
890 Jing X, Du L, Shi S, Niu A, Wu J, Wang Y, Wang C. Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 via Sponging miR-191-5p. Front Pharmacol 2022;13:806682. [PMID: 35652045 DOI: 10.3389/fphar.2022.806682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
891 Xu Y, Shu D, Shen M, Wu Q, Peng Y, Liu L, Tang Z, Gao S, Wang Y, Liu S, Cui D. Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of Immunology Research 2022;2022:1-22. [DOI: 10.1155/2022/9412119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
892 Li YL, Zhang MM, Wu LW, Liu YH, Zhang ZY, Zeng LH, Lin NM, Zhang C. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD. J Biomed Sci 2022;29:34. [PMID: 35655269 DOI: 10.1186/s12929-022-00817-y] [Reference Citation Analysis]
893 Liu Y, Li C, Fang L, Wang L, Liu H, Tian H, Zheng Y, Fan T, He J. Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c-Myc axis and SLC25A21 expression. Clin Transl Med 2022;12:e944. [PMID: 35735113 DOI: 10.1002/ctm2.944] [Reference Citation Analysis]
894 Wang H, Song Z, Xie E, Chen J, Tang B, Wang F, Min J. Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma. Research 2022;2022:1-18. [DOI: 10.34133/2022/9814652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
895 Yan H, He N, He S. HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription. Biochemical and Biophysical Research Communications 2022;608:170-6. [DOI: 10.1016/j.bbrc.2022.03.143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
896 Gao X, Wang WX, Zhang XL. A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients. Cancer Med 2023;12:808-23. [PMID: 35651286 DOI: 10.1002/cam4.4898] [Reference Citation Analysis]
897 Dogan B, Gumusoglu E, Ulgen E, Sezerman OU, Gunel T. Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer. Genomics Inform 2022;20:e20. [PMID: 35794700 DOI: 10.5808/gi.21067] [Reference Citation Analysis]
898 Salarikia SR, Kashkooli M, Taghipour MJ, Malekpour M, Negahdaripour M. Identification of hub pathways and drug candidates in gastric cancer through systems biology. Sci Rep 2022;12:9099. [PMID: 35650297 DOI: 10.1038/s41598-022-13052-0] [Reference Citation Analysis]
899 Cheng J, Xia L, Hao X, Gan F, Bai Y, Zhang C, Mao Y, Zhu Y, Pu Q, Park DW, Tavolari S, Mei J, Chen Y, Deng S, Liu L. Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway. Transl Lung Cancer Res 2022;11:1089-107. [PMID: 35832442 DOI: 10.21037/tlcr-22-396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
900 Li Z, She T, Yang H, Su T, Shi Q, Tao Z, Feng Y, Yang F, Cheng J, Lu X. A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy. Drug Deliv 2022;29:1698-711. [PMID: 35635308 DOI: 10.1080/10717544.2022.2079766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
901 Zhang W, Hu Y, Zhang W, Yi K, Xu X, Chen Z, Wang F. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4. Journal of Immunology Research 2022;2022:1-11. [DOI: 10.1155/2022/9385820] [Reference Citation Analysis]
902 Chen Y, Zeng L, Wang W, Yuan J, Sun R, Yang S. DDX47 promotes cell proliferation and migration in lung adenocarcinoma. Pathology - Research and Practice 2022;234:153921. [DOI: 10.1016/j.prp.2022.153921] [Reference Citation Analysis]
903 Tang F, Yang C, Li F, Yu D, Pan Z, Wang Z, Li Z. Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression. Molecular Therapy - Nucleic Acids 2022;28:716-731. [DOI: 10.1016/j.omtn.2022.04.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
904 Weber BZC, Agca S, Domaniku A, Bilgic SN, Arabaci DH, Kir S. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia. J Cachexia Sarcopenia Muscle 2022;13:1582-94. [PMID: 35373517 DOI: 10.1002/jcsm.12985] [Reference Citation Analysis]
905 Alam MS, Rahaman MM, Sultana A, Wang G, Mollah MNH. Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer. Comput Biol Med 2022;145:105508. [PMID: 35447458 DOI: 10.1016/j.compbiomed.2022.105508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
906 Zhang D, Fu Y, Tian G, Li J, Shang D, Zhou S. UCHL1 promotes proliferation and metastasis in head and neck squamous cell carcinoma and could be a potential therapeutic target. Oral Surg Oral Med Oral Pathol Oral Radiol 2022;133:684-97. [PMID: 35165060 DOI: 10.1016/j.oooo.2021.11.004] [Reference Citation Analysis]
907 Zhang S, Jiang M, Cao H, Xiong J, Xu J. CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation. JHC 2022;Volume 9:553-69. [DOI: 10.2147/jhc.s365302] [Reference Citation Analysis]
908 Søland TM, Solhaug MB, Bjerkli IH, Schreurs O, Sapkota D. The prognostic role of combining Krüppel-like factor 4 score and grade of inflammation in a Norwegian cohort of oral tongue squamous cell carcinomas. Eur J Oral Sci 2022;130:e12866. [PMID: 35363406 DOI: 10.1111/eos.12866] [Reference Citation Analysis]
909 Al-eryani G, Bartonicek N, Chan C, Anderson A, Harvey K, Wu SZ, Roden D, Wang T, Reeves J, Yeung BZ, Masle-farquhar E, Goodnow CC, Ma C, Phan TG, Lundeberg J, Junankar S, Swarbrick A. Integration of single-cell RNA and protein data identifies novel clinically-relevant lymphocyte phenotypes in breast cancers.. [DOI: 10.1101/2022.05.31.494081] [Reference Citation Analysis]
910 Ding W, Zhou X, Jiang G, Xu W, Long S, Xiao F, Liao Y, Liu J, Mei J. Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells. Journal of Oncology 2022;2022:1-20. [DOI: 10.1155/2022/3909030] [Reference Citation Analysis]
911 Zhang Z, Zhao W, Li Y, Li Y, Cheng H, Zheng L, Sun X, Liu H, Shao R. YOD1 serves as a potential prognostic biomarker for pancreatic cancer. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02616-9] [Reference Citation Analysis]
912 Zhang F, Waheed S, Armato U, Wu J, Zhang C, Li Z. eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma. Front Oncol 2022;12:848346. [DOI: 10.3389/fonc.2022.848346] [Reference Citation Analysis]
913 Lin Z, Huang X, Ji X, Tian N, Gan Y, Ke L. Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinoma. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13159-4] [Reference Citation Analysis]
914 Liu Y, Li R, Wang X, Xue Z, Yang X, Tang B. Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:824938. [DOI: 10.3389/fcell.2022.824938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
915 Wang L, Ye G, Wang Y, Wang C. Stearoyl-CoA desaturase 1 regulates malignant progression of cervical cancer cells. Bioengineered 2022;13:12941-54. [PMID: 35609330 DOI: 10.1080/21655979.2022.2079253] [Reference Citation Analysis]
916 Zheng Z, Zhang X, Bai J, Long L, Liu D, Zhou Y. PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway. Cancer Cell Int 2022;22:201. [PMID: 35614441 DOI: 10.1186/s12935-022-02545-7] [Reference Citation Analysis]
917 Deepti P, Pasha A, Kumbhakar DV, Doneti R, Heena SK, Bhanoth S, Poleboyina PK, Yadala R, S D A, Pawar SC. Overexpression of Secreted Phosphoprotein 1 (SPP1) predicts poor survival in HPV positive cervical cancer. Gene 2022;824:146381. [PMID: 35271951 DOI: 10.1016/j.gene.2022.146381] [Reference Citation Analysis]
918 Zhang Z, Wei Y, Li X, Zhao R, Wang X, Yang Z, Li T, Wang X, Li X, Wang X. IQGAP1 enhances cell invasion and matrix metalloproteinase-2 expression through upregulating NF-κB activity in esophageal squamous cell carcinoma cells. Gene 2022;824:146406. [PMID: 35276237 DOI: 10.1016/j.gene.2022.146406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
919 Wang C, Liang H, Li Y, Tang Z, Zhang Y. Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma. Bioengineered 2022;13:12738-48. [PMID: 35609322 DOI: 10.1080/21655979.2022.2069383] [Reference Citation Analysis]
920 Kodama T, Kodama M, Jenkins NA, Copeland NG, Chen HJ, Wei Z. Ring Finger Protein 125 Is an Anti-Proliferative Tumor Suppressor in Hepatocellular Carcinoma. Cancers (Basel) 2022;14:2589. [PMID: 35681566 DOI: 10.3390/cancers14112589] [Reference Citation Analysis]
921 Gao P, Ren G, Liang J, Liu J. STAT6 Upregulates NRP1 Expression in Endothelial Cells and Promotes Angiogenesis. Front Oncol 2022;12:823377. [PMID: 35600336 DOI: 10.3389/fonc.2022.823377] [Reference Citation Analysis]
922 Pan X, Li C, Cai Y, Wu S, Zhang Z. Comprehensive Pan-Cancer Analysis Reveals the Role of UHRF1-Mediated DNA Methylation and Immune Infiltration in Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/3842547] [Reference Citation Analysis]
923 Li H, Song J, He Y, Liu Y, Liu Z, Sun W, Hu W, Lei QY, Hu X, Chen Z, He X. CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4-Fatty Acid β-Oxidation Pathway. Adv Sci (Weinh) 2022;:e2105126. [PMID: 35603967 DOI: 10.1002/advs.202105126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
924 Seidel EC, Birkemeyer C, Baran-Schmidt R, Meixensberger J, Oppermann H, Gaunitz F. Viability of Glioblastoma Cells and Fibroblasts in the Presence of Imidazole-Containing Compounds. Int J Mol Sci 2022;23:5834. [PMID: 35628643 DOI: 10.3390/ijms23105834] [Reference Citation Analysis]
925 Zhao H, Wen B, Kang Y. Gene Expression Profiling Identifies Potential Biomarkers for Colorectal Cancer Using NanoString nCounter Assay. J Shanghai Jiaotong Univ (Sci ) 2022. [DOI: 10.1007/s12204-022-2440-7] [Reference Citation Analysis]
926 Lin X, Xiao M, Chen Z, Ding C, Zhang T, Li Q, Xu Y. Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors. Journal of Oncology 2022;2022:1-40. [DOI: 10.1155/2022/6115878] [Reference Citation Analysis]
927 Sun Y, Li D, Liu H, Huang Y, Meng F, Tang J, Li Z, Xie W. PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition. Cell Death Dis 2022;13:487. [PMID: 35597793 DOI: 10.1038/s41419-022-04940-4] [Reference Citation Analysis]
928 Yu L, Guo Q, Luo Z, Wang Y, Weng J, Chen Y, Liang W, Li Y, Zhang Y, Chen K, Chen Z, Ding Y, Zhang Y. TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN/NF-κB signaling pathway. Br J Cancer 2022. [PMID: 35597868 DOI: 10.1038/s41416-022-01835-1] [Reference Citation Analysis]
929 Kavec MJ, Urbanova M, Makovicky P, Opattová A, Tomasova K, Kroupa M, Kostovcikova K, Siskova A, Navvabi N, Schneiderova M, Vymetalkova V, Vodickova L, Vodicka P. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases MUTYH and hOGG1 in Colorectal Cancer Patients. Int J Mol Sci 2022;23:5704. [PMID: 35628513 DOI: 10.3390/ijms23105704] [Reference Citation Analysis]
930 Zheng X, Chen J, Nan T, Zheng L, Lan J, Jin X, Cai Y, Liu H, Chen W. FAM198B promotes colorectal cancer progression by regulating the polarization of tumor-associated macrophages via the SMAD2 signaling pathway. Bioengineered 2022;13:12435-45. [PMID: 35587159 DOI: 10.1080/21655979.2022.2075300] [Reference Citation Analysis]
931 Jiang Y, Han D, Zhao Y, Zhang C, Shi X, Gu W. Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma. Front Immunol 2022;13:872170. [PMID: 35558077 DOI: 10.3389/fimmu.2022.872170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
932 Wang R, Li J, Zhang C, Guan X, Qin B, Jin R, Qin L, Xu S, Zhang X, Liu R, Ye Q, Cheng L. Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity. Front Oncol 2022;12:821620. [DOI: 10.3389/fonc.2022.821620] [Reference Citation Analysis]
933 Guo J, Wang S, Jiang Z, Tang L, Liu Z, Cao J, Hu Z, Chen X, Luo Y, Bo H. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor. Front Immunol 2022;13:859730. [DOI: 10.3389/fimmu.2022.859730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
934 Reese RM, Helzer KT, Allen KO, Zheng C, Solodin N, Alarid ET. GRHL2 enhances phosphorylated estrogen receptor DNA-binding and regulates ER-mediated transcriptional activation and repression.. [DOI: 10.1101/2022.05.19.492733] [Reference Citation Analysis]
935 Gao S, Wang S, Zhao Z, Zhang C, Liu Z, Ye P, Xu Z, Yi B, Jiao K, Naik GA, Wei S, Rais-Bahrami S, Bae S, Yang WH, Sonpavde G, Liu R, Wang L. TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling. Nat Commun 2022;13:2792. [PMID: 35589707 DOI: 10.1038/s41467-022-30409-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
936 Wu Z, Wang Y, Li J, Wang H, Tuo X, Zheng J. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. Front Genet 2022;13:864578. [DOI: 10.3389/fgene.2022.864578] [Reference Citation Analysis]
937 Liu LY, Jiang D, Qu Y, Wang H, Zhang Y, Yang S, Xie X, Wu S, Zhou H, Xu G. Potential and functional prediction of six circular RNAs as diagnostic markers for colorectal cancer. PeerJ 2022;10:e13420. [PMID: 35611168 DOI: 10.7717/peerj.13420] [Reference Citation Analysis]
938 Yan Z, Gao Y, Yu J, Shen Z, Bu X, Passero LF. Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. Journal of Immunology Research 2022;2022:1-30. [DOI: 10.1155/2022/8972730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
939 Liu Z, Fang B, Cao J, Zhou Q, Zhu F, Fan L, Xue L, Huang C, Bo H. LINC00313 regulates the metastasis of testicular germ cell tumors through epithelial-mesenchyme transition and immune pathways. Bioengineered 2022;13:12141-55. [PMID: 35575252 DOI: 10.1080/21655979.2022.2073128] [Reference Citation Analysis]
940 Sun Q, Liu X, Peng Q, Hu L, Jiang X, Cui D. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/1584397] [Reference Citation Analysis]
941 Lin Z, Feng F, Liang J, Zeng H, Li J. lncRNA RP11-10A14.5: a potential prognosis biomarker for LUAD through regulation on proliferation and metastasis. Discov Oncol 2022;13:32. [PMID: 35575835 DOI: 10.1007/s12672-022-00493-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
942 Tao JH, Wang XT, Yuan W, Chen JN, Wang ZJ, Ma YB, Zhao FQ, Zhang LY, Ma J, Liu Q. Reduced serum high-density lipoprotein cholesterol levels and aberrantly expressed cholesterol metabolism genes in colorectal cancer. World J Clin Cases 2022; 10(14): 4446-4459 [DOI: 10.12998/wjcc.v10.i14.4446] [Reference Citation Analysis]
943 Zhang Q, Sun S, Xie Q, Wang X, Qian J, Yao J, Li Z. FAM81A identified as a stemness-related gene by screening DNA methylation sites based on machine learning-accessed stemness in pancreatic cancer. Epigenomics 2022. [PMID: 35574683 DOI: 10.2217/epi-2022-0098] [Reference Citation Analysis]
944 Yandım C, Karakülah G. Repeat expression is linked to patient survival and exhibits single nucleotide variation in pancreatic cancer revealing LTR70:r.879A>G. Gene 2022;822:146344. [PMID: 35183687 DOI: 10.1016/j.gene.2022.146344] [Reference Citation Analysis]
945 Liu H, Weng J. A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene 2022;822:146325. [PMID: 35183683 DOI: 10.1016/j.gene.2022.146325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
946 Zhang T, Cheng G, Chen P, Peng Y, Liu L, Li R, Qiu B. RS1 gene is a novel prognostic biomarker for lung adenocarcinoma. Thoracic Cancer. [DOI: 10.1111/1759-7714.14471] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
947 Xie Z, Kawasaki T, Zhou H, Okuzaki D, Okada N, Tachibana M. Targeting GGT1 Eliminates the Tumor-Promoting Effect and Enhanced Immunosuppressive Function of Myeloid-Derived Suppressor Cells Caused by G-CSF. Front Pharmacol 2022;13:873792. [PMID: 35548341 DOI: 10.3389/fphar.2022.873792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
948 Cui G, Xiao Y. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma. Autoimmunity. [DOI: 10.1080/08916934.2022.2076085] [Reference Citation Analysis]
949 lv Y, Yuan C, Han L, Huang G, Ju L, Chen L, Han H, Zhang C, Zeng L, Jinhui L. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/4091978] [Reference Citation Analysis]
950 Wu S, Liang Y, Zang Q, Xing Z, Yin P, Sun R, Dai B, Algalil FA. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma. Applied Bionics and Biomechanics 2022;2022:1-11. [DOI: 10.1155/2022/5160748] [Reference Citation Analysis]
951 Wu S, Liu S, Li Y, Liu C, Pan H. Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments. Front Cell Dev Biol 2022;10:837428. [DOI: 10.3389/fcell.2022.837428] [Reference Citation Analysis]
952 Saliani M, Jalal R, Javadmanesh A. Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells. Sci Rep 2022;12:7965. [PMID: 35562390 DOI: 10.1038/s41598-022-11697-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
953 Wang J, Shi M, Zhang H, Zhou H, Huang Z, Zhou Y, Shi J. PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration. Thorac Cancer 2022. [PMID: 35567329 DOI: 10.1111/1759-7714.14466] [Reference Citation Analysis]
954 Chu L, Yi Q, Yan Y, Peng J, Li Z, Jiang F, He Q, Ouyang L, Wu S, Fu C, Liu Y, Xu Z. A Prognostic Signature Consisting of Pyroptosis-Related Genes and SCAF11 for Predicting Immune Response in Breast Cancer. Front Med 2022;9:882763. [DOI: 10.3389/fmed.2022.882763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
955 Hu X, Chen M, Ruan Q, Shi C, Pan J, Luo L, Zhuo Z. Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/2039447] [Reference Citation Analysis]
956 Wang Y, Han J, Zhou H, Ai S, Wan D, Zhuo Z. A Prognosis Marker Dynein Cytoplasmic 1 Heavy Chain 1 Correlates with EMT and Immune Signature in Liver Hepatocellular Carcinoma by Bioinformatics and Experimental Analysis. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/6304859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
957 Long J, Liu L, Zhou X, Lu X, Qin L, Ding X. HLA-DQB1-AS1 Promotes Cell Proliferation, Inhibits Apoptosis, and Binds with ZRANB2 Protein in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/7130634] [Reference Citation Analysis]
958 Huang R, Wu C, Wen J, Yu J, Zhu H, Yu J, Zou Z. DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation. Cancer Med 2022;11:4688-702. [PMID: 35538918 DOI: 10.1002/cam4.4793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
959 Jeibouei S, Hojat A, Mostafavi E, Aref AR, Kalbasi A, Niazi V, Ajoudanian M, Mohammadi F, Saadati F, Javadi SM, Shams F, Moghaddam M, Karami F, Sharifi K, Moradian F, Akbari ME, Zali H. Radiobiological effects of wound fluid on breast cancer cell lines and human-derived tumor spheroids in 2D and microfluidic culture. Sci Rep 2022;12:7668. [PMID: 35538133 DOI: 10.1038/s41598-022-11023-z] [Reference Citation Analysis]
960 Wang L, Zhou S, Zhou Y, Lu J, Wang F. A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Journal of Immunology Research 2022;2022:1-18. [DOI: 10.1155/2022/8069858] [Reference Citation Analysis]
961 Zhang S, Chen K, Zhao Z, Zhang X, Xu L, Liu T, Yu S. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM). J Immunother 2022. [PMID: 35543550 DOI: 10.1097/CJI.0000000000000421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
962 Chen L, Zhang M, Zhou J, Zhang L, Liang C. Establishment of an age- and tumor microenvironment-related gene signature for survival prediction in prostate cancer. Cancer Med 2022. [PMID: 35535438 DOI: 10.1002/cam4.4776] [Reference Citation Analysis]
963 Sun S, Liu Y, Zhou M, Wen J, Xue L, Han S, Liang J, Wang Y, Wei Y, Yu J, Long X, Chen X, Liang H, Huang Z, Zhang B. PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner. Cell Biosci 2022;12:55. [PMID: 35526051 DOI: 10.1186/s13578-022-00788-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
964 Dai L, Tao Y, Shi Z, Liang W, Hu W, Xing Z, Zhou S, Guo X, Fu X, Wang X. SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. Front Oncol 2022;12:881801. [DOI: 10.3389/fonc.2022.881801] [Reference Citation Analysis]
965 Yang J, Zhou Y, Li Y, Hu W, Yuan C, Chen S, Ye G, Chen Y, Wu Y, Liu J, Wang Y, Du J, Tong X. Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis. Bioengineered 2022;13:11187-207. [PMID: 35510387 DOI: 10.1080/21655979.2022.2062537] [Reference Citation Analysis]
966 Hu X, Zhu H, Chen B, He X, Shen Y, Zhang X, Xu Y, Xu X. The oncogenic role of tubulin alpha-1c chain in human tumours. BMC Cancer 2022;22:498. [PMID: 35513790 DOI: 10.1186/s12885-022-09595-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
967 Peng Q, Hao LY, Guo YL, Zhang ZQ, Ji JM, Xue Y, Liu YW, Lu JL, Li CG, Shi XL. Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration. World J Clin Cases 2022; 10(13): 3989-4019 [DOI: 10.12998/wjcc.v10.i13.3989] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
968 Gong W, Li Y, Xian J, Yang L, Wang Y, Zhang X, Zhou Y, Wang X, Qiao G, Chen C, Datta S, Gao X, Lu J, Qiu F. Long non-coding RNA LSAMP-1 is down-regulated in non-small cell lung cancer and predicts a poor prognosis. Cancer Cell Int 2022;22:181. [PMID: 35524253 DOI: 10.1186/s12935-022-02592-0] [Reference Citation Analysis]
969 Bononi G, Di Stefano M, Poli G, Ortore G, Meier P, Masetto F, Caligiuri I, Rizzolio F, Macchia M, Chicca A, Avan A, Giovannetti E, Vagaggini C, Brai A, Dreassi E, Valoti M, Minutolo F, Granchi C, Gertsch J, Tuccinardi T. Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives. J Med Chem 2022. [PMID: 35522977 DOI: 10.1021/acs.jmedchem.1c01806] [Reference Citation Analysis]
970 Zhang R, Ma L, Wei Y, Wei K, Song T, Du Z, Feng Z, Shi W. KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/6000925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
971 Long Y, Chen R, Yu X, Tong Y, Peng X, Li F, Hu C, Sun J, Gong L. Suppression of tumor/host intrinsic CMTM6 drives anti-tumor cytotoxicity in a PD-L1 independent manner.. [DOI: 10.1101/2022.05.06.490847] [Reference Citation Analysis]
972 Eryi S, Zheng L, Honghua C, Su Z, Han X, Donggang P, Zhou Z, Liping Z, Bo C, Wang J. HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-β/Smad Signaling Pathway and Predicts a Poor Prognosis in Glioblastoma. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/8016102] [Reference Citation Analysis]
973 Zhu J, Jiang C, Hui H, Sun Y, Tao M, Liu Y, Qian X, Mei J. Overexpressed lncRNA LINC00893 Suppresses Progression of Colon Cancer by Binding with miR-146b-3p to Upregulate PRSS8. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/8002318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
974 Lu X, Wang J, Wang W, Lu C, Qu T, He X, Liu X, Guo R, Zhang E. Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer. Oncogene 2022. [PMID: 35508543 DOI: 10.1038/s41388-022-02292-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
975 Wang X, Lu X, Wang P, Chen Q, Xiong L, Tang M, Hong C, Lin X, Shi K, Liang L, Lin J. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. J Transl Med 2022;20:198. [PMID: 35509101 DOI: 10.1186/s12967-022-03399-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
976 Shen Q, Han Y, Wu K, He Y, Jiang X, Liu P, Xia C, Xiong Q, Liu R, Chen Q, Zhang Y, Zhao S, Yang C, Chen Y. MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling. Signal Transduct Target Ther 2022;7:147. [PMID: 35504869 DOI: 10.1038/s41392-022-00945-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
977 Vajen B, Bhowmick R, Greiwe L, Schäffer V, Eilers M, Reinkens T, Stalke A, Schmidt G, Fiedler J, Thum T, DeLuca DS, Hickson ID, Schlegelberger B, Illig T, Skawran B. MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation. Int J Mol Sci 2022;23:5131. [PMID: 35563522 DOI: 10.3390/ijms23095131] [Reference Citation Analysis]
978 Su Y, Xu B, Shen Q, Lei Z, Zhang W, Hu T. LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma. Front Immunol 2022;13:788375. [PMID: 35273591 DOI: 10.3389/fimmu.2022.788375] [Reference Citation Analysis]
979 Hu S, Zhang J, Guo G, Zhang L, Dai J, Gao Y. Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma. PLoS One 2022;17:e0267117. [PMID: 35482720 DOI: 10.1371/journal.pone.0267117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
980 De Marchi F, Okuda M, Morishita S, Imai M, Baba T, Horino M, Mori Y, Furuya C, Ogata S, Yang Y, Ando J, Ando M, Araki M, Komatsu N. Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms. Leukemia Research 2022. [DOI: 10.1016/j.leukres.2022.106883] [Reference Citation Analysis]
981 Liang D, Yu C, Ma Z, Yang X, Li Z, Dong X, Qin X, Du L, Li M. Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning. Acta Pharm Sin B 2022;12:2429-42. [PMID: 35646536 DOI: 10.1016/j.apsb.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
982 Ouyang J, Qin G, Liu Z, Jian X, Shi T, Xie L. ToPP: Tumor online prognostic analysis platform for prognostic feature selection and clinical patient subgroup selection. iScience 2022;25:104190. [DOI: 10.1016/j.isci.2022.104190] [Reference Citation Analysis]
983 Song J, Song H, Wei H, Sun R, Tian Z, Peng H. Requirement of RORα for maintenance and antitumor immunity of liver-resident natural killer cells/ILC1s. Hepatology 2022;75:1181-93. [PMID: 34510508 DOI: 10.1002/hep.32147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
984 Bi L, Jia S, Hu W, Su X, Chen X, Tang H. Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia. BMC Med Genomics 2022;15:101. [PMID: 35501867 DOI: 10.1186/s12920-022-01251-7] [Reference Citation Analysis]
985 Albogami S. Comprehensive Analysis of Gene Expression Profiles to Identify Differential Prognostic Factors of Primary and Metastatic Breast Cancer. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.103318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
986 Shi Y, Shen M, Xu M, Tao M, Chen K, Zhu Q. Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast Cancer. IJGM 2022;Volume 15:4925-36. [DOI: 10.2147/ijgm.s350971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
987 Heyliger SO, Soliman KFA, Saulsbury MD, Reams RR. Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Finger Proteins in Clear Cell Renal Carcinoma. Cancer Genomics Proteomics 2022;19:305-27. [PMID: 35430565 DOI: 10.21873/cgp.20322] [Reference Citation Analysis]
988 Yang Y, Li J, Tang M, Nie B, Huang W. Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma. CMAR 2022;Volume 14:1627-39. [DOI: 10.2147/cmar.s364346] [Reference Citation Analysis]
989 Bao Z, Cheng J, Zhu J, Ji S, Gu K, Zhao Y, Yu S, Meng Y. Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival. IJGM 2022;Volume 15:4959-74. [DOI: 10.2147/ijgm.s354826] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
990 Zhang G. Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma. JHC 2022;Volume 9:423-36. [DOI: 10.2147/jhc.s363200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
991 Chen Z, Qi L, Fu H, Ma L. Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase. Bioengineered 2022;13:14013-27. [PMID: 35723009 DOI: 10.1080/21655979.2022.2086382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
992 Li K, Niu Y, Yuan Y, Qiu J, Shi Y, Zhong C, Qiu Z, Li K, Lin Z, Huang Z, Zhang C, Zuo D, He W, Yuan Y, Li B. Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene. [DOI: 10.1038/s41388-022-02334-6] [Reference Citation Analysis]
993 Dutta M, Das B, Mohapatra D, Behera P, Senapati S, Roychowdhury A. MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. Life Sci 2022;301:120592. [PMID: 35504332 DOI: 10.1016/j.lfs.2022.120592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
994 Ajucarmelprecilla A, Pandi J, Dhandapani R, Ramanathan S, Chinnappan J, Paramasivam R, Thangavelu S, Mohammed Ghilan A, Aljohani SAS, Oyouni AAA, Farasani A, Altayar MA, Althagafi HAE, Alzahrani OR, Durairaj K, Shrestha A. In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-12. [DOI: 10.1155/2022/6316158] [Reference Citation Analysis]
995 Luo Y, Huang S, Wei J, Zhou H, Wang W, Yang J, Deng Q, Wang H, Fu Z. Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1-Wnt/β-catenin-TFE3 feedback loop signalling. Clin Transl Med 2022;12:e752. [PMID: 35485210 DOI: 10.1002/ctm2.752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
996 Lyu C, Niu Y, Lai W, Wang Y, Wang Y, Dai P, Ma C, Chen S, Li Y, Jiang G, Liang Z, Ma W, Gao Z, Tong WM, Wang H. Rare and misincorporated DNA N6-methyladenine is a hallmark of cytotoxic stresses for selectively stimulating the stemness and proliferation of glioblastoma cells. Cell Discov 2022;8:39. [PMID: 35501312 DOI: 10.1038/s41421-022-00399-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
997 Zhou X, Shen G, Ren D, Guo X, Han J, Guo Q, Zhao F, Wang M, Dong Q, Li Z, Zhao J. Expression and clinical prognostic value of CYB561 in breast cancer. J Cancer Res Clin Oncol 2022. [PMID: 35486183 DOI: 10.1007/s00432-022-03928-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
998 Rehman AU, Olsson PO, Akhtar A, Padhiar AA, Liu H, Dai Y, Gong Y, Zhou Y, Khan N, Yang H, Tang L. Systematic molecular analysis of the human secretome and membrane proteome in gastrointestinal adenocarcinomas. J Cell Mol Med 2022. [PMID: 35488454 DOI: 10.1111/jcmm.17338] [Reference Citation Analysis]
999 Fang W, Gan Y, Zhang L, Xiong J. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma. Front Oncol 2022;12:853026. [DOI: 10.3389/fonc.2022.853026] [Reference Citation Analysis]
1000 Zhao Y, Chen P, Lv HJ, Wu Y, Liu S, Deng X, Shi B, Fu J. Comprehensive Analysis of Expression and Prognostic Value of Selenoprotein Genes in Thyroid Cancer. Genet Test Mol Biomarkers 2022;26:159-73. [PMID: 35481968 DOI: 10.1089/gtmb.2021.0123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
1001 Jiang H, Cui J, Chu H, Xu T, Xie M, Jing X, Xu J, Zhou J, Shu Y. Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer. Cell Death Discov 2022;8:235. [PMID: 35487914 DOI: 10.1038/s41420-022-01033-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
1002 Pal A, Shukla A, Das S. The “LINC” in between Δ40p53-miRNA axis in the regulation of cellular homeostasis.. [DOI: 10.1101/2022.04.28.489891] [Reference Citation Analysis]
1003 Wang L, Zhao J, Zhu C, Yang K, Zhu L, Liu Y. Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma. Genes 2022;13:785. [DOI: 10.3390/genes13050785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
1004 Zeng Y, Zhang X, Li F, Wang Y, Wei M. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. J Clin Lab Anal 2022;:e24437. [PMID: 35478418 DOI: 10.1002/jcla.24437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1005 Luan H, He Y, Zhang T, Su Y, Zhou L. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma. BMC Cancer 2022;22:463. [PMID: 35477379 DOI: 10.1186/s12885-022-09577-2] [Reference Citation Analysis]
1006 Wei R, Zhang H, Cao J, Qin D, Li S, Deng W. Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes. Int J Mol Sci 2022;23:4792. [PMID: 35563183 DOI: 10.3390/ijms23094792] [Reference Citation Analysis]
1007 Wang L, Liu D, Liu S, Liao T, Jiao Y, Jiang X, Wang Y, Chen Y, Ma H, Cai H. Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis. Transl Oncol 2022;21:101435. [PMID: 35483170 DOI: 10.1016/j.tranon.2022.101435] [Reference Citation Analysis]
1008 Fang X, Wang J, Chen J, Zhuang M, Huang T, Chen Z, Huang Y, Zheng B, Wang X. Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer. Front Genet 2022;13:851390. [PMID: 35464847 DOI: 10.3389/fgene.2022.851390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
1009 Xiao X, Shan H, Niu Y, Wang P, Li D, Zhang Y, Wang J, Wu Y, Jiang H. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma. Front Mol Biosci 2022;9:647826. [DOI: 10.3389/fmolb.2022.647826] [Reference Citation Analysis]
1010 Li M, He M, Xu F, Guan Y, Tian J, Wan Z, Zhou H, Gao M, Chong T. Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma. PLoS One 2022;17:e0264553. [PMID: 35245343 DOI: 10.1371/journal.pone.0264553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
1011 Rudzinska-radecka M, Frolova AS, Balakireva AV, Gorokhovets NV, Pokrovsky VS, Sokolova DV, Korolev DO, Potoldykova NV, Vinarov AZ, Parodi A, Zamyatnin AA. In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer. Cells 2022;11:1455. [DOI: 10.3390/cells11091455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
1012 Mehraj U, Sofi S, Alshehri B, Mir MA. Expression pattern and prognostic significance of CDKs in breast cancer: An integrated bioinformatic study. CBM 2022. [DOI: 10.3233/cbm-210186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
1013 Liang LJ, Wang D, Yu H, Wang J, Zhang H, Sun BB, Yang FY, Wang Z, Xie DW, Feng RE, Xu KF, Wang GZ, Zhou GB. Transcriptional regulation and small compound targeting of ACE2 in lung epithelial cells. Acta Pharmacol Sin 2022. [PMID: 35468992 DOI: 10.1038/s41401-022-00906-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1014 Zhang Y, Kadasah S, Xie J, Gu D, Alzahrani MY. Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker. Applied Bionics and Biomechanics 2022;2022:1-14. [DOI: 10.1155/2022/3051907] [Reference Citation Analysis]
1015 Lv Y, Lin W. Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer. Discov Oncol 2022;13:29. [PMID: 35467222 DOI: 10.1007/s12672-022-00489-y] [Reference Citation Analysis]
1016 He RZ, Zheng JH, Yao HF, Xu DP, Yang MW, Liu DJ, Sun YW, Huo YM. ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00117-5. [PMID: 35508435 DOI: 10.1016/j.hbpd.2022.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1017 Wang J, Zhang Y, Wang Q, Wang L, Zhang P. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics. Evid Based Complement Alternat Med 2022;2022:4651432. [PMID: 35449823 DOI: 10.1155/2022/4651432] [Reference Citation Analysis]
1018 Liu N, Chen Y, Yang L, Shi Q, Lu Y, Ma W, Han X, Guo H, Li D, Gan W. Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma. Clin Transl Med 2022;12:e797. [PMID: 35452181 DOI: 10.1002/ctm2.797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1019 Cao Y, Deng S, Yan L, Gu J, Mao F, Xue Y, Qin L, Jiang Z, Cai W, Zheng C, Nie X, Liu H, Sun Z, Shang F, Tao K, Wang J, Wu K, Zhu B, Cai K. The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers. Front Genet 2022;13:818994. [PMID: 35444692 DOI: 10.3389/fgene.2022.818994] [Reference Citation Analysis]
1020 Lesavage BL, Gilchrist AE, Krajina BA, Karlsson K, Smith AR, Karagyozova K, Klett KC, Curtis C, Kuo CJ, Heilshorn SC. Engineered extracellular matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids.. [DOI: 10.1101/2022.04.22.488943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1021 Bacigalupa ZA, Brown WA, Krystofiak ES, Wolf MM, Hongo RA, Landis M, Amason EK, Beckermann KE, Rathmell JC, Rathmell WK. ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma.. [DOI: 10.1101/2022.04.21.489116] [Reference Citation Analysis]
1022 Liao S, Wang K, Zhang L, Shi G, Wang Z, Chen Z, Zhu P, He Q. PRC1 and RACGAP1 are Diagnostic Biomarkers of Early HCC and PRC1 Drives Self-Renewal of Liver Cancer Stem Cells. Front Cell Dev Biol 2022;10:864051. [PMID: 35445033 DOI: 10.3389/fcell.2022.864051] [Reference Citation Analysis]
1023 Rahiminejad S, Maurya MR, Mukund K, Subramaniam S. Modular and mechanistic changes across stages of colorectal cancer. BMC Cancer 2022;22:436. [PMID: 35448980 DOI: 10.1186/s12885-022-09479-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1024 Qin T, Xiao Y, Qian W, Wang X, Gong M, Wang Q, An R, Han L, Duan W, Ma Q, Wang Z. HGF/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR/NGF axis. Cell Death Dis 2022;13:387. [PMID: 35449152 DOI: 10.1038/s41419-022-04799-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
1025 Wang J, Chang H, Su M, Qiao Y, Sun H, Zhao Y, Zhang S, Shan C. Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma. Int J Mol Sci 2022;23:4583. [PMID: 35562974 DOI: 10.3390/ijms23094583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1026 Wang D, Wan B, Zhang X, Sun P, Lu S, Liu C, Zhu L. Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation. BMC Gastroenterol 2022;22:198. [PMID: 35448958 DOI: 10.1186/s12876-022-02260-7] [Reference Citation Analysis]
1027 Yu S, Ma J. Spindle and Kinetochore-Associated Complex is Associated With Poor Prognosis in Adrenocortical Carcinoma. J Surg Res 2022;277:50-9. [PMID: 35460921 DOI: 10.1016/j.jss.2022.03.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
1028 Xu Y, Peng Y, Shen M, Liu L, Lei J, Gao S, Wang Y, Lan A, Li H, Liu S, Raza F. Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients. Journal of Oncology 2022;2022:1-21. [DOI: 10.1155/2022/1525245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
1029 Peschl V, Seitz T, Sommer J, Thasler W, Bosserhoff A, Hellerbrand C. Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis. J Cell Biochem 2022. [PMID: 35442524 DOI: 10.1002/jcb.30248] [Reference Citation Analysis]
1030 Wang R, Guo Y, Ma P, Song Y, Min J, Zhao T, Hua L, Zhang C, Yang C, Shi J, Zhu L, Gan D, Li S, Li J, Su H. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Front Oncol 2022;12:851766. [PMID: 35433474 DOI: 10.3389/fonc.2022.851766] [Reference Citation Analysis]
1031 Liang S, Zhu C, Suo C, Wei H, Yu Y, Gu X, Chen L, Yuan M, Shen S, Li S, Sun L, Gao P. Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5. Front Oncol 2022;12:857968. [PMID: 35433434 DOI: 10.3389/fonc.2022.857968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1032 Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, Tang M, Niu Z, Wang C, Wang Y, Zhang Z, Liang J, Ruan B, Gao L, Chen Z, Melino G, Wang X, Sun Q. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Discov 2022;8:35. [PMID: 35436988 DOI: 10.1038/s41421-022-00387-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
1033 Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, Legrave N, Koenis DS, Koifman G, Sugimoto Y, Llorian Sopena M, MacRae J, Nye E, Howell M, Snijders AP, Prachalias A, Zen Y, Sarker D, Behrens A. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun 2022;13:2070. [PMID: 35440539 DOI: 10.1038/s41467-022-29684-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
1034 Ferreira WAS, Vitiello GAF, da Silva Medina T, de Oliveira EHC. Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas. Sci Rep 2022;12:6442. [PMID: 35440701 DOI: 10.1038/s41598-022-10114-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1035 Sun Q, Ye Y, Gui A, Sun X, Xie S, Zhan Y, Chen R, Yan Y, Gu J, Qiu S, Liu W, Zuo J, Zhang Q, Yang L. MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma. Cancer Lett 2022;:215678. [PMID: 35447282 DOI: 10.1016/j.canlet.2022.215678] [Reference Citation Analysis]
1036 Li Q, Yang H, Wang P, Liu X, Lv K, Ye M. XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03369-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
1037 Zhu Y, Zheng S, Zhai X, Wang C, Liu A, Ju J, Peng X, Chen L, Zhang Y, Ren N, Xie Y, Fan J, Zhao K, Liu M, Zhuo Z. Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/5501476] [Reference Citation Analysis]
1038 Huang M, Dong W, Xie R, Wu J, Su Q, Li W, Yao K, Chen Y, Zhou Q, Zhang Q, Li W, Cheng L, Peng S, Chen S, Huang J, Chen X, Lin T. HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program. Cancer Commun (Lond) 2022. [PMID: 35434944 DOI: 10.1002/cac2.12284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
1039 Chen H, Zhao L, Liu J, Zhou H, Wang X, Fang X, Xia X. Bioinformatic Analyzes of the Association Between Upregulated Expression of JUN Gene via APOBEC-Induced FLG Gene Mutation and Prognosis of Cervical Cancer. Front Med 2022;9:815450. [DOI: 10.3389/fmed.2022.815450] [Reference Citation Analysis]
1040 Yin X, Wu Q, Hao Z, Chen L. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Biomed Eng Online 2022;21:26. [PMID: 35436915 DOI: 10.1186/s12938-022-00995-8] [Reference Citation Analysis]
1041 Cabiati M, Gaggini M, De Simone P, Del Ry S. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression. Clin Exp Metastasis 2022. [PMID: 35429302 DOI: 10.1007/s10585-022-10164-9] [Reference Citation Analysis]
1042 Kang N, Xie X, Zhou X, Wang Y, Chen S, Qi R, Liu T, Jiang H. Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02257-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
1043 Bao J, Xu C, Li B, Wu Z, Shen J, Song P, Peng Q, Hu G. Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma. Front Oncol 2022;12:834728. [PMID: 35425701 DOI: 10.3389/fonc.2022.834728] [Reference Citation Analysis]
1044 Munquad S, Si T, Mallik S, Das AB, Zhao Z. A Deep Learning-Based Framework for Supporting Clinical Diagnosis of Glioblastoma Subtypes. Front Genet 2022;13:855420. [PMID: 35419027 DOI: 10.3389/fgene.2022.855420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
1045 Zhang G, Li T, Tan G, Song Y, Liu Q, Wang K, Ai J, Zhou Z, Li W. Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma. Cancer Medicine. [DOI: 10.1002/cam4.4623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
1046 Fei X, Xie X, Qin R, Wang A, Meng X, Sun F, Zhao Y, Jiang D, Chen H, Huang Q, Ji X, Wang Z. Proteomics analysis: inhibiting the expression of P62 protein by chloroquine combined with dacarbazine can reduce the malignant progression of uveal melanoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09499-z] [Reference Citation Analysis]
1047 Troike KM, Silver DJ, Ghosh PK, Mulkearns-hubert EE, Hubert CG, Connor JR, Fox PL, Kristensen BW, Lathia JD. Tumor cell-intrinsic HFE drives glioblastoma growth.. [DOI: 10.1101/2022.04.13.487917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1048 Wu Q, Zheng Z, Zhang J, Piao Z, Xin M, Xiang X, Wu A, Zhao T, Huang S, Qiao Y, Zhou J, Xu S, Cheng H, Wu L, Ouyang K. Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma. Front Oncol 2022;12:862751. [DOI: 10.3389/fonc.2022.862751] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1049 Liu W, Zhang Y, Huang F, Ma Q, Li C, Liu S, Liang Y, Shi L, Yao Y. The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility. Front Oncol 2022;12:772405. [DOI: 10.3389/fonc.2022.772405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
1050 Chen L, Shi Z, Deng L, Wu J, Wang H, Lu Y, Fan T, Lu J, Huang W, Hu K. Construction of MicroRNA-mRNA Regulatory Network in the Molecular Mechanisms of Bleomycin-Induced Pulmonary Fibrosis. Biomed Res Int 2022;2022:7367328. [PMID: 35402615 DOI: 10.1155/2022/7367328] [Reference Citation Analysis]
1051 He Z, Xu J, Shi H, Wu S. m5CRegpred: Epitranscriptome Target Prediction of 5-Methylcytosine (m5C) Regulators Based on Sequencing Features. Genes 2022;13:677. [DOI: 10.3390/genes13040677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1052 Obinata D, Funakoshi D, Takayama K, Hara M, Niranjan B, Teng L, Lawrence MG, Taylor RA, Risbridger GP, Suzuki Y, Takahashi S, Inoue S. OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer. Sci Rep 2022;12:6094. [PMID: 35413990 DOI: 10.1038/s41598-022-10099-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1053 Marsland M, Dowdell A, Jiang CC, Wilmott JS, Scolyer RA, Zhang XD, Hondermarck H, Faulkner S. Expression of NGF/proNGF and Their Receptors TrkA, p75NTR and Sortilin in Melanoma. Int J Mol Sci 2022;23:4260. [PMID: 35457078 DOI: 10.3390/ijms23084260] [Reference Citation Analysis]
1054 Li Z, Wang R, Qiu C, Cao C, Zhang J, Ge J, Shi Y. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment. Front Immunol 2022;13:834606. [PMID: 35392073 DOI: 10.3389/fimmu.2022.834606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1055 Chen C, Bao H, Lin W, Chen X, Huang Y, Wang H, Yang Y, Liu J, Lv X, Teng L. ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer. J Cancer 2022;13:1985-2000. [PMID: 35399734 DOI: 10.7150/jca.69544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1056 Lin S, Xu H, Pang M, Zhou X, Pan Y, Zhang L, Guan X, Wang X, Lin B, Tian R, Chen K, Zhang X, Yang Z, Ji F, Huang Y, Wei W, Gong W, Ren J, Wang JM, Guo M, Huang J. CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma. Front Oncol 2022;12:831268. [DOI: 10.3389/fonc.2022.831268] [Reference Citation Analysis]
1057 Chen S, Zhao Z, Wang X, Zhang Q, Lyu L, Tang B. The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis. Front Mol Biosci 2022;9:809509. [DOI: 10.3389/fmolb.2022.809509] [Reference Citation Analysis]
1058 Veatch JR, Lee SM, Shasha C, Singhi N, Szeto JL, Moshiri AS, Kim TS, Smythe K, Kong P, Fitzgibbon M, Jesernig B, Bhatia S, Tykodi SS, Hall ET, Byrd DR, Thompson JA, Pillarisetty VG, Duhen T, McGarry Houghton A, Newell E, Gottardo R, Riddell SR. Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function. Cancer Cell 2022;40:393-409.e9. [PMID: 35413271 DOI: 10.1016/j.ccell.2022.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
1059 Yao Y, Li Z, Gao W. Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis. Front Genet 2022;13:855789. [DOI: 10.3389/fgene.2022.855789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1060 Lin Z, Zhang Z, Zheng H, Xu H, Wang Y, Chen C, Liu J, Yi G, Li Z, Wang X, Huang G. Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma. Cancer Cell Int 2022;22:151. [PMID: 35410293 DOI: 10.1186/s12935-021-02373-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1061 Wang W, He Y, Zhai LL, Chen LJ, Yao LC, Wu L, Tang ZG, Ning JZ. m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Epigenetics 2022;:1-15. [PMID: 35404184 DOI: 10.1080/15592294.2022.2061117] [Reference Citation Analysis]
1062 Tian L, Long F, Hao Y, Li B, Li Y, Tang Y, Li J, Zhao Q, Chen J, Liu M. A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning. Front Med 2022;9:880326. [DOI: 10.3389/fmed.2022.880326] [Reference Citation Analysis]
1063 Shi H, Xu H, Chai C, Qin Z, Zhou W. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24381] [Reference Citation Analysis]
1064 Zhou Y, Yong H, Cui W, Chu S, Li M, Li Z, Bai J, Zhang H. Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9. Cell Death Discov 2022;8:192. [PMID: 35410446 DOI: 10.1038/s41420-022-01004-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1065 Karlsson K, Przybilla M, Xu H, Kotler E, Karagyozova K, Sockell A, Liu K, Mah A, Lo Y, Lu B, Houlahan KE, Khan A, Ma Z, Suarez CJ, Barnes CP, Kuo CJ, Curtis C. Experimental evolution in TP53 deficient human gastric organoids recapitulates tumorigenesis.. [DOI: 10.1101/2022.04.09.487529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1066 Lin A, Qi C, Wei T, Li M, Cheng Q, Liu Z, Luo P, Zhang J. CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Brief Bioinform 2022:bbac129. [PMID: 35395670 DOI: 10.1093/bib/bbac129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
1067 Peng T, Chen DL, Chen SL. LINC01088 promotes the growth and invasion of glioma cells through regulating small nuclear ribonucleoprotein polypeptide A transcription. Bioengineered 2022;13:9172-83. [PMID: 35392763 DOI: 10.1080/21655979.2022.2051786] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1068 Bao ZM, Yao D, Qian X, Zhang HG, Yang M, Guo YH, Qin L. Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the WHSC1-mediated TOP2A/PI3K/AKT axis. Kaohsiung J Med Sci 2022. [PMID: 35394699 DOI: 10.1002/kjm2.12536] [Reference Citation Analysis]
1069 Liu Y, Wang D, Li Z, Li X, Jin M, Jia N, Cui X, Hu G, Tang T, Yu Q. Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors. Sci Rep 2022;12:5924. [PMID: 35395865 DOI: 10.1038/s41598-022-09889-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1070 Khan MM, Mohsen MT, Malik MZ, Bagabir SA, Alkhanani MF, Haque S, Serajuddin M, Bharadwaj M. Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods. Genes 2022;13:655. [DOI: 10.3390/genes13040655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
1071 Chen S, Zhang Y, Ding X, Li W. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarker